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When a person realizes he has been deeply heard, his eyes moisten.  
I think in some sense he is weeping for joy. It is as though he were saying 
“Thank God somebody heard me.  
Someone knows what it’s like to be me” 
~Carl Rogers 
 
 
I do have to say this is one of the first times anyone in a medical setting has asked me my 
perception of the disorder I have, which is one of the things I had a really hard time 
understanding. Especially whenever I would tell the doctor my understanding of my disorder and 
they would tell me that I was wrong and not want to listen. So I think that’s already extremely 
important, and I’m very happy someone even bothered to ask. 
-Participant D 
 
 
Because if people find out they look at you differently. They look at you like they’re waiting for 
something to happen, like a crazy person. They look at you like you’re just weird. And it’s 
totally different. And it sucks. Honestly, it’s deplorable. I’m kind of glad you’re doing this 
research study because maybe it’ll go viral and a whole bunch of people will read it, and think 
differently about the things that they say… 
-Participant E 
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Abstract 
While early-onset bipolar disorder (EOBD) has increased in prevalence, much remains to be 
understood about its phenomenology. Research and treatment models remain rooted in 
neurobiological conceptualizations of the illness that borrow heavily from models for the 
traditional adult-onset form of bipolar disorder. This study utilized a transcendental 
phenomenological design as a first step in obtaining an understanding of the lived experience of 
EOBD. A purposive sample of eight participants ages 18-25 participated in semi-structured 
interviews that elicited information on experiences of EOBD symptomatology and course of 
illness, stigma, experience with healthcare and treatment, and impact on identity, interpersonal 
relationships, and coping responses. Transcendental phenomenological analysis was used to 
construct individual and composite descriptions of participants’ experience of EOBD between 
ages 13 and 17. Implications of findings are presented for research and treatment of EOBD, as 
well as social work education and policy reform.  
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Chapter One: Introduction 
Bipolar disorder is a significant, pervasive mental disorder comprised of a spectrum of 
manic and depressive symptoms manifested during episodic mood states (American Psychiatric 
Association, 2013; Price & Marzani-Nissen, 2012). While symptoms may remit partially or in 
full between episodes, bipolar disorder has an unremitting longitudinal course. Bipolar disorder 
is associated with significant and pervasive impairments in occupational, educational, 
interpersonal, and daily functioning that persist across the lifespan.  
Bipolar disorder has historically been conceptualized and operationalized across research 
and clinical settings as an adult disorder, with the onset and course of symptoms diagnosed and 
treated after 18 years of age (Garnham et al., 2007). However, bipolar symptoms often begin in 
adolescence. Twenty-eight percent of adults with bipolar disorder report experiencing manic and 
depressive symptoms prior to age 13, and 66% of adults with bipolar disorder report 
experiencing symptoms prior to age 18 (Perlis et al., 2004). Early-onset bipolar disorder 
(EOBD), in which the illness manifests in full prior to age 18, is regarded as potentially difficult 
to diagnose accurately and treat effectively; this is largely due to dispute regarding diagnostic 
criteria, nosology, and treatment interventions for the juvenile population (Ghaemi & Martin, 
2007).  
The impact of bipolar disorder extends beyond its symptoms and affects the individual’s 
sense of self, identity, and self-esteem. The stigma of bipolar disorder is reflected through the 
individuals’ sense of loss of control over their lives due to persistent symptoms, self-blame for 
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symptoms, and believing a healthy sense of self is contingent upon successful symptom 
management (Crowe et al., 2012).  
Bipolar disorder influences psychosocial development extending through adolescence 
and into emerging adulthood. The presence of patterns of conflict, communication, and support 
within the family system and peer relationships during adolescence impact not only psychosocial 
functioning during adolescence but identity development, relationships, and goal attainment 
during the period of emerging adulthood (Aquilino, 2006; Arnett, 2006a; Collins & van Dulmen, 
2006; Miklowitz, 2008). Protective factors in peer and family relationships, including reappraisal 
support, validation, and increased capacity to build intimacy facilitate adjustment and acceptance 
of bipolar disorder and counteract the inception of associated stigma and self-stigma (Dahl, 
2004; Doherty & MacGeorge, 2012).  
Theoretical Underpinnings 
 To achieve a more accurate and thorough understanding of the phenomenology of 
EOBD, the incorporation of multiple theoretical frameworks is needed. A greater understanding 
of the individual course of illness and treatment response, family history and functioning, and 
biological markers can improve diagnosis and treatment of EOBD (Ghaemi and Martin, 2007).  
Theories of neurology and biology, stigma, and interpersonal functioning provide both 
explanatory and predictive properties to better understand the etiology, nosology, prognosis, 
course of illness, and associated psychological and developmental changes in functioning 
incurred by EOBD. 
 Neurological and biological theories have largely dominated the study of bipolar 
disorder. Neurobiological theories propose a bipolar disorder etiology consisting of biological 
vulnerabilities such as smaller amygdala volumes (Bitter et al., 2011), enlarged portions of the 
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basal ganglia (Ahn et al., 2007), variances in limbic volumes (Frazier et al., 2008), and different 
psychophysiological responses to stimuli for frustration and reward (Alloy et al., 2012b; Rich et 
al., 2007).  Much of the cumulative literature has been devoted to identifying biological or 
genetic risk factors for bipolar disorder, including patterns of heredity and factors associated with 
onset of symptoms (Alloy et al., 2012a; Berk et al., 2009; Daban, Colom, Sanchez-Moreno, 
García-Amador, & Vieta,  2006; Goldstein, 2012). 
 While neurobiological theories address the etiology of bipolar disorder, they offer limited 
contributions toward other facets of the phenomenology of bipolar disorder. Individuals with 
bipolar disorder are subject to critical and judgmental messages from both external and internal 
sources, affecting developmental processes such as development of identity and self-esteem 
(Moses, 2009). Indeed, modified labeling theory describes stigma as the byproduct of the social 
exchange between the individuals with bipolar disorder and larger society. Furthermore, higher 
levels of stigma and self-stigma correlate with poorer prognosis, management of the illness, 
recovery between episodes, and overall functioning in individuals with bipolar disorder (Alreja, 
Mishra, Sengar, & Singh, 2009; Cerit, Filizer, Tural, & Tufan, 2012; Moses, 2009). 
 The theory of emerging adulthood offers explanatory properties for the experience of 
early-onset bipolar disorder in the present study’s sample. Theory of emerging adulthood 
identifies a unique and distinct period between adolescence and adulthood (between ages 18-25), 
characterized by increased opportunity and independence, as well as a lack of stability regarding 
attainment of adult goals. This conflict includes struggles in building relationships and intimacy, 
identity development, and goal attainment (Arnett, 2006a; Bynner, 2005).  
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Gaps in Cumulative and Existing Research 
The literature on EOBD is characterized by efforts to conceptualize bipolar disorder and 
prescribe appropriate interventions for the juvenile population. This movement, however, has 
occurred largely without the inclusion of the qualitative perspectives of the individuals with an 
EOBD diagnosis. This may be due in part to the domination of clinical research by the medical 
sciences; however, even within the medical sciences, various authors (Parry & Levin, 2012; 
Sullivan & Miklowitz, 2010) have stated the need for qualitative research to explore the full 
phenomenon of bipolar disorder. Current literature includes quantitative inquiries into 
epidemiology (e.g., Goldstein, 2012; Harris, 2005), differential diagnosis (e.g., Carlson, 2012; 
Galanter et al., 2012), psychopharmacology (e.g., Dusetzina et al., 2011; Raven & Parry, 2012) 
and prognosis of EOBD (e.g., Axelson et al., 2011; Berk et al., 2009; Daban et al., 2006; Perlis et 
al., 2004), but does not incorporate the perspectives of the individuals with the disorder. One 
exception is a study by Moses (2009) that combined both qualitative and quantitative data from 
54 adolescents with various mental illnesses. While the interviews and standardized measures 
created a more thorough understanding of the adolescents’ experiences with stigma and self-
labeling through interviews and standardized measures, the study was not specific to EOBD. 
These limitations notwithstanding, the literature to date has not incorporated such qualitative 
approaches to better understand adolescents’ experiences of mental health. 
Moreover, while the literature on bipolar disorder references the importance of 
interventions to address families and stigma (Heflinger & Hinshaw, 2010; Perlick et al., 2007; 
Perlick et al., 2008), these studies focus on adult-onset bipolar disorder and incorporate 
quantitative approaches to evaluate the effectiveness of interventions (e.g., Brown, Rempfer, & 
Hamera, 2008; Struening et al., 2001) rather than eliciting the first-person experience of bipolar 
5 
disorder. Aquilino (2006) highlights the absence of qualitative inquiries in research on emerging 
adulthood incorporating both clinical and community samples. 
Purpose of the Study 
The purpose of the present qualitative study is to explore the experience of EOBD 
through semi-structured interviews of emerging adults with a history of EOBD diagnosis. Semi-
structured interviews will elicit a deeper knowledge of EOBD through participants’ descriptive 
accounts. First-person qualitative reports are perhaps the most important and overlooked 
resource in the search to conceptualize and treat EOBD. This study will address aspects of 
EOBD such as onset, diagnosis, and experience of symptoms; psychosocial and identity 
development; stigma; treatment interventions; and developmental changes occurring through 
emerging adulthood. 
Research questions 
This qualitative study will address the following research questions:  
1) How do emerging adults (ages 18-25)  describe the experience of EOBD during 
adolescence (ages 13-17) in terms of experience of symptoms; changes in individual, 
social, and family functioning caused by course of illness; and the experience and 
perception of stigma and self-stigma? 
2) How do emerging adults (ages 18-25) characterize the cumulative influence of 
interactions with healthcare systems and treatment interventions on their experience of 
EOBD? 
3) What are the characteristics of the relationship between EOBD, social and family 
relationships and the developmental transition to adulthood according to emerging 
adults? 
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4) How have stigma and self-stigma associated with EOBD affected the social, emotional, 
and cognitive development of emerging adults ages 18-25? 
Relevance and Significance of Study 
 Within the last 20 years, the prevalence of bipolar disorder diagnoses prior to age 18 has 
increased at a rate disproportionate to our understanding of its phenomenology (Carlson, 2012; 
Ghaemi & Martin, 2007; Harris, 2005; Moreno et al., 2007). The cumulative literature illustrates 
efforts not only to establish the etiology and nosology of EOBD, but also to develop treatment 
interventions for the juvenile population.  
 Social workers are present throughout the healthcare system in hospital, outpatient, and 
intensive treatment settings as an integral part of treatment approaches for individuals with 
bipolar disorder and their families. Interventions incorporating the multitheoretical framework of 
neurobiological, modified labeling, and developmental theories specific to the unique 
phenomenology of EOBD are needed to improve treatment outcomes (Brown et al.  2008; 
Corrigan, Powell & Rüsch, 2012).  Limitations in the development and delivery of psychosocial 
rehabilitation interventions targeted to issues of stigma, individual and family functioning, and 
symptom management are emphasized throughout the literature (Camp, Finlay, & Lyons, 2002; 
Cerit et al., 2012; Crowe et al., 2012; Davis, Kurzban, & Brekke, 2012; Heflinger & Hinshaw, 
2010). Several researchers have identified the need to improve understanding of the 
phenomenology of EOBD through qualitative research with adolescents and their families 
(Moses, 2009; Sullivan & Miklowitz, 2010). 
 This study constitutes an important first step in improving conceptualization and 
treatment of EOBD by providing a more accurate and thorough phenomenology of EOBD from 
the perspective of emerging adults with history of EOBD diagnosis. The integration of multiple 
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theoretical frameworks will create a comprehensive perspective from which to understand 
EOBD. Study conclusions and implications will address gaps in existing research and better 
inform the development of theory and therapeutic interventions for EOBD.   
Definitions 
 Bipolar disorder. Bipolar disorder is a mental illness comprised of a longitudinal pattern 
of depressive and manic or hypomanic episodes (APA, 2013). Bipolar I disorder consists of a 
cyclical progression of manic and depressive episodes, while bipolar II disorder consists of a 
similar progression of hypomanic and depressive episodes in the absence of manic symptoms 
(APA, 2013). 
 A manic episode is defined by the presence of “abnormally and persistently elevated, 
expansive, or irritable mood and abnormally and persistently increased goal-directed activity or 
energy” (APA, 2013, p. 124). Manic episodes last a minimum of one week in duration and 
include behavior changes such as grandiosity, decreased need for sleep, pressured speech, racing 
thoughts and flight of ideas, distractibility, increase in psychomotor activity and agitation, and 
excessive involvement in reckless activities with high potential for adverse consequences. 
Symptoms must be severe enough to cause impairment of the individual’s normal functioning 
and cannot be attributed solely to a medical condition or substance (APA, 2013). 
 A hypomanic episode is defined by the presence of manic symptoms at a lesser severity, 
such that the individual’s ability to function is not as fully impaired as in a manic episode. 
Additionally, the minimum duration of a hypomanic episode is 4 days, compared with the one 
week minimum duration for a manic episode. Hypomanic episodes occur in both bipolar I and II 
disorders and often are preceded or followed by depressive episodes (APA, 2013). 
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 A depressive episode lasts for a minimum of two weeks and includes the following 
symptoms: depressed mood (sadness, hopelessness, tearfulness), diminished interest or pleasure 
in almost all activities, unintended weight gain or loss (5% or more of body weight within a one-
month period), insomnia or hypersomnia, psychomotor agitation or retardation, fatigue, feelings 
of worthlessness or inappropriate guilt, diminished ability to think or concentrate, and recurrent 
thoughts of death or suicidal ideation. Depressive episodes cause significant distress and 
impairment in the individual’s ability to function and similarly cannot be solely caused by a 
medical condition or substance.  Bipolar disorder may additionally include atypical features such 
as episodes with concurrent (“mixed”) manic and depressive features, rapid cycling, psychosis, 
catatonia, and a seasonal presentation of symptoms (APA, 2013).  
 Early-onset bipolar disorder. Early-onset bipolar disorder (EOBD) is defined as the 
presence of bipolar disorder symptomatology (depressive and manic or hypomanic episodes) 
manifested in full prior to age 18 (APA, 2013). While each individual’s presentation of bipolar 
symptoms and course of illness may vary (i.e.,  increased incidence of rapid cycling, episodes 
with mixed manic-hypomanic and depressive symptoms, and increased risk of suicide in the 
juvenile population), the diagnostic criteria for bipolar disorder, regardless of age of onset, 
persists across the lifespan (Perlis et al., 2004). In the fifth edition of its Diagnostic and 
Statistical Manual of Mental Disorders (DSM-5, 2013), the APA further emphasized the 
longitudinal congruence of bipolar disorder with the introduction of Disruptive Mood 
Dysregulation Disorder (DMDD, discussed below) to categorize disturbances in affect occurring 
in childhood and adolescence that do not meet criteria for full bipolar symptomatology. 
 Stigma. Stigma is defined as stereotypes, discrimination, and devaluation associated with 
a condition or trait perceived as negative (Corrigan, 2005). While stigma originates from external 
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sources such as stereotypes and beliefs of the general population, self-stigma occurs when the 
individual internalizes stigmatizing beliefs as self-directed criticism (Corrigan et al., 2012). 
Through stigma, individuals are devalued due to their membership in an undesirable or defective 
group with low social power. Stigma has been shown to increase the subjective burden of mental 
illness while negatively affecting the help-seeking behaviors and functioning of both individuals 
and families (Heflinger & Hinshaw, 2010; Perlick et al., 2008; Struening et al., 2001). 
 Emerging adulthood. Emerging adulthood is defined as a distinct developmental stage 
occurring between ages 18-25 that spans the gap between adolescence and adulthood (Arnett, 
1999). Emerging adulthood is a time of exploration of identity, interpersonal relationships, and 
goal attainment occurring alongside increased independence and agency in decision-making 
responsibilities (Arnett, 2006a, 2006b). As emerging adults, the participants’ experience of 
bipolar disorder during adolescence will be recent; therefore, participants will be able to 
accurately recall the adolescent experience of EOBD while providing the insight and cognitive 
depth associated with emerging adulthood. The resulting phenomenological data will 
significantly enrich and expand upon current understanding of the phenomenology of EOBD. 
Delimitations 
 This study seeks to better understand the phenomenology of EOBD as defined above. 
Several issues therefore fall outside the scope of this study. These issues are present across the 
debate within the literature regarding nosology, differential diagnosis, and etiology of EOBD. 
 Phenotype controversy. Much of the literature on EOBD has reflected the nosological 
debate between the narrow phenotype and broad phenotype definitions of bipolar disorder. The 
narrow phenotype, preserved by the APA (2013) in DSM-5, specifies an episodic course of 
illness comprised of distinct manic and depressive symptoms that differ significantly from the 
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individual’s baseline functioning. The broad phenotype incorporates a more inclusive 
presentation of a continuous, non-episodic course of persistent irritability and affective instability 
that may be difficult to distinguish from the individual’s personality and functioning (Ghaemi & 
Martin, 2007). This study adheres to the DSM-5 definition of bipolar disorder and does not 
incorporate the more inclusive broad phenotype conceptualization of EOBD. 
 Disruptive mood dysregulation disorder. In the DSM-5, the APA (2013) introduced a 
new diagnosis, Disruptive Mood Dysregulation Disorder (DMDD), as an alternative to a broad 
phenotype diagnosis of EOBD.  DMDD is included in DSM-5 solely as an alternative diagnosis 
for the severe, non-episodic irritability and affective instability that has frequently been 
misdiagnosed as EOBD. Whereas an adolescent with EOBD experiences manic and depressive 
episodic mood states, an adolescent with DMDD experiences anger outbursts and continuous 
irritability in the absence of the episodic bipolar mood states. The APA states a prevalence of 
DMDD in 2-5% of children and adolescents, compared with EOBD prevalence of less than 1% 
prior to age 18 (p. 157). 
 DMDD and EOBD are defined as mutually exclusively occurring disorders, and as such 
cannot be diagnosed in the same individual (APA, 2013). This study explores the 
phenomenology of EOBD; and as such, selected only participants with an EOBD diagnosis 
during adolescence. 
 Heritability and genetic risk factors. The family system has been extensively 
incorporated into bipolar disorder research. Much of this research, however, has focused on 
heritability and genetic predisposition to bipolar disorder. This study does not address or explore 
the presence or heritability of psychiatric symptomatology in family members. 
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Chapter Two: Literature Review 
 This literature review will address two main areas related to the phenomenology of 
EOBD. First, theoretical frameworks will be reviewed as they relate to EOBD among 
adolescents and their caregivers. Second, pertinent domains such as the identity development and 
perception of self, interactions with the healthcare system, and stigma will be examined. Gaps in 
the literature will be discussed and research questions will be presented.  
Theoretical Framework 
 This section reviews the neurobiological, modified labeling, and emerging adulthood 
theoretical frameworks that guide and inform this study’s design.  
 Neurobiological theories. Neurobiological theories offer causal explanations for the 
presence and development of bipolar disorder symptomatology. Neurobiological theories address 
physical abnormalities of the brain, dysregulation of neurotransmitters, and dysfunction of brain 
activity. 
 Structural brain irregularities. Research utilizing neurobiological testing indicates 
several brain structural abnormalities are associated with bipolar disorder. Ahn et al. (2007) 
reported an association between increased volume of nucleus accumbens (NA), a basal ganglia 
(BG) structure, and EOBD diagnosis in participants age 6-16. Ahn et al. reported psychotropic 
medications were negatively correlated with decreased structural abnormality, possibly 
illustrating the effect of pharmacological interventions on bipolar disorder. Frazier et al. (2008) 
reported findings indicating not only larger NA volumes in participants ages 6-17 with EOBD, 
but also smaller left and right cerebral volumes. Bitter et al. (2011) reported abnormal 
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development of the amygdala in participants age 12-17 following onset of EOBD 
symptomatology. While amygdala volume was within normal limits at onset of EOBD 
symptomatology, volume did not increase as expected during the first year with active 
symptomatology. These findings are consistent with structural abnormalities of the prefrontal 
cortex, BG, hippocampus, anterior cingulate, and amygdala associated with adult-onset bipolar 
disorder (Miklowitz & Johnson, 2006). 
 Brain activity dysfunction. In addition to structural abnormalities, abnormal functioning 
of brain activity is associated with bipolar disorder. Rich et al. (2007) reported significant 
differences in the response to frustration in participants with EOBD that indicate executive 
attention deficits and inability to modulate attention in the presence of increased emotional 
demands. 
 Behavioral approach system (BAS) sensitivity, a type of brain activity dysfunction, is 
highly correlated with EOBD and may predict the onset of symptomatology (Alloy et al., 
2012b). The BAS model is a biobehavioral system activated by goal- or reward-relevant stimuli. 
Behavioral approach system (BAS) activation includes increased motor behavior, incentive-
reward motivation, and positive goal-striving emotions. Individuals with EOBD are likely to 
have a BAS with greater sensitivity and response to environmental cues. Behavioral Approach 
System (BAS) hyperactivation is associated with manic symptoms of bipolar disorder; increased 
reward responsiveness and increased goal-striving may be predictors of onset of bipolar 
symptoms. BAS hypoactivation is associated with depressive symptoms of bipolar disorder. 
Adolescents with greater BAS hyperactivation and hypoactivation had greater incidence of 
development of bipolar disorder. Alloy et al. (2012b) reported 42.1% of adolescent participants 
with high to moderate BAS activity had first-episode onset of bipolar II disorder, while 10.5% 
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experienced first-episode onset of bipolar I disorder within the 4.5 year follow-up period. BAS 
hypersensitivity is therefore associated with vulnerability to onset of EOBD as well as course of 
illness and may offer predictive properties regarding onset of illness. 
 Neurotransmitter dysregulation. Neurotransmitter dysregulation is a primary 
contributing factor to bipolar disorder symptomatology. While manic and depressive symptoms 
of bipolar disorder have been attributed to imbalances in transmission of the chemicals 
dopamine, serotonin, and norepinephrine within the brain, current neurobiological theories focus 
on the functioning of larger neurotransmitter systems. Miklowitz and Johnson (2006) point to the 
interaction of dopamine and serotonin systems with other neurotransmitter systems (such as 
gamma-Aminobutyric acid (GABA)) as causes of manic and depressive symptoms. 
 Manic symptoms such as hyperverbality, heightened mood, increased energy, and sleep 
deprivation are associated with dopamine dysregulation (Miklowitz & Johnson, 2006). 
Dopamine dysregulation is linked to brain functioning associated with reward motivation (i.e., 
BAS) and regions such as the NA (Ahn et al., 2007; Alloy et al., 2012; Frazier et al., 2008), 
indicating an association between the increased sensitivity of dopaminergic pathways and the 
subsequent onset of bipolar disorder symptomatology. While decreased sensitivity of serotonin 
receptors has been associated with mood disorder symptomatology, including bipolar disorder, 
the exact nature of serotonergic system dysregulation remains undefined (Miklowitz & Johnson). 
 Neurobiological theories offer an explanation for EOBD symptomatology and course of 
illness comprised of a complex, interwoven pattern of dysfunction in the brain involving 
neurotransmitters, structural irregularities, and activity disturbances within the brain’s interactive 
systems.  Neurobiological theories continue to strongly influence research and treatment of 
EOBD and bipolar disorder.  
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 Modified labeling theory. Modified labeling theory asserts that individuals with and 
without mental illnesses internalize role behaviors associated with mental illness. While 
individuals with mental illnesses internalize ‘sick’ behaviors, individuals without mental 
illnesses internalize the devaluation and discrimination of those with mental illness. Modified 
labeling theory states that stigma is manifested through devaluation, in which the presence of 
mental illness decreases the perceived value of the individual, and discrimination, in which the 
individual is distanced and ostracized from larger society (Link, Cullen, Struening, Shrout, & 
Dohrenwend, 1989). 
 Modified labeling theory can be used to explain the inception of stigma within the 
healthcare system as well as society. Psychiatric diagnoses assigned by the healthcare profession 
carry labels not only for the behaviors associated with mental illnesses, but also the expectations 
and limitations regarding individual functioning and prognosis. Individuals with mental illnesses 
internalize healthcare providers’ conceptualizations of mental illness. The provision of treatment 
interventions that decrease symptomatology often incorporates labeling practices by healthcare 
professionals that facilitate the inception and perpetuation of stigma. Labeling within the 
healthcare system also produces devaluation and discrimination; the individual with mental 
illness comes to expect rejection from others and subsequently adopts avoidance coping, in 
which potential sources of stigma are avoided (Kroska & Harkness, 2006).  
 Longitudinal effects of stigma and labeling include negative connotation toward mental 
illness, self-blame, social withdrawal, and secrecy that occur independently of the type of mental 
disorder and length of treatment history. Furthermore, stigma may increase risk of relapse of 
mental illness and failure of symptoms to remit, thus contributing to the identity as well as 
mental health of the individual (Link et al., 1989). 
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 Labeling in adolescence. Stigma and labeling associated with mental illness occur with 
adolescents as well as adults. In a study of adolescents with mental illness, Moses (2009) found 
that 37% did not self-label or view themselves as mentally ill. These adolescents described 
psychiatric symptoms and associated behaviors in terms of situational contexts and 
manifestations of identity rather than symptomatic of mental illness. Approximately 42% of 
adolescents reported ambivalence regarding labeling and self-labeling through the healthcare 
system. These ambivalent adolescents identified psychiatric symptoms, yet expressed both 
uncertainty and limited understanding of diagnostic issues and labels from healthcare 
professionals. Ambivalent adolescents displayed a tendency to attribute symptoms and 
psychiatric hospitalizations to identity and personal choices rather than the label of a mental 
disorder. Approximately 20% of adolescents strongly endorsed diagnostic labels. The self-
labeling group displayed a tendency to attach the possessive pronoun “my” to a diagnosis (i.e., 
“my bipolar disorder”), thereby fusing the disorder to their identity. The self-labeling adolescents 
additionally displayed higher levels of self-awareness and insight regarding symptomatic 
behaviors (Moses, 2009). 
 Moses (2009) concluded that adolescents vary regarding their endorsement and 
application of labeling. Self-labeling adolescents reported experiencing more rejection, more 
difficulties in social functioning, and more avoidance coping. Moses hypothesized that 
adolescents’ ambivalence regarding self-labeling may be related to continuing psychological and 
cognitive development, social context, or limited understanding of the phenomenology of mental 
illness. Self-labeling among adolescents was correlated with higher self-stigma and depression. 
Moses asserted that self-labeling in adolescents with mental illness may be demoralizing, 
stigmatizing, and disempowering. While higher levels of public stigma, social rejection, 
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devaluation, discrimination, and depression correlated with self-labeling, it is unknown whether 
self-labeling is the causal factor or by-product of these processes. Depressive symptoms may be 
symptomatic of mental illness as well as an outcome of social rejection and stigma. Furthermore, 
Moses reported that younger age at onset of symptoms was associated with increased self-
labeling; this could be due to increased experience with labeling of the healthcare system, public 
stigma, devaluation, discrimination, or social rejection. While the nature of the relationship 
between labeling and self-labeling in adolescents remains largely undefined, the process of 
labeling and self-labeling is an integral part of the phenomenology of adolescent mental illness. 
 Theory of emerging adulthood. Theory of emerging adulthood asserts that the period 
between ages 18 and 25 is a distinct stage occurring between adolescence and adulthood in 
which increased independence and exploration facilitate growth and development across multiple 
domains. Emerging adulthood encompasses five main features: 1) identity exploration, 2) 
instability regarding life circumstances and decisions; 3) focus on self; 4) feeling ‘in between’ 
adolescence and adulthood; and 5) possibility and optimism of the emerging adults in response to 
increased ability to effect change on their lives (Arnett, 1999; Arnett, 2006a). Factors influencing 
identity development and exploration include life events such as moving out of the family home, 
the formation of new relationships, and choice of occupation; as well as environmental 
influences, the individual’s collective social support, and belief system. (Bynner, 2005; 
Schwartz, Côté, & Arnett, 2005). Emerging adulthood inherently incorporates a perceived sense 
of uncertainty regarding adult tasks such as marriage, beginning a family, and creating a career 
path; and the associated decision-making to attain these goals that requires an established sense 
of identity (Arnett, 2006a). Emerging identity varies culturally and is subjectively defined. 
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Emerging adulthood is considered complete once the individual feels adult goals have been 
attained, thereby completing the transition to adulthood (Arnett, 1999). 
 Emerging adulthood and psychosocial development. Psychosocial development in 
emerging adulthood is characterized by a sense of opportunity and possibilities that include 
changes and developments in family, social, and romantic relationships.  During emerging 
adulthood, the relationship between the emerging adult and the parent changes toward a 
relationship comprised of two adults, rather than a parent and dependent child. This change in 
the parental relationship requires the parent’s acknowledgement of their child as an emerging 
adult in terms of status, independence, and agency. While patterns of parent-child interaction and 
family dynamic during childhood and adolescence influence the parent-child relationship during 
adulthood, this influence weakens as the emerging adult moves further into adulthood. Affection, 
open communication, and mutual respect in family relationships influence identity development 
and exploration in emerging adulthood (Aquilino, 2006). Increased independence in emerging 
adulthood allows emerging adults to detach from unhealthy family relationships and establish 
strong bonds in both peer and romantic relationships (Arnett, 2006b; Aquilino, 2006; Collins & 
van Dulmen, 2006).   
   Emerging adulthood and stigma. Emerging adults remain susceptible to stigma and 
self-stigma, particularly regarding identity development. Components of stigma such as viewing 
oneself self as “less than” others without mental illness, avoidance, and coping methods present 
in adolescence continue through emerging adulthood and present as a challenge to identity 
development. Moreover, emerging adults with mental illness reported difficulty disclosing the 
mental illness, which carries significant implications for relationship building during emerging 
adulthood (Elkington et al. 2012).  
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 Support from relationships in emerging adulthood may be the greatest protective factor 
against stigma and self-stigma. Appraisal support, which encourages the individual to reframe 
situations in a more positive light, is particularly associated with decreased stigma among 
emerging adults with mental illness (Dahl, 2004; Doherty & MacGeorge, 2012).  
 Emerging adulthood and EOBD. Emerging adults with a diagnosis of bipolar disorder 
are more likely to have received the diagnosis in recent years; the majority of cases have onset of 
symptoms and diagnosis between ages 18-25 (Dahl, 2004; McGorry, Purcell, Goldstone, & 
Amminger, 2011). Furthermore, emerging adults’ family and social support, relationship 
building, and efforts to cope with stigma are processes that began during adolescence (Aquilino, 
2006; Elkington et al., 2012).  
 Paradoxically, a positive correlation occurs between mental illness and wellness during 
emerging adulthood; while psychopathology of mental illness increases during emerging 
adulthood, well-being and self-esteem increase as well (Arnett, 2006b; Galambos, Barker, & 
Krahn, 2006; Schulenberg & Zarrett, 2006). Processes that occur in emerging adulthood such as 
increase in social support, commitment to education and goal attainment, and greater sense of 
meaning are associated with increased well-being (Galambos et al., 2006; Schulenberg & Zarrett, 
2006; Steger, Oishi, & Kashdan, 2009). Thus, while emerging adults may encounter the 
difficulties associated with experiencing symptomatology of mental illness, the developmental 
processes occurring during emerging adulthood may provide protective properties and facilitate 
development of healthy identity and relationships (Arnett, 1994; Elkington et al., 2012; 
Schulenberg & Zarrett, 2006). This study’s sample is comprised of emerging adults who offer 
both the recent experience of EOBD symptomatology and the insights of emerging adulthood. 
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 Interpersonal functioning and social support. Social support in bipolar disorder is an 
important component toward maintaining wellness, as it is associated with decreased 
vulnerability to bipolar depressive episodes and a shorter recovery time following symptomatic 
episodes (Johnson et al., 1999). Individuals with bipolar disorder report increased difficulty in 
social activities and interpersonal relationships, including social and family interactions 
(Calabrese et al., 2003).  During symptomatic episodes, deficits in interpersonal functioning 
increase; while during periods of symptomatic recovery interpersonal functioning has been 
shown to improve (Weinstock, Keitner, Ryan, Solomon, & Miller, 2006). Furthermore, deficits 
in social cognition and functioning in adults with bipolar disorder are also present in EOBD and 
believed to persist across the lifespan throughout the course of illness (McClure et al., 2005).  
Social functioning and relationships therefore have significant implications for the course of 
bipolar disorder. 
 Interpersonal social rhythm therapy. Social functioning is a core concept in 
interpersonal social rhythm therapy (IPSRT), a therapeutic intervention for bipolar disorder that 
seeks to stabilize symptomatic episodes through achieving lifestyle balance. IPSRT integrates 
behavioral, interpersonal, and psychoeducational models to alleviate severity and frequency of 
symptomatic episodes of bipolar disorder. IPSRT focuses on stabilizing circadian rhythms and 
sleep-wake patterns, as well as the social cues that affect these patterns. Personal relationships 
and their social demands are viewed as mediators between biological and psychological 
vulnerabilities for symptomatic episodes of bipolar disorder (Frank, Swartz, & Kupfer, 2000).  
 Family-focused treatment. For families affected by bipolar disorder, impairment in 
family functioning is associated with course of illness and persists even in the absence of 
symptomatic episodes (Weinstock et al., 2006). Therefore, it is important that therapeutic 
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approaches to bipolar disorder also focus on interpersonal functioning within the family. Family-
Focused Treatment (FFT) is a therapeutic approach that focuses on the balancing patterns of 
interpersonal communication and expressed emotion (EE) within the family system. Greater 
levels of EE within the family are associated with high levels of criticism, hostility, and 
emotional over-involvement as well as risk of symptomatic relapse for the individual with 
bipolar disorder (Miklowitz, 2008; Morris, Miklowitz, & Waxmonsky, 2007). FFT aims to 
stabilize bipolar disorder by balancing protective and risk factors in family and social 
environments. FFT interventions address interpersonal functioning within the family through 
psychoeducation, relapse prevention, communication enhancement, and problem-solving with 
family members (Miklowitz, 2008). When used with EOBD, FFT addresses age-appropriate 
developmental tasks, the family experience of EOBD, and works to reduce negative high EE 
family behaviors such as criticism and hostility (Morris et al., 2007). 
Extant Knowledge on EOBD 
 The phenomenology of EOBD is explored across five domains within the literature: a) 
scope of the illness; b) the adolescent perception of self; c) interactions with the healthcare 
system; d) the family system; e) stigma. When viewed collectively, the research across these 
domains provides a comprehensive understanding of existing knowledge of EOBD. 
Scope of EOBD. Prevalence data and course of bipolar disorder illness are discussed 
across the lifespan, with consideration and implications for EOBD. Information presented for 
bipolar disorder is inclusive to both early- and adult-onset presentations in accordance with the 
DSM-5 conceptualization of bipolar disorder (APA, 2013). 
Prevalence. Bipolar disorder occurs in 1-2% of the adult population. While EOBD 
prevalence is consistent with adult-onset prevalence at 0 – 2% of adolescents in community 
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samples and 6.0 - 6.9% of adolescents in clinical samples, it has been diagnosed in up to 13% of 
the adolescent and child population across community and clinical samples (APA, 2013; Harris, 
2005; Miklowitz & Johnson, 2006). The discrepancy between EOBD prevalence and diagnostic 
rates is not rooted in whether bipolar disorder symptomatology can manifest prior to age 18, but 
in whether EOBD is conceptualized and operationalized consistently with adult-onset bipolar 
disorder (Miklowitz & Johnson, 2006). The trending conceptualization of EOBD as a chronic 
and continuous state of irritability, tearfulness, and psychomotor agitation with prolonged temper 
outbursts, rather than as an episodic illness with distinct manic and depressive states has 
impacted treatment interventions, prognosis, course of EOBD illness, and the psychological 
development of adolescents with EOBD (Biederman, 1995; Biederman et al., 1995; Faedda et 
al., 1995; Wozniak et al., 1995). 
Bipolar disorder is the sixth cause of disability worldwide, and its functional impairment 
occurs even in the absence of full symptomatic episodes (Cerit et al., 2012; Judd et al., 2002). 
Psychotropic medications may decrease the severity and frequency of both subthreshold and full 
symptomatic episodes, but management of bipolar disorder remains challenging. In a study of 
five guideline-concordant psychotropic medications, only 58-63% of participants’ symptoms 
responded partially or in full to the prescribed medications (Garnham et al., 2007). Furthermore, 
up to 30% of individuals with bipolar I disorder and 15% of those with bipolar II disorder 
experience impairment in functioning in the absence of symptomatic episodes. As many as 20% 
of individuals with bipolar disorder transition between symptomatic episodes without periods of 
symptom-free recovery (APA, 2013). 
 Course of illness. The average age of onset of bipolar I disorder is 18 years and for 
bipolar II disorder occurs in the mid-20s (APA, 2013). However, the literature indicates onset of 
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symptoms occurs an average of ten years prior to a diagnosis (Berk et al., 2009; Torrey & 
Knable, 2002). Within the literature, varying estimates indicate a significant portion of 
individuals with bipolar disorder report onset of symptoms in their youth. Torrey and Knable 
stated 20-40% of individuals with bipolar disorder report onset of symptoms in childhood, while 
Perlis et al. (2004) reported onset of symptoms prior to age 13 in  28% of individuals with 
bipolar disorder and onset of symptoms prior to age 18 in 66% of individuals.  
The onset of bipolar disorder often occurs over with symptomatology progressively 
increasing to its full diagnostic presentation over the course of several years. In a clinical sample, 
45% of participants age 7-17 progressed from subthreshold symptoms to bipolar I or II disorders 
over a period of 5 years. Twenty-three percent of participants developed bipolar I disorder, 9 of 
which first progressed to bipolar II disorder within the sample timeframe. Twenty-two 
participants met criteria for bipolar II disorder (not including the 9 participants who eventually 
met criteria for bipolar I disorder) by conclusion of the study. Furthermore, hypomanic 
symptoms were present in 85% of participants within one month prior to onset of bipolar I or II 
symptomatologies (Axelson et al., 2011). 
The polarity (i.e., manic or depressive) of the first episode at onset of bipolar disorder 
may contain important clues for the prognosis and course of illness. Approximately two-thirds of 
adults with bipolar disorder (67%) reported first episode was depressive in nature, and 75% of 
these adults with depressive onset reported a course of illness dominated by depressive episodes. 
In comparison, only 27.9% of participants with manic episode at onset of illness experienced 
course of illness dominated by depressive episodes. Improved identification of episode polarity 
at onset of bipolar disorder may facilitate improved intervention and course of illness (Daban et 
23 
al., 2006). Additionally, successful treatment early in the course of illness is associated with an 
improved prognosis (McGorry, 2010). 
Determining first episode polarity in adolescents with emerging mood symptomatology 
can be challenging for the clinician due to factors such as differential diagnosis between bipolar 
disorder subtypes (i.e., type I, II, or unspecified; APA, 2013). Furthermore, clinicians face the 
often-nuanced nosological diagnostic challenges of distinguishing between mood swings and 
mood episodes, continuous irritability and episodic course of illness, and rage outbursts in 
contrast to true manic symptoms in order to make an accurate EOBD diagnosis. Co-occurring 
conditions such as psychotic features, substance abuse, atypical depression, and ADHD further 
complicate the clinician’s ability to accurately diagnose EOBD. Additional factors include 
consideration of the adolescent’s age and cognitive and normative development, the clinician’s 
adherence to either broad or narrow conceptualization of EOBD, the reliability of child and 
parent report of symptoms, and utility of family history in making a diagnosis (Carlson, 2012).  
 EOBD and adolescent perception of self. Neuroplasticity and neurobiological changes 
are a critical component in the onset of EOBD and have significant implications for emotional 
and social development, including normative processes of cognitive and psychosocial 
development, achieving symptomatic and syndromic recovery, and identity development that 
begin during adolescence and continue through emerging adulthood (Dahl, 2004).  
Adolescent cognitive development. Adolescence is a developmental period frequently 
defined as occurring between ages 11 – 22 in which significant changes occur in biological, 
cognitive, emotional, and social functioning (Gutsegell & Payne, 2004). Cognitive, emotional, 
and social development each occur at differing rates as influenced by biological pubertal 
changes, rather than as a uniform process occurring consistently throughout adolescence 
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(Steinberg, 2005). Cognitive improvements in reasoning, information processing, self-regulation, 
self-evaluation, and coordination of affect and cognition occur alongside growth in the prefrontal 
cortex region in the brain (Steinberg, 2005). Adolescents progress from operating based on 
conceptualizations of concrete rules and ideals to independent reasoning based on deductive 
hypotheses and logic (Piaget, 1964). Adolescents may begin to use reasoning and logic in early 
adolescence but continue to refine this process of formal operations (Piaget, 1964; Steinberg, 
2005). Cognitive development is influenced by social context and emotion, and in turn 
influences social and emotional development. Self-regulation, comprised of the coordination of 
emotional, intellectual, and behavioral processes, is the desired outcome of adolescent cognitive 
development (Steinberg, 2005).  
Adolescent moral and psychosocial development. While an EOBD diagnosis can affect 
the adolescent’s self-concept and psychosocial development, the symptomatic course of EOBD 
illness can impact normal, emotional, cognitive, and social development (Birmaher et al., 2006; 
Parry & Levin, 2012). During adolescence, a process of moralization occurs alongside cognitive 
development, in which the interaction between the adolescent and social environment transforms 
both the adolescent’s attitudes and conceptualizations of their environment (Kohlberg, 1963). 
Between ages 10-16, adolescents typically progress from conventional morality to post-
conventional morality according to Kohlberg’s stages of moral development; obedience to 
authority is replaced with abstract conceptualizations of justice and the value of individual rights 
may override adherence to rules. Moral development during adolescence reflects patterns of 
interaction between the adolescent, social environment, and peer groups (Kohlberg, 1963). 
Peer relationships and social functioning in adolescence have significant implications for 
the course of EOBD illness and identity development. Peer rejection and subsequent loneliness 
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are associated with a trajectory of illness that consists of more depressive symptoms (Pederson, 
Vitaro, Barker, & Borge, 2007). Challenges to social functioning such as romantic interests, 
increased self-consciousness, and social anxiety occur concurrent to biological and behavioral 
changes associated with adolescence (Forbes & Dahl, 2010). Peer relationships may influence 
self-regulatory skills both negatively and positively, while self-regulatory skills can influence the 
quality and quantity of peer relationships (Farley & Kim-Spoon, 2014). The development of a 
personal identity is an essential task during adolescence. Social relationships serve as a 
mediating factor through which a strong sense of self can be developed, as opposed to persistent 
role confusion and identity diffusion (Erikson, 1997). 
Early-onset bipolar disorder (EOBD) symptomatology can negatively affect adolescent 
progress toward developmental tasks pertaining to identity, relationships, academic functioning, 
and psychological autonomy (Miklowitz & Johnson, 2006). While psychiatric and therapeutic 
treatment interventions can potentially decrease the symptomatic effect on adolescent 
development, adolescents remain vulnerable to stigmatizing messages through healthcare 
systems and society that impact normative processes of identity development (Alreja et al., 2009; 
Miklowitz & Johnson, 2006).  
 Effect on psychosocial development. The diagnosis and treatment of EOBD are 
influential to the adolescent’s physical and psychosocial development. As a result of an 
overreliance on neurobiological theories, comprehensive and multidisciplinary treatment 
approaches have frequently been reduced solely to pharmacotherapy; and the significance of 
contributing factors such as the family system and impact of environmental triggers has been 
minimized. Pharmacological interventions carry the potential for both positive and negative 
outcomes in child and adolescent populations. While psychotropic medications have 
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demonstrated similar benefits in the adult and juvenile population bipolar populations, these 
medications carry significant health risks for the juvenile population, such as health 
complications (i.e., weight gain; metabolic syndrome; tardive dyskinesia; polycystic ovarian 
syndrome; thyroid and parathyroid function; and hyperprolactinemia associated with changes in 
estrogen levels) and documented fatalities (Correll & Carlson, 2006; Parry & Levin, 2012). The 
long-term effects of pharmacotherapy on the adolescent’s physical health remain largely 
unknown; and impact on self-concept, psychological development, and family communication 
have been questioned as well (Parry & Levin, 2012). 
 Defining recovery. While treatment interventions for bipolar disorder have primarily 
focused on the reduction and management of bipolar symptomatology, research is increasingly 
exploring the concept of recovery. Conus et al. (2006) identified three types of recovery: 
syndromic, symptomatic, and functional. Syndromic recovery consists of a clinically significant 
reduction (> 50%) in severity of bipolar symptomatology to the extent that diagnostic criteria are 
no longer met; however, mild residual manic or depressive symptoms may persist (McMurrich et 
al., 2012; Sachs & Rush, 2003; Stotland, Mattson, & Bergeson, 2008). Symptomatic recovery 
refers to an improvement in the magnitude of symptoms while diagnostic criteria remain 
significant (McMurrich et al., 2012; Stotland, Mattson, & Bergeson, 2008). Functional recovery 
incorporates a return to previous level of functioning and psychosocial activity (McMurrich et 
al., 2012; Zarate, Tohen, Land, & Cavanagh, 2000). Functional recovery consists of 
improvements in social functioning, occupational functioning, and independent living, and 
therefore addresses impairments and life stressors associated with bipolar symptomatology, 
medication side effects, and societal stigma (Stotland et al., 2008). 
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 Within the literature, complete syndromic and symptomatic recovery from bipolar 
disorder are viewed as potentially unattainable. Bipolar disorder has a chronic course of illness 
that worsens over time without proper treatment, and is characterized by high recurrence of 
symptomatic episodes as well as chronic and unremitting residual symptoms that occur between 
symptomatic episodes (Angst & Sellaro, 2000; Frank et al., 2000; McMurrich et al., 2012). A 
permanent cure, or complete remission of bipolar disorder symptomatology, is considered to be 
nonexistent due to the course of illness—as many as 90% of individuals who have experience 
one manic episode will experience another throughout their lifetime (Sachs & Rush, 2003). 
Furthermore, subsyndromal and residual symptoms persist even in the absence of full 
symptomatic episodes and are associated with profound psychosocial impairments (Zaretsky, 
2003). Bipolar disorder is considered in to be partial remission if symptomatic recovery was 
achieved for a two-month period, and in full remission if syndromic recovery was achieved for a 
two-month period (APA, 2013; Perlis et al., 2009; Sachs & Rush, 2003).  
 Inquiries across the interdisciplinary literature regarding longitudinal aspects of EOBD 
recovery are limited. As compared to adult-onset bipolar disorder, EOBD course of illness is 
associated with poorer treatment outcomes and course of illness; includes higher incidence of 
rapid cycling without asymptomatic periods of recovery between symptomatic episodes; and is 
associated with greater stressful live events, poorer quality of life, and increased risk of 
impairment in social functioning (Elgie & Morselli, 2007; Findling et al., 2001; Paykal, 2001; 
Perlis et al., 2009).  Other aspects of recovery such as the developmental impact of EOBD, 
resilience factors, functional impairment, and maturation effects on episode recovery, recurrence, 
subsyndromal and residual symptoms also remain under researched (Strober et al., 2006).  
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 EOBD course of illness is affected by both risk and protective factors that influence 
treatment outcomes. Identified risk factors include lower perceived social support, stressful life 
events, disruption in social and circadian rhythms, and medication noncompliance (Cohen, 
Hammen, Henry, & Daley,  2004; Frank et al.,  2000). Protective factors include high levels of 
social support, psychotherapy and psychosocial interventions, higher level of education, being 
married, and short duration of illness (Johnson et al., 1999; Sachs, 2008; Wingo, Baldessarini, 
Holtzheimer, & Harvey, 2010).  
 Identity development and stigma. Individuals with bipolar disorder report concern 
regarding not only the effects and experience with psychotropic medication, but also the effect of 
bipolar disorder itself on their identity. In a phenomenological study of adult patients after 
receiving a diagnosis of bipolar disorder, participants reported ambivalence and hesitation 
regarding psychotropic medications specifically due to concern regarding side effects such as 
decreased cognitive functioning, weight gain, decreased energy, and decreased creativity. The 
trial-and-error approach of trying multiple medications was reported as frustrating, but some 
participants reported willingness to tolerate side effects if symptom reduction was deemed 
beneficial (Proudfoot et al., 2009). 
 Participants identified symptom management as one of their greater concerns associated 
with receiving a diagnosis of bipolar disorder. Some participants reported “terrifying” fear of 
symptomatic episodes due to perceived loss of control over their lives. While some participants 
reported feeling relief after receiving the diagnosis of bipolar disorder following years of 
experiencing symptoms, some participants reported denial, anger, disbelief, and shock. 
Participants discussed attempts to come to terms with their ‘new’ identity and merge ‘old’ and 
‘new’ identities. Participants reported difficulty regarding trusting their thoughts, emotions, 
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impulses, and reality-testing ability.  Additionally, participants reported questioning course of 
illness, ability to function, and ability to have a ‘normal life’ regarding social, family, and work 
relationships (Proudfoot et al., 2009). 
 Proudfoot et al. (2009) reported individuals with bipolar disorder may experience a loss 
of self following a diagnosis of bipolar disorder, and reported stigma was also of significant 
concern. Participants reported fearing they would lose relationships if people found out about the 
bipolar disorder diagnosis and worried about how to disclose the diagnosis to others. Participants 
reported that stigma increased the isolation of bipolar disorder, specifically when support people 
were unsure how to help. Proudfoot et al. identified the need for psychoeducation for friends, 
family, and the larger community, to increase support for individuals with bipolar disorder. 
 EOBD and interaction with the healthcare system. Treatment for EOBD occurs within 
the healthcare system and includes psychiatric, pharmacological, and therapeutic interventions 
designed to alleviate bipolar disorder symptomatology and improve both individual and family 
functioning. This section reviews stigma and treatment as experienced through the healthcare 
system. Inception of stigma, loss of autonomy, and psychiatric, pharmacological, and therapeutic 
interventions are discussed. 
 Inception of stigma. Labeling and stigma associated with mental illness often originate 
within the healthcare system. Stigmatizing practices such as labeling and referring to the youth 
by their diagnosis (i.e., “that bipolar boy” or “that boy is bipolar”), focusing treatment and 
assessment on deficits indicated by the medical model, and treatment planning without the youth 
or family present commonly occur within the healthcare system. Treatment models often focus 
exclusively on symptomatology rather than a holistic and strengths-based approach incorporating 
protective family and environmental factors. Individuals and families often experience a 
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dichotomous relationship between the ‘expert’ healthcare professional and ‘ignorant’ patient, 
rather than a collaborative relationship in which the youth and family are experts as well. 
Stigmatizing practices within the healthcare system may negatively affect the recovery of 
individuals with bipolar disorder and influence families to avoid contact with the healthcare 
system (Browne, Hemsley, & St. John, 2008; Heflinger & Hinshaw, 2010). Families, as well as 
individuals, are subject to stigma through the healthcare system, which may lead to reduced 
contact with the healthcare system to avoid stigmatizing services (Heflinger & Hinshaw, 2010). 
Recovery-oriented interventions that enhance functional recovery and minimize stigma are more 
successful in facilitating the individual’s recovery (Stotland, Mattson, & Bergeson, 2008). 
 Loss of autonomy. Stigmatization and labeling experienced through the healthcare 
system negatively affect individuals’ self-esteem, and result in loss of identity and loss of 
confidence (Browne et al., 2008). In a qualitative study of adults with bipolar disorder the core 
theme from participants was feeling out of control regarding the illness and over their lives 
(Crowe et al., 2012). Participants reported difficulty managing symptoms, and stated the onset of 
symptoms created a significant change in their lives. Participants reported their self-identity was 
affected by their experience of bipolar symptoms as well as the responses of others to their 
symptoms. Participants reported feeling flawed, powerless, and incapacitated by symptomatic 
episodes. Psychotropic medications were associated with loss of autonomy, defectiveness, and 
identity; in turn, loss of autonomy was associated with interaction with healthcare professionals. 
Participants reported the need to take medication indicated they were not normal and were not 
who they wanted to be. Participants reported believing they were different in negative ways, 
even in the absence of these beliefs from others; this indicated the internalization and 
endorsement of stigmatizing beliefs (Crowe et al., 2012).  
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 Therapeutic interventions. Therapeutic interventions have significant implications for 
the long-term course of bipolar illness. Therapeutic interventions for EOBD include individual, 
group, and family modalities. While data on EOBD remains limited, the literature on adult-onset 
bipolar disorder indicates the combination of psychotherapy, and pharmacotherapy is effective in 
reducing rates of symptomatic relapse by 30 – 40% over a 12 to 30 month period. Benefits such 
as symptom reduction, improved interpersonal and daily functioning, and medication adherence 
were present for one or more years following termination of therapy services (Miklowitz, 2008). 
 Informal support. Community-based peer supports provide recovery-oriented, 
complimentary approaches to clinical interventions for bipolar disorder and EOBD. Perceived 
social support can be both a risk and protective factor for individuals with bipolar disorder. 
DeVylder and Gearing (2013) identified declining social support occurring in adolescents prior 
to psychiatric hospitalization, and advocated for social interventions to indirectly improve 
symptomatology. Peer support is associated with enhancing individual’s sense of empowerment, 
reducing stigma, improving self-esteem, decrease symptomatology, and decrease risk of 
symptomatic relapse (Corrigan, Powell, & Rusch, 2012; Davis et al., 2012). Perlick et al. (2004) 
reported a correlation between stigma and intentional reduction in social functioning, and 
advocated for recovery-based peer support to inoculate against the effects of stigma. While peer 
supports do not directly address symptomatology as clinical interventions do, participants in peer 
support groups report a simultaneous decrease in symptomatology and increase in hope and 
empowerment (Brown et al., 2008; Fukui, Davidson, Holter, & Rapp, 2010). 
EOBD and the Family. The family system is an important mediating variable in the 
comprehensive management and course of illness of bipolar disorder. This section discusses 
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family burden and stigma, family functioning, and the family’s experience of bipolar disorder 
symptomatology.  
 Family functioning. Family functioning and cohesion are each affected by bipolar 
disorder. During both symptomatic and symptom-free episodes families appear to operate in a 
more cohesive, adaptive manner, while during prodromal and recovery periods, families 
experience less cohesion, ability to adapt, and more conflict.  Family functioning may also be 
affected by relationship stress and conflict common during symptomatic episodes of bipolar 
disorder (Sullivan & Miklowitz, 2010). 
 Conversely, family functioning may influence the severity of bipolar disorder 
symptomatology. Living with an intact biological family and enhancing family relationships are 
protective factors toward alleviating symptomatic episodes and improving course of illness, 
while family hostility, stigma, misunderstanding, and low maternal warmth are risk factors 
associated with increased symptomatic episodes  (Elgie & Morselli, 2007; Geller et al., 2002).  
Adolescents with EOBD in families with greater conflict experienced more severe manic 
symptoms over a two-year period, while adolescents in families with greater cohesion 
experienced decreased severity of depressive symptoms (Sullivan, Judd, Axelson, & Miklowitz, 
2012).  While family functioning has important implications for the treatment and course of 
bipolar disorder, the cumulative literature has not explored the possibility of positive family 
outcomes due to EOBD. Family cohesion has been identified as a protective factor to reduce 
bipolar symptomatology and incorporated into Family Focused Treatment (FFT) intervention 
(Miklowitz, 2008; Sullivan & Miklowitz, 2010; Sullivan et al., 2012); however, family cohesion 
has not been studied as a positive outcome of EOBD. 
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EOBD and Stigma. Stigma has been discussed in the context of the perception of self, 
the healthcare system, and the family. In this section, stigma is reviewed in more detail regarding 
its relationship to symptomatology, social and occupational functioning and predictive ability of 
functioning. 
 Symptomatology and stigma. As explained by modified labeling theory, societal views 
contribute to the stigma associated with mental illness. In bipolar disorder, societal stigma and 
labeling may differ according to each symptomatic episode. In a sample of college students, 40% 
described manic symptoms as voluntarily aggressive, dangerous, and unpredictable with a lack 
of self-control, and expressed irritability, lack of understanding, and the desire to withdraw from 
the individual. In contrast, participants reacted to depressive symptoms with pity and desire to 
help the individual (Wolkenstein & Meyer, 2008). While stigma research specific to the 
fluctuations in bipolar mood states is limited, this study suggests varying societal attitudes 
relative to manic and depressive symptoms. 
 While symptomatology may influence societal stigma, stigma appears to affect bipolar 
symptomatology as well. Cerit et al. (2012) identified three predictors of functioning in 
individuals with bipolar disorder: severity of depression, perceived social support, and 
internalized stigmatization. Severity of depression emerged as the strongest predictor of poor 
functioning; recurrent mild depressive symptoms in particular were negatively associated with 
functional recovery in bipolar disorder. Stigma directly predicted functioning as well as 
predicted pathways for other predictors of functioning. Cerit et al. (2012) suggested a 
bidirectional relationship exists between bipolar disorder and stigma, in which stigma can 
exacerbate bipolar symptomatology; and in turn, symptoms perpetuate stigma beliefs. Therefore, 
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treatment interventions for bipolar disorder that address stigma may have important implications 
for symptom reduction. 
 Social functioning and stigma. Sensitivity and concern regarding stigma may impair 
social functioning. In a clinical sample of adults with bipolar disorder and their caregivers, 
participants that reported greater concern regarding stigma displayed greater impairment in 
social functioning. Stigma was associated with increased avoidance coping, including increased 
psychosocial isolation, but not with decrease in family functioning. Participants who reported 
concern regarding stigmatization experienced poorer social adjustment at the seven-month 
follow up (Perlick et al, 2004). Stigma appears to negatively affect social functioning and 
recovery in individuals with bipolar disorder. 
Limitations of Previous Studies 
 At present there are no published studies investigating the experience of EOBD by 
adolescents or emerging adults with a history of EOBD diagnosis. The cumulative literature 
predominantly adheres to the medical model, with a quantitative focus on establishing 
neurobiological markers for EOBD and effectiveness of pharmacological interventions used to 
treat adult bipolar disorder. With a few exceptions (i.e., Moses, 2009), there is an overwhelming 
absence of qualitative inquiries into the experience of adolescent mental illness. Research and 
treatment for EOBD have largely been conducted in the absence of the self-report of the 
adolescents affected by bipolar illness as a primary data source (Heflinger & Hinshaw, 2010). 
Emerging adulthood has been similarly overlooked as a source of information and reflection of 
past experience of EOBD in adolescence.  
 Various authors have recognized these limitations within the literature and addressed the 
need for qualitative, family- and adolescent-focused research to better understand the 
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phenomenology of EOBD. Sullivan and Miklowitz (2010) stated the need for qualitative 
research to better understand family experience and functioning during symptomatic episodes of 
bipolar disorder. Miklowitz (2008) identified the need for increased research to improve 
pharmacological and therapeutic interventions for EOBD, including greater inquiry into the 
adolescent experience of EOBD.  Miklowitz, Biuckians, and Richards (2006) called for research 
to investigate EOBD adolescent physiological and symptomatic responses to family conflict. 
Heflinger and Hinshaw (2010) questioned the application of theoretical frameworks from the 
adult to the juvenile population as well as the absence of theory specific to the juvenile 
population. In summary, the first-person experience of adolescents with EOBD has been largely 
peripheral in research, despite the acknowledgement within existing research of the need for the 
phenomenological data.  
Aims of Present Study 
 To address limitations of previous studies, the present study will explore EOBD in a 
sample of emerging adults ages 18-25 with a history of EOBD diagnosis. Many existing studies 
have utilized quantitative methodologies, relying on the scoring of standardized measures to 
approximate an understanding of the phenomenology of EOBD. While past inquiries have 
included quantitative investigations into neurobiological malfunctioning, pharmacological 
approaches, and family functioning, the present study will utilize qualitative methodology to 
explore the full phenomenology of EOBD.  
 While the literature on bipolar disorder has incorporated self-report from adults with 
bipolar disorder, adolescents and emerging adults have been underutilized as primary informants 
and sources of data in EOBD research. The present study utilizes the reflection of emerging 
36 
adults to reconstruct their experience of EOBD in adolescence to increase understanding of the 
phenomenology of EOBD with implications for current functioning. 
 Previous studies have explored EOBD through various theoretical perspectives; however, 
our understanding of the phenomenology of EOBD remains limited. The present study proposes 
the integration of neurobiological, modified labeling theories with the theory of emerging 
adulthood as the foundation for a more complete and multidimensional understanding of the 
phenomenology of EOBD.  
Summary of the Study 
This qualitative study will explore the phenomenology of EOBD among emerging adults 
by addressing the following research questions:  
1) How do emerging adults (ages 18-25)  describe the experience of EOBD during 
adolescence (ages 13-17) in terms of experience of symptoms; changes in individual, 
social, and family functioning caused by course of illness; and the experience and 
perception of stigma and self-stigma? 
2) How do emerging adults (ages 18-25) characterize the cumulative influence of 
interactions with healthcare systems and treatment interventions on their experience of 
EOBD? 
3) What are the characteristics of the relationship between EOBD, social and family 
relationships and the developmental transition to adulthood according to emerging 
adults? 
4) How have stigma and self-stigma associated with EOBD affected the social, emotional, 
and cognitive development of emerging adults ages 18-25? 
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Chapter 3: Methodology 
 To obtain an understanding of the lived experience of EOBD and best address research 
questions, this study incorporated a transcendental phenomenological design. This chapter 
reviews transcendental phenomenology and its application to study design, including sampling, 
data collection, and data analysis. 
Transcendental Phenomenology 
 Phenomenology is the philosophy and study of pure phenomena through human 
consciousness (Husserl, 1965, 2012; Moustakas, 1994). Derived from the Greek word 
phaenesthai, ‘phenomenon’ means ‘to bring to light’ or ‘show itself completely’ (Moustakas, 
1994). A phenomenon is a reality contained within the human experience. Phenomenological 
data is obtained through the individual’s subjective report of the experience (Groenewald, 2004). 
In transcendental phenomenology, the researcher sets aside all previous habits of thought and 
breaks down the barriers or biases generated by these habits in order to uncover the pure essence 
of the phenomenon (Groenewald, 2004; Husserl, 2012). The goal of phenomenology is a return 
to things as they truly are, rather than how they are perceived and judged (Groenewald, 1994; 
Moustakas, 1994). 
 Transcendental phenomenology seeks to uncover the essence of human experience 
through a transcendental, or pure, ego free of prejudgment and presupposition. To accomplish 
this, transcendental phenomenology asks two questions: a) what is the essence of the experience 
of the phenomenon; and b) in what context(s) did the experience occur (Moustakas, 1994)? 
Through transcendental phenomenology, an accurate description of the phenomenon is obtained 
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through explication and synthesis of the subjective experiences of the phenomenon (Groenewald, 
2004; Moerer-Urdahl & Creswell, 2004).  
 Transcendental phenomenology utilizes qualitative methods to obtain the lived 
experiences of the phenomenon of study through the individuals’ self-report. The philosophical 
assumptions of transcendental phenomenology uniquely focus on eliciting the experience of the 
phenomenon, as opposed to similar methodologies such as ethnography, in which the 
phenomenon is observed by the clinician, and narrative approaches such as oral history, in which 
the focus is on narration. Qualitative interviews are interactive and semi-structured, relying on 
the two core transcendental phenomenological questions as stated in the previous paragraph to 
guide the interview while incorporating flexibility, allowing for the full revelation of the 
experience as directed by the individual rather than the researcher (Moustakas, 1994). 
Phenomenological interviews are iterative in nature, as the researcher continuously reflects on 
the relationship between the individual’s self-report and core research questions, often diverging 
from intended questions to allow the individual to guide the interview and capture the essence of 
the phenomenon as he or she experienced it. The goal of the phenomenological interview is for 
the individual to share as much of the experience as authentically and unselfconsciously as 
possible in his or her own words (DiDicco-Bloom & Crabtree, 2006).  
 Epoche, intentionality, noema, and noesis. Several concepts are central to the design 
and implementation of transcendental phenomenology. Here, these concepts are discussed here 
in brief, with further application in data analysis. 
 Epoche. In transcendental phenomenology, a transcendental state incorporates “a 
readiness to see in an unfettered way, not threatened by the customs, beliefs, and prejudices of 
normal science, by the habits of the natural world or by knowledge based on unreflected 
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everyday experience” (Moustakas, 1994, p. 41). The absence of bias is accomplished through a 
process called epoche (from the Greek έποχή) in which all judgment is suspended in order to 
view the phenomenon as it is.  
 Epoche is regarded both as a philosophical concept and a component of data analysis. 
Epoche is the first step in the phenomenological reduction process, in which the experience is 
conceptualized according to recurrent themes and textural descriptions present in interview data; 
phenomenological reduction is discussed further in discussion of data analysis. While pure 
epoche is difficult to achieve, even its approximation reduces researcher bias and maximizes the 
credibility of the study (Moerer-Urdahl & Creswell, 2004; Moustakas, 1994). Through epoche, 
the researcher gains the ability to collect, describe, and analyze the phenomenon of study as 
accurately as possible without the influence of his or her own experiences. 
 Intentionality. Intentionality is the awareness, or perception, of the phenomenon. 
Intentionality is not the phenomenon itself, but rather the subjective lived experience of the 
phenomenon and includes judgment, interpretation, and value of the phenomenon (Moustakas, 
1994). Intentional experiences contain the essence of the experience of the phenomenon, and are 
therefore sought out through phenomenological interviews as representative of the phenomenon 
of study (Husserl, 2012). The essence of the phenomenon is constructed through a compilation of 
multiple intentional experiences. 
 Noema and noesis. Each intentionality is comprised of a noema and noesis. In its most 
simple definition, noema refers to the phenomenon itself, the object of the experience, and noesis 
is how the phenomenon is experienced. Noema represents the sensory experience of the 
phenomenon, while noesis contains the meaning of the experience through perception, emotion, 
memory, and judgment. Through reflecting on the noema the noesis is uncovered, and with it the 
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essence of the phenomenon. Transcendental phenomenology seeks to discover both noema and 
noesis of each intentional experience of the phenomenon, and it is through this process that the 
phenomenon can be truly understood (Moustakas, 1994). 
Participants 
 Transcendental phenomenology utilizes a homogenous sample of individuals who have 
experienced the phenomenon of study. This study utilized purposive sampling to recruit 
emerging adults ages 18-25 with history of diagnosis of EOBD between the ages 13-17 per self-
report. Participant eligibility and recruitment are discussed below.  
  Participant eligibility. Participants were eligible to take part in this study if they met the 
following inclusion criteria: a) between 18 and 25 years of age; b)  diagnosed with bipolar 
disorder between the ages of 13 and 18; c) spoke English fluently; d) did not have an active 
substance abuse or substance dependence disorder, drug-induced mood disorder, pervasive or 
intellectual developmental disorder, unremitting psychosis or psychotic disorder, posttraumatic 
stress disorder, or a life-threatening eating disorder (adapted from Sullivan & Miklowitz, 2010); 
e)did not display imminent danger to self or others.  
 Recruitment of sample. The researcher coordinated with clinical sites and community 
support groups in Tampa, Florida and Orlando, Florida areas and also recruited participants via 
online advertising, summarized in Table 1. Sample sites were provided with study flyers and 
were asked to display and/or distribute flyers to potential eligible participants. A study flyer is 
included in Appendix A. 
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Table 1. Study Recruitment Sources 
 Tampa Orlando Internet 
Clinical sites 
USF Counseling Center 
USF Psychological 
Services Center 
USF Student Health 
Services 
USF Psychiatry Clinic 
UCF Counseling and 
Psychological Services 
UCF Student Health Services 
Aspire Health Partners 
18 Clinicians in private practice 
WeSearchTogether.org 
DBSA.org online listing 
DBSA.org online 
support group listing 
Facebook page and 
advertisement Community 
support 
DBSA Tampa Bay 
MHA Tampa Bay 
NAMI Hillsborough 
Greater Orlando Bipolar Support 
MHA Orlando 
NAMI Greater Orlando 
 
 Response and enrollment. The researcher was contacted by 26 potential participants. 
Five were excluded due to not meeting study criteria for current age or age of EOBD diagnosis. 
Eleven potential participants reported meeting study criteria but did not follow through or 
maintain communication with the researcher. Two potential participants were scheduled for 
interviews but “no-showed” (confirmed interview but never responded to phone or email contact 
attempts at scheduled time).  
Eight participants consented and were enrolled in the study between May and December 
2016. The sample consisted of 7 females and 1 male between ages 18 – 25 (M = 21.75; SD = 
2.31); participants reported receiving EOBD diagnosis between ages 13 and 17 (M = 15.56; SD = 
1.50). Table 2 summarizes the sample recruitment.  
As part of the iterative process of phenomenological research, the researcher reviewed 
interview recordings and transcripts in October 2016. The researcher observed then that content 
and description was similar across participant interviews, creating a consistent and detailed 
portrait of participants’ experience of EOBD. As a result, the researcher noted that the study 
sample was approaching saturation in terms of data as well as size for a phenomenological 
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design (Creswell, 2007; Dukes, 1984; Edward, 2005; Smith, 2004). By the end of December 
2016, eight participants were enrolled and recruitment concluded. 
 
Table 2. Sample Recruitment 
Category N 
Excluded (Criteria) 5 
Never scheduled 11 
No-Show 2 
Drop-Out 0 
Enrolled 8 
Total 26 
 
 Obtaining informed consent. Data collection was facilitated through telephone 
interviews. Following initial phone or email contact, the researcher emailed the USF Institutional 
Review Board (IRB) Verbal Consent form (see Appendix B) to participants for review. At the 
beginning of the scheduled interview telephone call, the researcher reviewed and obtained verbal 
informed consent. Participants additionally were asked for permission to audio record interviews; 
all participants consented to have their interviews recorded by the researcher.  
Ethical Considerations 
DiCicco-Bloom and Crabtree (2006) propose four ethical issues pertaining to participant 
involvement in qualitative research: a) reducing the risk of unanticipated harm; b) protecting the 
participant’s information; c) effectively informing participants about the nature of the study; and 
d) reducing the risk of exploitation. These considerations are addressed in the IRB protocol and 
are discussed here in brief. 
Risk of unanticipated harm to participants. The first ethical issue addresses the risk of 
unanticipated harm to participants. The qualitative interviews address the phenomenon of EOBD 
as experienced by emerging adults ages 18-25. The phenomenon of EOBD may be a sensitive 
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issue to participants, and while the researcher is a licensed clinician and therapist, it is not 
appropriate for the researcher to provide clinical services to study participants. To address this 
possibility, participants were provided with information for follow-up care if needed. As part of 
obtaining verbal informed consent, the researcher advised each participant that the interview 
could be stopped, paused, or discontinued at any time at the participants’ discretion (i.e., due to 
emotional distress or discomfort). Per IRB, if any participant displayed indications of significant 
emotional distress during or following the interview that necessitate immediate intervention, the 
researcher would contact emergency medical services with the physical address provided by the 
participant at time of interview. This did not occur, but was designed to address care and safety 
of participants throughout data collection. 
Protection of participant data and identifying information. The second ethical issue 
involves the protection of participant data and identifying information. Audio recordings, 
transcripts, and identifying information of participants were stored by the researcher in two 
locations: a locked cabinet and a secure storage drive in the researcher’s office.  Participants 
were informed that referral sites would not be informed of their participation in the study and no 
identifying information or data would be released to referral sources.  
Nature of the study. The third ethical issue addresses informing participants of the 
nature of the study 
The researcher obtained verbal informed consent via telephone per IRB policy. Informed 
consent addressed the extent and nature of the study. Participants were informed that the purpose 
of the study was solely to collect data and that no treatment interventions would be provided. Per 
IRB, participants were additionally informed that while the study was considered minimal risk, 
the content of interview questions could potentially result in emotional distress. The researcher 
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provided participants with information on follow-up mental health care and informed 
participants they had the right to withdraw from the study at any time.  
To facilitate participants’ understanding of the nature of the study, the researcher sent the 
verbal informed consent form, interview questions, a detailed overview of the study, and follow-
up care information to participants via email prior to the telephone interview for their review. 
The researcher reviewed each of these documents prior to obtaining informed consent and 
proceeding with the research interview.  
 Participant exploitation. The fourth ethical issue addresses the risk of participant 
exploitation. Participants were not exploited for personal gain or for the sake of the study. 
Participants were each compensated for their time and participation with a $20 gift card 
following completion of the interview.   
Data Collection 
 Qualitative interviews. Phenomenological studies utilize qualitative, semi-structured 
interviews to collect data from participants (DiDicco-Bloom & Crabtree, 2006). 
Phenomenological interviews contain pre-determined, open-ended questions generated by the 
study’s research questions; yet during the interview these questions may be modified in whole or 
in part, omitted, or expanded upon according to the participants’ self-report of the experience of 
the phenomenon of study (DiCicco-Bloom & Crabtree, 2006; Moustakas, 1994).  
 The researcher’s flexibility and reflexivity throughout the interview establishes rapport 
with the participant and facilitated obtaining the full essence of the participant’s experience. 
Table 3 displays the semi-structured interview questions organized by research question and 
theory. Appendix C contains the semi-structured interview schedule as delivered during 
participant interviews. 
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Participant interviews were conducted via telephone, audio recorded, and transcribed by 
the researcher. Interviews were 45 – 75 minutes in length. While participants agreed to 
participate in a second interview for clarification or expansion of qualitative data if needed, no 
second interviews were conducted. No clarification or expansion of data was needed during data 
analysis, as participant accounts provided rich description that led to achievement of thematic 
saturation. Additionally, participants reported during member checking (discussed further below) 
that their individual and composite descriptions were accurate with no missing or incorrect 
information, and stated that no additional interviews were needed. Using the steps in 
phenomenological data analysis described below, interview transcripts were then analyzed to 
construct individual and composite descriptions of the phenomenology of EOBD. 
Data Analysis 
 Analysis of phenomenological data includes the processes of epoche, phenomenological 
reduction, and imaginative variation. In contrast to quantitative data analysis, the goal of 
phenomenological reduction is the explication of data, rather than explanation of data—the 
phenomenon is exposed and described using the participants’ own words, rather than explained 
and interpreted by the researcher (Van Kaam, 1969). This study used Moustakas’ (1994) 
transcendental modification of the Van Kaam anthropological method of analysis of 
phenomenological data (Van Kaam, 1969). Moustakas adapts Van Kaam’s method to 
transcendental phenomenology, thus altering the data source from observed behavior to 
participant self-report via semi-structured interviews. Table 4 summarizes Moustakas’ 
modification of Van Kaam’s phenomenological data analysis as applied in this study. 
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Table 3. Interview Questions Arranged by Research Question 
Variable Theory Question 
Q1. How do emerging adults (ages 18-25) describe the experience of EOBD during adolescence (ages 13-17) 
in terms of experience of symptoms; changes in individual, social, and family functioning caused by course 
of illness; and the experience and perception of stigma and self-stigma? 
EOBD Neurobiological How old were you when you were diagnosed with bipolar 
disorder? How old are you now? 
What was it like to receive the diagnosis of bipolar disorder? 
What did the illness mean to you at that time? 
How would you describe your experience of bipolar symptoms 
during your teenage years? What were your manic episodes like? 
Your depressive episodes?  
Did you feel that other people (friends, family, healthcare 
providers) understood your experience of bipolar disorder? 
Q2. How do emerging adults (ages 18-25) characterize the cumulative influence of interactions with 
healthcare systems and treatment interventions on their experience of EOBD? 
EOBD Neurobiological; 
Modified labeling 
theory 
Who diagnosed you with bipolar disorder? In what treatment 
setting (inpatient, outpatient)? 
What events led up to the diagnosis? 
Did you have a psychiatrist? A therapist? What was your 
experience with them? 
Have you ever been hospitalized due to bipolar disorder? If so, 
what was that like? 
Were you prescribed medication for bipolar disorder during this 
time? How would you describe your experience with medication? 
Did you feel that the treatment you received was helpful? 
[Whether yes or no:] In what way? 
Did your experience of bipolar disorder change during or after 
receiving treatment? If so, in what way? 
Q3. What are the characteristics of the relationship between EOBD, social and family relationships and the 
developmental transition to adulthood according to emerging adults? 
Interpersonal 
Support and 
Relationships; 
Transition to 
Adulthood 
Emerging 
Adulthood; 
Modified 
Labeling 
After the onset of bipolar symptoms but prior to diagnosis, do you 
remember whether any changes occurred in relationships with 
your family or with friends during this time? 
After receiving the diagnosis of bipolar disorder, do you 
remember any changes occurring in relationships with your 
family or friends during this time?  
What were your greatest supports during this time? What were 
your greatest challenges? 
How did these changes affect you as you moved from 
adolescence into young adulthood? 
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Table 3 (Continued) 
 
Variable Theory Question 
Q4. How have stigma and self-stigma associated with EOBD affected the social, emotional, and cognitive 
development of emerging adults ages 18-25? 
Stigma; Social, 
emotional, cognitive 
development/identity 
Modified labeling; 
Emerging 
Adulthood 
Did you experience self-stigma, in which you label or judge 
yourself, during this time? If so, what was that like? 
Do you feel that any of the changes you experienced in your 
support system or related to stigma or sense of self had an effect 
on your bipolar disorder and mental health during this time? 
Do you feel that your sense of self (sense of identity) changed due 
to your experience of bipolar disorder during this time? If so, in 
what way? 
Did you feel that you understood the changes in your life that 
were occurring due to bipolar disorder? 
 
 
 Epoche. Establishing and maintaining epoche allowed the researcher to analyze findings 
in terms of participants’ experiences of the phenomenon, rather than the researcher’s 
interpretation through preexisting bias. To facilitate epoche, the researcher maintained a 
reflexive journal throughout the study; this is discussed further under implementation of 
strategies for rigor, below. 
 Phenomenological reduction. Phenomenological reduction includes the processes of 
horizonalization, reduction and elimination, clustering, and validation of themes. These 
processes are reviewed in terms of application in this study. 
Horizonalization. Horizonalization consists of identifying and listing every relevant 
expression of the experience; these expressions or moments of the experience are also referred to 
as intentionalities. Intentionalities include both sensory components of the experience (noema) 
and the perceptions, emotions, and meaning attached to the experience (noesis). 
 The researcher read each interview transcript three times to obtain not only an overall 
understanding of participants’ experiences, but also to identify and compile written descriptions 
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of units of meaning of participants’ descriptions. After reviewing all interviews three times, the 
researcher had a compilation of intentionalities, or units of the essences of participants’ 
experiences.  
 
Table 4. Modification of Van Kaam’s Phenomenological Method of Data Analysis 
Step Process 
1) Listing and Preliminary 
Grouping (Horizonalization) 
List every expression relevant to the experience. 
2) Reduction and Elimination 
Review descriptions and keep only those that describe a unit of 
the essence of the experience (invariant constituents). Merge and 
eliminate descriptions as needed to remove overlapping, vague, 
and repetitive descriptions. 
3) Clustering and Thematizing 
the Invariant Constituents 
Organize related invariant constituents (codes) into themes and 
sub-themes. 
4) Final Identification of the 
Invariant Constituents and 
Themes by Application: 
Validation 
Review codes, sub-themes, and themes to verify they accurately 
represent participants’ collective experiences. Discard any themes 
that are not compatible or relevant. 
5) Individual Textural 
Description 
Using codes, sub-themes, and themes, create a description for 
each participants’ experience of the phenomenon. 
6) Individual Structural 
Description 
Using codes, sub-themes, and themes, create a description for 
each participants’ description of the meaning and associated 
thoughts and emotions experienced as part of the phenomenon. 
7) Textual-Structural Description 
Combine the textural and structural descriptions for each 
participant to create complete individual descriptions of 
participants’ full experience of the phenomenon. 
8) Composite Description 
From the individual textural-structural descriptions, develop a 
composite description of the meanings and essences of the 
experience, representing the group as a whole 
Note: Adapted from Phenomenological Research Methods by C. Moustakas, 1994 and Existential 
Foundations of Psychology by A. Van Kaam, 1969. 
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Reduction and elimination. The researcher then reviewed the compiled list of 
intentionalities according to two criteria:  
1) Does it contain an essential moment of the experience? 
2) If yes, can this intentionality be described abstractly and labeled?  
Expressions that did not meet both criteria, that overlapped, were repetitive, or non-
descriptive were discarded. The labeled intentionalities that remained represented the invariant 
constituents (codes), or elements of the participants’ experiences. 
Clustering and thematizing the invariant constituents. The researcher next organized 
the invariant constituents into visual clusters according to participants’ descriptions. The 
researcher re-read interview transcripts and reviewed the clusters both separately and 
comparatively to ensure the notes were grouped in a way that accurately represented the 
participants’ experiences. The researcher then created a label for each cluster. 
The resulting product was a visual series of seven clusters of invariant constituents:  
family, experience of illness, identity, impact of illness, peer relationships, stigma, and 
management of illness. The researcher compiled the visual code-mapping into a preliminary 
codebook that contained the seven clusters (families) and a total of 115 codes.  
Final identification of invariant constituents and validation of themes by application. 
The researcher then reviewed transcribed interviews from participants A, E, and H, and coded 
each interview with the preliminary codebook. Each code was then reviewed three times against 
the following criteria: 
1) Is the code expressed equally throughout each individual transcription, as well as 
among transcriptions A, E, and H? 
2) Are codes explicitly stated and compatible? 
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Through this process, the invariant constituents (codes) were validated, or confirmed, 
through application to interviews A, E, and H. Codes that were not consistently present 
throughout the data, or were not explicitly stated or compatible were removed from the 
codebook. The final codebook includes 54 codes and is included as Appendix D. 
Imaginative Variation. Through imaginative variation, the data is explicated to expose 
the essential structures of the phenomenon and establish the participants’ experience. 
Imaginative variation answers the two core phenomenological questions: a) what is the essence 
of the experience of the phenomenon; and b) in what context(s) did the experience occur 
(Moustakas, 1994)? 
 The completed output from imaginative variation includes four components: an 
individual textural description; an individual structural description; an individual combined 
textural-structural description; and a composite description for all participants. 
 Use of qualitative software in data analysis. The researcher utilized ATLAS.ti software 
during steps 4 through 8 illustrated in the phenomenological data analysis process presented in 
Table 4. While the initial identification of invariant constituents and codes were developed by 
hand, the researcher used ATLAS.ti was used validate codes, code each interview, and 
incorporate code reports in synthesis of themes and sub-themes used to create the individual and 
composite descriptions. The codebook was revised and finalized through consensus coding and 
review of each interview. Following verification of codes, the researcher entered the final 
codebook into ATLAS.ti. Using ATLAS.ti, each interview transcript was analyzed and coded 
with the final study codebook. Once interviews were coded, the researcher created code reports 
that guided the grouping and consolidation of codes into themes and sub-themes. Code reports 
were created for individual interviews as well as for the project (Hermeneutic Unit, or HU). 
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Individual descriptions. Imaginative variation begins with analysis of the individual 
participant’s experiences. Using ATLAS.ti software, the researcher coded participant interviews 
and created an individual code report linking each code with the participant’s quotations. From 
the code report, the researcher created the individual textural and structural descriptions 
incorporating participants’ wording to capture the full essence of participants’ descriptions 
Textural description (noema). A textural description was completed for each participant 
to describe their experience of EOBD, including onset of symptoms, diagnosis, and course of 
illness. In analysis, this emerged as the code family for the experience of the illness itself (i.e., 
symptomatology). 
Structural description (noesis). A structural description was completed for each 
participant to describe their experience of the impact of EOBD, including perception, thought, 
emotion, and coping reactions. Participants described their experience of identity, the healthcare 
system, interpersonal relationships, labeling, and mediating factors associated with EOBD during 
adolescence. 
Textural-structural description. The researcher constructed a merged description for each 
participant that included their experience of EOBD, the illness itself, as well as their experience 
with the impact and effects of EOBD on their sense of self, relationships, and coping behaviors 
during adolescence. The individual textural-descriptions are included in a companion volume to 
this manuscript. 
Emerging adulthood. While the interviews elicited retrospective data, throughout the 
course of the interviews the participants discussed related components of their experience with 
bipolar disorder during emerging adulthood. Participants’ accounts of emerging adulthood 
yielded distinct and separate invariant constituents and themes as compared to participants’ 
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accounts of adolescence. As this study’s purpose and research questions address participants’ 
experiences of EOBD between ages 13 -17, the presentation of findings include only the themes 
encompassed by the study research questions that pertain to adolescence. Additionally, 
participants’ experiences of bipolar disorder after the age of 17 no longer fit within the scope of 
the study, as EOBD is defined as occurring with the ages of 13 – 17. The data on emerging 
adulthood is therefore not included in the composite description and phenomenology of EOBD; 
however, this data is included in the audit trail and within the individual descriptions for each 
participant. 
Composite textural-structural description. In the final step of phenomenological 
analysis, the researcher creates a combined textural-structural description that incorporates the 
invariant constituents and themes of participants’ combined experiences into a composite 
description, or explication, of the phenomenon of study. This final step embodies the essence of 
the experience of the phenomenon.  
Following completion of the individual textural-structural descriptions, the researcher 
constructed the composite textural-structural description. Using the process outlined above, the 
researcher used ATLAS.ti to synthesize codes into sub-themes and themes that represented 
participants’ complete experience of EOBD. The composite textural-structural description is 
presented in Chapter 4. 
Strategies to Maximize Rigor 
 This section reviews strategies to maximize trustworthiness and enhance the rigor and 
validity of the study. Reflexivity of the researcher, member checking, peer examination, audit 
trail, and thick description are discussed with applications for this study.   
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Reflexivity of the researcher. Strategies for enhancing rigor must be built into the study 
design, rather than solely during post-hoc evaluation (Morse et al., 2002). Similar to construct 
validity in quantitative research, reflexivity refers to the researcher’s attitude and mindfulness 
regarding how his or her preconceptions affect the research (Thomas & Magilvy, 2011). 
Reflexivity of the researcher affects the methodological coherence of a study. Considerations of 
sampling strategies and composition, data collection and saturation, and data analysis must be 
congruent to the research questions and methodology. These considerations are established 
during study design but are confirmed and modified throughout the execution of the study 
through the reflexivity of the researcher (Morse et al., 2002).  
In this study, reflexivity of the researcher was employed through continuous iteration—
implementation, reflection, and evaluation of the phenomenological research design—throughout 
data collection and analysis. The researcher’s reflexivity facilitated maintaining mindfulness and 
adherence with study measures designed to maximize trustworthiness, such as reflexive journal, 
audit trail, consensus coding, and member checking. 
Reflexive Journal. Through the study, the researcher used a reflexive journal to record, 
express, and ventilate not only preexisting bias but also the researcher’s reactions and responses 
to participant data during data collection and analysis. The journal was used in a raw and honest 
matter; entries chronicle the researcher’s reflexivity and iteration in designing and implementing 
the study, responses to planned and unanticipated events, and the researcher’s candid and 
sometimes emotional reactions to participant data; as a result, the researcher maintained the 
ability to remain ‘in the moment’ with minimal bias. 
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Peer review and reliability. To ensure dependability and reliability, the researcher 
utilized two qualitative approaches: consensus coding (interrater reliability) and stability 
reliability. Table 5 summarizes reliability in coding of participant interviews. 
 
Table 5. Summary of Reliability in Interview Coding 
Interview Agreements Disagreements Consensus 
Participant A 76 5 .938 
Participant B 60 11 .845 
Participant C 98 16 .860 
Participant D 40 8 .833 
Participant E 68 15 .819 
Participant F 50 10 .833 
Participant G 49 6 .907 
Participant H 68 9 .883 
Total Consensus 509 80 .864 
Stability reliability consensus (A, B, C, E) = .865 
Interrater reliability consensus (D, F, G, H) = .8625 
 
Consensus coding. Four of the eight transcribed interviews (D, F, G, H) were coded and 
compared through consensus coding with a peer reviewer. Two peer reviewers assisted in this 
study: a classmate provided consensus coding for the first interview with the initial codebook, 
which included identification and validation of codes by application. The second peer reviewer 
was the researcher’s major professor, who also provided consensus coding and validation of 
codes by application for four interviews.  
Reliability coefficient. To establish dependability and reliability of data analysis, an 
interrater reliability ratio of .70 was used for each of the four interviews in consensus coding 
(Hays & Singh, 2012). 
Stability reliability. To maximize dependability of individual coding, the researcher 
independently coded interviews A, B, C, and E; and recoded the interviews two days later. As 
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with comparison coding, the researcher compared both codings for each interview and created a 
merged consensus coding using the same interrater reliability ratio of .70. The same codebook 
was used to code all eight interviews.  
Peer examination. An external review can enhance the study’s credibility (Creswell & 
Miller, 2000). Collaboration between the external reviewer and the researcher occurring 
throughout the study can produce an exchange of feedback, criticism, and examination of study 
method and processes. To maximize credibility, the researcher maintained communication and 
collaboration with her major professor throughout design, implementation, and review of the 
study. The major professor provided feedback on implementation of study methods, with 
suggestions for improvement and review. 
Audit trail. The researcher maintained an audit trail throughout the study, beginning with 
the dissertation proposal defense in 2014. The audit trail is presented as a companion volume to 
this manuscript and includes the following components: a) an explicit statement of purpose; b) 
rationale for sampling strategy and selection; c) detailed descriptions of the process of data 
collection and length of time required; d) thorough explanation of data analysis, including 
thematic reduction; e) discussion of the interpretation and presentation of findings; and f) 
verification strategies to establish credibility of study conclusions (Thomas & Magilvy, 2011).  
The audit trail allows for external review and feedback to confirm that study findings are 
grounded in data, inferences are logical, methodology is justifiable and appropriate, extent of 
researcher bias, and use of verification strategies were used to enhance rigor and credibility 
(Creswell & Miller, 2000). 
 Thick description. Rich descriptions of the setting, participants, and themes further 
establish the credibility of the study (Creswell & Miller, 2000). Thick descriptions allow the 
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reader to feel the experience of the phenomenon being investigated. In contrast with descriptions 
simply reporting facts or conclusions, thick descriptions employ a constructivist perspective and 
provide as much detail as possible regarding interaction with participants, participants’ language 
and perhaps body language, and examples of interaction and experience with the participants. In 
this study, thick description consisted of direct quotations and wording of participants to describe 
their experiences of living with EOBD.  
Member checking. Member checking is the most crucial technique for establishing 
credibility (Lincoln & Guba, 1985). Study participants present as a lens through which to 
establish study validity (Creswell & Miller, 2000). From the constructivist perspective, 
participants’ self-report is reality. Therefore, verifying the accuracy of the study’s representation 
of participant data is essential to establishing the rigor of the study.  Through member checking, 
participants review both data and interpretation (data analysis) for confirmation and verification.  
After completing participants’ individual textural-structural descriptions, the researcher 
contacted the eight participants to request engagement in member checking. Four participants 
replied that they would participate, while one participant replied that she did not wish to 
participate and entrusted the researcher with the analysis. Three participants did not reply to 
multiple series of communication from the researcher. 
The four participants who agreed (A, B, F and H) to participate in member checking were 
sent their individual textural-structural descriptions and a summary of themes from the 
composite description. Participants were asked to address a) if themes and study conclusions in 
both their individual and composite descriptions were accurate; b) whether any elements of their 
missing were inaccurate or needed adjustment; c) whether any elements of their experience were 
missing and needed to be included; and d) to provide any additional information or feedback on 
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their descriptions. Participants A, B, F and H each replied that they found the individual and 
composite descriptions to be accurate, but did not offer any additional comments or request a 
second interview. Appendix E includes a summary of the themes sent to participants for member 
checking of composite description. 
In summary, four of eight participants (50%) participants responded to member checking 
and verified their individual description as accurate, while 4 of 8 participants (50%) responded 
and verified the composite description as accurate.  
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Chapter 4: Findings 
The purpose of the present qualitative study is to explore the experience of EOBD 
through semi-structured interviews of emerging adults with a history of EOBD diagnosis. Data 
analysis yielded a construction of participants’ experience of EOBD as an interconnected web of 
five main themes and fifteen sub-themes that characterized participants’ experience of EOBD. 
When describing themes and sub-themes, participants consistently depicted themes as 
experienced in relation to or in conjunction with other themes. Figure 1 displays the 
interconnectivity of participant themes.  
Figure 1. Thematic Illustration of the Phenomenology of EOBD 
 
Study findings are therefore presented in two sections. First, the composite textural-
structural description of participants’ experiences is presented in relation to the purpose of the 
study. Table 6 presents the five themes and sub-themes that comprise the composite textural-
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structural description. Second, themes and sub-themes are discussed according to study research 
questions. Table 7 displays the themes and sub-themes characterizing participants’ experience of 
EOBD as organized by research question. 
Composite Textural-Structural Description of the Phenomenology of EOBD  
 Participants described their experience of EOBD across five main themes: managing and 
coping with EOBD, effect on relationships, change and uncertainty, impact on identity, and 
experience of stigma and labeling. Each theme and its associated subthemes are presented below. 
 
Table 6. Summary of Themes and Sub-Themes 
Managing & 
Coping with 
EOBD 
Effect on 
Relationships 
Change and 
Uncertainty Impact on Identity  
Experience of 
Stigma & 
Labeling 
Experience of 
Illness 
Seeking and 
receiving support 
Change in illness Adaptation & 
integration 
 
Labeling 
Treatment and 
engagement with 
healthcare system 
Difficulty 
maintaining social 
functioning 
Change in identity 
and sense of self 
 
Emotional 
adjustment 
Self-labeling 
Perceptions of 
healthcare and 
treatment 
 
Change in 
relationships 
Secrecy & selective 
disclosure of illness 
Challenging and 
rejecting 
labeling 
Knowledge and 
understanding of 
illness 
Life changes 
Use of coping skills 
 
 
Managing and Coping with EOBD 
Participants described their efforts to manage and cope with EOBD symptoms and course 
of illness. Sub-themes include participants’ experience of illness, perceptions of healthcare and 
treatment, treatment and engagement with the healthcare system, knowledge and understanding 
of illness, and use of coping skills. 
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Experience of Illness. Participants described their experience of EOBD as characterized 
by manic and depressive symptoms, changes in illness, and comorbid symptoms such as anxiety 
and self-injury. Participants’ age at the time of EOBD diagnosis varied from 13 to 17 years old 
(M = 15.56, SD = 1.50). Participants reported age at onset of EOBD symptoms between 7 and 17 
years old (M = 12.88, SD = 2.66). Three participants reported polarity at onset of symptoms as 
manic, while four reported polarity at onset of symptoms as depressive. Participants’ experiences 
of EOBD symptomatology and course of illness are explored here. 
Manic and hypomanic symptoms. Three participants described the polarity of their first 
episode as manic, and all eight participants described experiencing manic or hypomanic 
symptoms during adolescence. Participants described their experience of mania in terms of 
increased energy and productivity, impulsivity, decrease in rational decision-making, increase in 
risky behavior, increased social activity, increased energy and hyperactivity, racing thoughts, 
decreased sleep, euphoria and elation, agitation and aggression, delusional thoughts, grandiosity, 
and hallucinations. 
Participant H described his first manic episode: 
…and I would say my manic episode probably started sometime right 
around when high school started, like the beginning of the year. But it was 
definitely a lot of classic symptoms of bipolar mania[pause] it was like 
delusional thoughts, hard to relate to people in social situations, grandeur 
thoughts, grandiosity [pause] towards the end was I was being 
hospitalized there were some hallucinations going on [pause] just kind of 
out of touch, having that out of touch feeling…feeling like you’re on top of 
the world, you can get anything done [pause] just having really elated 
thoughts, elated emotions that were blown out of proportion. And just like 
overly emotional in situations, like no control over. 
 
 Participant D similarly described her experience with mania: 
When I was younger it would kind of be like I would study nonstop, I 
would read everything, I would do, like, everyone’s homework…I would 
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do so much. I would literally be running up and down my hallway, like 
screaming and studying, and I would get so hyper. Then, like a lot of 
racing thoughts that I would get just kind of made me a good student and 
at the time there was [sic] no depressive symptoms so everyone just told 
me that I was smart and hyper. And so I thought it was normal. But it 
wasn’t really that normal. I had a bit of a hard time sleeping. I would just 
do a little too much than most normal people would… 
 
Two participants reported experiencing dysphoric symptoms, including agitation and 
aggression. Participant G described her manic symptoms in this manner: 
I would get aggressive with my parents. They would even have to call the 
police sometimes, and they would have me take a walk and get me to calm 
down because it would go on for hours at a time. Aggravation, a lot of 
yelling and arguing.  
 
 Depressive symptoms. Five participants described their first episode as 
depressive, and all eight participants described experiencing symptoms of depression 
during adolescence. Participants characterized depression as low mood, sadness, social 
isolation, decreased focus and clarity of thought, decreased motivation, decreased ability 
to do things, crying, and spending a great deal of time in bed.  
Participant C described feeling “numb” and “defeated,” and elaborated further: 
And I knew it was depression, but either way [pause] I was lack of myself. 
I was lack of life. I was basically black and white. Everything was just 
nothing. 
 
 Participant B described her experience with depression: 
When I was depressed I remember laying in bed for months just watching 
TV, just showering was hard, anything like that. I played thoughts in my 
head over and over, like I wasn’t good enough, like no one cared about 
me, and just stuff like that. I would cry a lot, so sometimes I would fall 
asleep crying and wake up crying. 
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 Participant H described experiencing significant changes in cognition and social 
impairment: 
And my depressive symptoms [pause] I’ve never been [pause] I’ve not 
usually been suicidal. I’ve never attempted suicide. But just really low 
motivation, low social desire, low desire to get out or do anything, low 
drive to accomplish anything, your thoughts are a little cloudier, and your 
cognitive function I think is affected slightly since you just are not 
interested in anything. You’re not really—your brain doesn’t really get 
going. It doesn’t really get your gears going about anything…[it] renders 
me not wanting to do anything for anywhere of period of a few weeks to a 
few months. 
 
Comorbid symptoms. Seven of the eight participants described experiencing symptoms 
or diagnoses of other mental health conditions, including anxiety, self-injury, eating disorders, 
and substance abuse. Only one participant described experiencing exclusively manic and 
depressive symptoms throughout adolescence. 
 Six participants described experiencing symptoms of anxiety, including excessive worry, 
panic and panic attacks, and ritualistic behavior to alleviate anxiety. Participants described 
anxiety as emerging from other stressors, as well as stressors associated with EOBD itself. 
Participants D and F described experiencing anxiety as a result of the illness and stressors 
associated with seeking treatment. Participant G described being treated for anxiety prior to 
EOBD diagnosis.  
 Participant C described her experience of having a panic attack: 
I do get a lot of anxiety episodes, and a lot of them are really random. No 
reason to happen. But I could be driving to Home Depot and next thing 
you know I’m having a full-blown panic attack and I’m having to pull off 
the side of the road. 
 
 Three participants described engaging in self-injury during adolescence concurrent to 
bipolar symptomatology. For participants, self-injury was consistently described while 
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discussing anxiety, interpersonal stressors, and lack of control over situations or bipolar 
symptomatology. Methods of self-injury included cutting, burning, and hitting oneself. 
 Participant B described self-injury as a component of her experience of depressive 
symptoms: 
I would kind of like make decisions, like just to stay in my room, and I 
don’t know, like hit things and stuff. But then I also cut myself and would 
burn myself. Stuff like that. I hit myself sometimes. 
 
 Participant D described self-injury as related to depression and suicidality: 
I think that I was 13 turning 14 or something like that, and I basically 
started cutting myself when I was 11 [pause] so it progressed over the 
years and when I was 13 turning 14 I was cutting a lot more and I cut 
very, very deeply so I had to go to [pause] I was feeling suicidal and I 
wanted to practice cutting myself so that I could commit suicide. I don’t 
know what I was thinking. I was young. Um, anyways. So during this 
episode of cutting I had slit my wrists too deep and my brother saw it, so 
they took me to the hospital. 
 
 Two participants described being diagnosed with attention-deficit disorder. Participant H 
described ADHD as an additional challenge during adolescence: 
I was getting tested because I thought I had ADHD. And I eventually got 
diagnosed and medicated for ADHD, and it felt like the right thing to do 
because I was really struggling to focus on my schoolwork, but I only 
stayed on medication for about 3 years [pause] just getting on the meds 
itself was a challenge. And dealing with a dual diagnosis, another 
diagnosis, ADHD, in addition to bipolar disorder… 
 
One participant described comorbid substance use during adolescence. Participant E 
described marijuana and alcohol use that coincided with onset of her first manic episode. 
Participant E described her substance use as a trigger that obscured the onset of symptoms. 
I started smoking and drinking, and then after that it was just like… you 
know sometimes with drugs it makes things more uh [pause] amplified I 
guess. Like they really bring out the symptoms. And when I was at school, 
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I would smoke a lot and I would drink a lot. And I remember one night I 
started hallucinating, and I was like ‘yo, like I’m seein’ shit’—excuse my 
language. I curse a lot—‘I’m seein’ shit, like what is going on?’ And my 
roommates were looking at me like, ‘what? Like, are you that high?’ At 
first it was cool that I was smoking, that I could put everything on a drug 
and just be like ‘oh I was high. That’s some strong weed!’ and people 
obviously didn’t really know that I was like having a breakdown.  
 
 Participants B and C described having an eating disorder during adolescence. Participant 
C stated her eating disorder began following a significant reduction in appetite due to ADHD 
medication, while Participant B described her eating disorder as associated with self-esteem, 
self-judgment, and self-labeling. 
Suicidality. Two participants reported experiencing suicidal ideation with suicide 
attempt.  
 Participant D described her suicidal thought processes: 
…at the time I felt like, ‘oh well I should [commit suicide] [pause] if this is 
who I am, like, I should just kill myself.’ I was like, if I’m sick why am I 
going through this, or whatever [pause] and for some reason I didn’t 
[commit suicide]. I don’t know why. 
 
 Participant C described feeling defeated as a part of depression, and associated defeat 
with suicidal ideation: 
And I always kind of knew I was kind of defeated and I wanted to defeat 
myself, I wanted to hurt myself, I wanted to end my life. I did several 
suicide attempts to try to do that. And all the suicide attempts that I have 
done have failed. 
 
 Two participants described suicide attempt in addition to ideation. Participant C 
recounted her experience with a failed suicide attempt: 
And I actually attempted suicide. I had a belt that I was trying to hang 
myself with, but it broke. And it took a lot for me to build up to do that, 
and when it failed I didn’t really have—I couldn’t build myself up to do it 
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again. I guess I was just scared of what would happen. I wasn’t scared of 
dying, I was just more scared of what would happen after I went. You 
know, what would my parents say about me? 
 
Treatment and engagement with healthcare and treatment. As part of symptom 
management and treatment for EOBD, participants described their experiences with the 
healthcare system. All participants described accessing healthcare at varying levels of acuity 
ranging from psychiatric hospitalization to outpatient treatment. Participants described sub-
themes that included their perceptions of healthcare, as well as ease or difficulty of access to 
services. 
Accessibility of healthcare.  All participants described utilization of healthcare services 
throughout adolescence. All participants described seeing a psychiatrist and taking psychotropic 
medication following receipt of EOBD diagnosis, while five participants described additionally 
seeing a therapist. Five participants reported history of psychiatric hospitalization due to bipolar 
disorder. Two participants were diagnosed in hospital settings, while six were diagnosed in an 
outpatient setting by a psychiatrist or therapist. Two participants described initially accessing 
healthcare and treatment involuntarily through law enforcement, while six participants described 
voluntarily seeking treatment. Accessing healthcare did not necessarily coincide with onset of 
symptoms or receipt of EOBD diagnosis. While four participants described receiving EOBD 
diagnosis and treatment upon first accessing healthcare, the other four participants described 
initially seeking and receiving treatment and non-EOBD diagnosis such as depression or anxiety.  
  Participant H described entering the healthcare system through hospitalization during his 
first manic episode after a prolonged experience of untreated symptoms: 
So at 14 when I first got diagnosed, that was probably the worst manic 
episode I’ve ever had. And it was the first time I ever experienced the 
symptoms of my bipolar disorder. And it was probably as bad as it was 
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because I was unmedicated. My parents never thought about treating me 
for a mental illness or going to see a psychiatrist for any of my issues that 
I had…and I would say my manic episode probably started sometime right 
around when high school started, like the beginning of the year. And it 
only took me 6 to 8 weeks into high school to have full-blown manic 
feelings and to have my mom realize ‘okay, you need to go to the hospital.’ 
 
All participants described continuing healthcare and treatment for EOBD in some form 
throughout adolescence. Six participants described maintaining continuous psychiatric care and 
psychotropic medications, while two participants described receiving only psychiatric care, one 
participant described receiving only therapeutic care, and two participants described inconsistent 
compliance with treatment of any kind. Participants ascribed their decisions to maintain 
engagement in healthcare as related to their perceptions of treatment, discussed further.  
Psychotropic medication. Psychotropic medication was a core component of all eight 
participants’ treatment for EOBD, and was described as profoundly impacting their experience 
of EOBD throughout adolescence. All participants reported taking medication throughout 
adolescence. Five participants described an improvement in symptoms with medication and 
maintained compliance with psychiatric treatment, while two participants reported that 
medications at times appeared to exacerbate symptoms and reported intermittently discontinuing 
medication as a result. One participant described resistance to psychotropic medication 
throughout adolescence and stated she did not begin taking medication until age 19.  
All participants described having multiple healthcare providers during adolescence and 
taking several medications before finding a medication that worked with tolerable side effects. 
Of the seven participants who were prescribed psychotropic medication during adolescence, all 
identified medication side effects as a significant challenge.  
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Participant H described experiencing significant side effects from medication that 
included sedation, cognitive dulling, and weight gain, and described being “like a zombie.”  
Over the course of my adolescence I probably gained 75 pounds or 
something, and some of it might be due just to growing—I mean not 
growing height-wise, but just growing, everything filling in—some of it 
was definitely due to the medication and weight gain. And then from 18 to 
23, with the different medications I’ve been on, I’ve gained an additional 
100 pounds. And I’m not even that fat of a person, I’m like 6’ 3” and 
weigh 270 right now. But the fact that being on medications caused me to 
gain almost 200 pounds in the course of my lifetime is just crazy. 
 
All seven participants who reported taking medication during adolescence described 
being prescribed stronger medication during and immediately following symptomatic episodes, 
with adjustments in medication strength occurring as symptoms stabilized.  
Participants C and G described reported mixed benefit from medication and stated at 
times their symptoms appeared to worsen with medication. Participant G described experiencing 
increased agitation, suicidality, and sedation due to medication, while Participant C described 
experiencing cognitive changes: 
 
I had a very terrible effect with that medication. I was driving to work and 
I felt like I was detached—I felt like I was a puppet on strings and it just 
felt like when I stood up or did anything, it just felt like the strings got cut. 
So it really felt like I just couldn’t move myself. Someone just took—it felt 
like they just took my soul away. It really just—all of me they just kind of 
removed. All my personality they just removed. And I only took it once, a 
very low dose too…Either way, I was driving and I had a bad reaction to 
it and I almost got into a car accident. It just wasn’t a good medication. 
 
 Participant H described medication as beneficial, but also addressed the challenge of 
medication for differing manic and depressive episodic states. Participant H described the 
desired outcome of balance and remission of symptoms as difficult to attain.  
68 
And it [EOBD] sometimes can get helped with the medication, but 
sometimes the medication can only help so much without them wanting to 
induce a manic episode. So I think that’s the toughest part of bipolar 
disorder—you need to stay in the middle and that’s not how medications 
work all the time. 
 
While participants described the challenges associated with psychotropic medication, 
they also acknowledged its benefits. Six of the seven participants who were prescribed 
medication in adolescence described psychotropic medication as the catalyst for their 
symptomatic improvement. Participant A described medication as effective and the key factor to 
her stability: 
I don’t know if I would be able to effectively handle it if I had just had 
counseling. I just know that since I started taking the medication my life 
has improved immensely. And there has not been a point where I have 
gone off my medication and had issues. So I think that is—that has to be 
what is helping. 
 
Participant B described both the benefit and uncertainty associated with psychotropic 
medication: 
You know, I think medicine has helped me so much. I really do think it’s 
helped save my life. And it’s still really difficult. It’s really hard when the 
medicine stops working and you have to try a new one. You don’t know 
what it will do. And the side effects [pause] it’s really difficult. But I want 
to do everything I can to help myself, so I think medicine is a good thing. 
  
Psychoeducation. Participants described psychoeducation as helpful in understanding 
EOBD and their experience of symptoms during adolescence. Participants described obtaining 
psychoeducation from providers as well as through their own self-education. Participants 
described psychoeducation being provided to family members as well. 
Participant G described psychoeducation she received at time of diagnosis: 
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They said it was a mood disorder mostly. Nothing to do with physical or 
real bad mental issues, but they said I would need to take medicine for it, 
come back for treatment, and basically get it in check to see if everything 
was okay. 
 
 Participant H described receiving psychoeducation from providers, but stated his own 
research and self-education were beneficial in understanding EOBD: 
I still think that [psychoeducation from providers] got me halfway there. 
And the other halfway was me reading online about bipolar disorder and 
learning about it myself. 
 
While participants described the value of psychoeducation, they did not describe a 
change in stigma, acceptance of denial of illness, or interpersonal relationships concurrent to 
psychoeducation. Additionally, knowledge and understanding of illness was described as 
separate and unrelated to provision or receipt of psychoeducation. Psychoeducation, therefore, 
emerged as the transmission of information rather than the absorption, incorporation, or 
understanding of the information. 
Perceptions of healthcare and treatment. Participants described their perception of 
healthcare and treatment for EOBD as both beneficial and non-beneficial. Participants 
additionally described the healthcare system as potentially difficult to navigate. Participants also 
expressed avoidance and ambivalence toward healthcare and treatment for EOBD.   
Healthcare is beneficial. All participants described healthcare and treatment for EOBD 
as beneficial. Psychotropic medication and psychotherapy were identified as particularly 
beneficial to participants.  
Participants who described psychotherapy as beneficial identified validation, 
psychoeducation and normalization of their experience, unconditional regard from healthcare 
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providers, and ability for self-expression were as specific components of their experience that 
were beneficial. 
 Participant G additionally described her therapist as beneficial due to validation, self-
expression, and gaining an understanding of her experience: 
And my therapist, talking to them [therapist] actually helped me out a lot, 
being able to get stuff off my chest that I wasn’t able to with my own 
family. But being able to talk the situation out with somebody else that 
actually had somewhat of an understanding of what I was feeling made the 
situation a lot better. 
 
 Participant B described therapy as beneficial because it “served as an escape” from 
stressors and symptoms. Participant B also described therapy as beneficial when it was 
individualized and incorporated her use of art as a coping skill.  
 Participants also described the combined treatment approach of psychiatric care and 
psychotropic medication as beneficial. Participant A described seeing several therapists during 
adolescence, but stated it was upon seeing a psychiatrist and beginning medication that EOBD 
symptoms began to improve, while Participant E described healthcare and treatment as beneficial 
in helping “taming” the illness and stabilizing symptoms. 
 Participant F described her experience with therapy and medication as an influential part 
of her adolescent experience: 
Yeah looking back—well the therapy that I had when I was a teenager was 
so important. And she was a really good therapist and helped me through. 
But yeah, the psychiatry too, because I wouldn’t have had my medication 
corrected with the mood stabilizer and would probably be a very different 
person or in a very different place if I hadn’t been put on it. 
 
Healthcare is not beneficial. Six participants described aspects of their experiences with 
psychotherapy, medication, and hospitalization as not beneficial. Participants identified lack of 
knowledge and understanding of illness as the factor that determined whether healthcare and 
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treatment were beneficial. Lack of knowledge and understanding of illness emerged as the most 
common code across all participants and is discussed further below. 
Several participants described therapy as non-beneficial due to lack of rapport and 
therapist understanding of their experience. When asked about whether her experience with 
therapy was beneficial, Participant D replied: 
The therapy no because…the therapy, especially no, because she would 
just scribble things in her notebook and ask one question, sit there ten 
minutes in silence. So therapy, no. 
 
 Participant H described experiencing therapists’ lack of knowledge and understanding: 
In understanding what I was going through and also, as a therapist it’s 
your responsibility to help people get through what issues they need to 
work on, and I just don’t feel like they were able to provide that especially 
in the context of having bipolar disorder. 
 
 Participants described psychiatric hospitalization as a negative experience with limited 
benefit. Overall, hospitalization was described in terms of lack of understanding by staff and 
providers, as well as lack of control over admission, discharge, and treatment. Participant D 
described her experience with psychiatric hospitalization in terms of lack of knowledge and 
understanding by hospital staff and providers: 
So they don’t know [pause] there’s different levels of illness I want to say 
in the hospital setting, or mental health setting, medical setting…so it’s 
like, they stick us all—these different levels. And it’s like this one person 
might be very hostile…I mean, in the hospital this girl was throwing a 
chair at me, and like threatening to kill me, and they didn’t know what to 
do about it. And I told them—before it even happened—this girl is 
harassing me, I know it’s going to get worse; can you do something? They 
would just tell me that I’m being paranoid, that with my disorder making 
me think things that aren’t true. And, so just like…I don’t know. There’s a 
lot of things. It’s like the fact that they think you should just do whatever 
because you have a disorder and not take care of you. It’s negligence. And 
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the setting itself is just [pause] a lot of things about it. I don’t even know 
how to get into it, so I’m just going to leave it there. 
 
Avoidance of healthcare. Several participants described avoidance of psychiatric 
treatment and psychotropic medication during adolescence. Participant F described seeing a 
therapist while declining medication until she noticed EOBD symptoms were not improving. 
Participant A described beginning therapy in eighth grade, but stated she did not see a 
psychiatrist or begin medication until age 17; at which point she was diagnosed with EOBD 
when symptoms had not improved. 
Participant B stated that while she received multiple EOBD diagnoses by psychiatrists at 
age 16, she refused to return for psychiatric treatment and medication until age 19. Participant B 
described her decision in terms of avoidance to preserve autonomy and self-sufficiency: 
I just wanted to be able to do it by myself instead of having something to 
help me. Because I didn’t like taking them [medications] every day and 
like, I just didn’t like being on meds. I don’t know why I was really so 
against it as a teenager. 
 
 Participants C and G described self-discontinuing a medication regimen for several years 
due to negative experiences with medication effects and side effects. Participants D, E, and H 
also described efforts to prevent and avoid psychiatric hospitalization following negative 
experiences.  
Difficulty navigating the healthcare system. Three participants described difficulty 
accessing healthcare due to issues with insurance or ability to afford services, finding available 
providers, getting medication on time, and coordinating between providers. Participant G 
described difficulty finding providers due to insurance, and stated she continued to see 
ineffective providers for years due to lack of alternate options: 
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At times it was hard to find a provider, be able to get different help, 
because a lot of the providers didn’t accept the insurance that I was 
getting, and they wouldn’t accept it for therapists and psychiatrists. So it 
was a lot of moments where I felt like I was not able to get help for myself, 
but I went back to the same provider for those 4 years because I wasn’t 
able to get the help that I needed at the time.  
 
 Participant F described difficulty coordinating between providers, specifically between 
psychiatrists and pharmacies to ensure they received psychotropic medication regularly. This 
participant also described incidents of having to forego medication temporarily due to difficulty 
navigating coordination between providers: 
Ambivalence toward healthcare. One participant described ambivalence and uncertainty 
regarding treatment interventions and providers associated with lack of trust and loss of 
autonomy. Participant H described his ambivalence toward healthcare providers: 
Like, they’re [healthcare providers] the people you’re supposed to trust, 
and they’re the people you rely on for your medication. Like if I went off 
my medication I would go bipolar again. And I can’t have that. And so it’s 
really hard…you’re put in a really tough spot where it’s like you’re forced 
to trust them, they have no—like, you have no cards in your hand and the 
cards are all in their hand.  
 
 Knowledge and understanding of illness. Knowledge and understanding of 
EOBD, as well as lack of knowledge and understanding of EOBD also emerged as core 
components of participants’ experiences. While six participants described knowledge and 
understanding of EOBD as part of their experience, lack of knowledge and understanding 
of illness was endorsed by all eight participants and was the most common invariant 
constituent throughout all interviews. Participants described not only their own lack of 
knowledge and understanding, but that of their families, peers, and healthcare providers.  
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 Lack of knowledge and understanding of illness. Participants described 
experiencing confusion and lack of understanding of emerging symptoms. Participants 
described having a limited understanding of EOBD at the time of diagnosis. 
Participant D described her own confusion and lack of understanding of EOBD 
symptoms: 
It’s still hard because my brain isn’t even fully developed yet, nor was it 
when I was at that age. With my emotions and everything, it was like 
really hard. I didn’t understand any of it. Like, when I was younger I 
literally didn’t understand what was going on, why I couldn’t focus or why 
I was having strange thoughts that I couldn’t really explain. And it just 
kind of felt like [pause] I don’t know. It was confusing. 
 
 Participants described their families’ lack of knowledge and understanding of EOBD 
throughout adolescence. While some family members lacked understanding of specific 
components of EOBD, others viewed EOBD as an ‘excuse’ for unstable and symptomatic 
behavior. Participants A and F described their parents as understanding components of EOBD, 
specifically depression, without understanding the full scope and nature of EOBD and need for 
psychiatric treatment. 
Participant F stated her parents did not fully understand bipolar disorder 
symptomatology:  
…they just don’t always seem to get what’s happening because—or they 
see it still as depression rather than bipolar. Because they don’t really 
understand the manic part of it, and that my mom has had bouts of 
depression in her life, so they don’t really understand the manic part of it 
at all. 
  
 Participants C and G described their families’ lack of understanding of EOBD and stated 
their families viewed the illness as attempts to justify behavior disturbances. Participant C 
described her mother’s lack of knowledge and understanding: 
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My mom basically had to deal with me and all my appointments and my 
bipolar symptoms. She was there to, like, see it all, but yet she didn’t 
understand. So she would come home and get upset, why didn’t you do the 
dishes, why didn’t you do this, why didn’t you do that. Like, it’s almost 
kind of like every parent says that. So this would go on for weeks. I 
wouldn’t get out of bed. She didn’t really understand it. 
 
 Participant A attributed her family’s lack of understanding in part to the difficulty 
distinguishing between normative adolescent mood swings and EOBD symptomatology:  
I think that people generally expect teenagers to be super moody and 
fluctuate in terms of how they feel all the time, and so I think that being a 
teenager with bipolar disorder is extremely hard because you have to 
communicate that what you’re feeling is not within the normal range. 
When people expect that kind of depressive symptoms. And I think that 
was the hardest thing with my family, with trying to convince my mom that 
she was wrong to think that what I was experiencing was normal. So I 
think that’s the biggest challenge. Because once you get older, I think if 
you have symptoms of bipolar disorder people generally tend to think that 
they are abnormal and you get help faster but as a teenager they’re 
introducing so many things that people can’t look into how difficult it is 
for you in comparison to others.  
 
Knowledge and understanding of illness. Participants described attaining their 
own understanding of the illness and discussed the knowledge and understanding of 
illness of their support system as well as healthcare providers. All participants described 
knowledge as part of receiving the EOBD diagnosis and attaining an understanding of the 
symptoms, course of illness, and treatment implications for EOBD. Seven participants 
described receiving the EOBD diagnosis as a confirmation of the problematic symptoms 
they had been experiencing. 
Participant D described her reaction to receiving the EOBD diagnosis: 
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…but it did also provide me some sort of feeling of understanding of what 
I was going through, like the sixth sense. Like there’s a pattern here, you 
know? 
 
Participant F described gaining an understanding of her experience: 
 
…because I’m a really upbeat person, so depression never seemed right. 
Because I would have manic episodes and not really get how that fit into 
it, so having the diagnosis of bipolar just made so much more sense as to 
what was going on with me personally. 
 
 Denial of illness. While participants described knowledge and lack of knowledge 
and understanding of illness, six participants additionally described experiencing denial 
of illness, in which the knowledge and understanding of EOBD was present but 
simultaneously refuted. Participants described their own denial as well as that of their 
support systems. Participants described difficulty accepting EOBD diagnosis as 
influencing engagement in treatment and interpersonal relationships; as well as related to 
participants’ sense of self. 
Participant H described EOBD diagnosis as difficult to accept. Participant B described 
being “in denial a little bit,” getting three EOBD diagnoses by multiple providers (the initial 
diagnosis as well as a second and third opinion), and avoiding seeing a psychiatrist or taking 
medication for several years. 
 Participant E described experiencing denial during onset of symptoms and for several 
years following diagnosis. Participant E described compliance with treatment out of fear of 
relapse, but stated she continued to hope the diagnosis was wrong: 
…it’s like yes, I understood it but I was in denial for I would say…I was in 
denial for about 4 years or so. So I knew it, like I would go to a 
psychiatrist and get medicine and stuff like that. But I was still kind of 
hoping that, in the back of my mind I was always hoping that I really 
wasn’t bipolar and really it was just like the drugs that were doing 
something. 
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 Five participants described their family’s denial of illness and need for treatment. 
Participants described others’ denial of illness as unaffected by interactions with healthcare 
providers and psychoeducation.  
Participant A described recognizing and accepting EOBD symptoms; however, described 
her mother’s denial: 
And my mom was also very adamant about the fact that she didn’t want to 
have a child with mental illness, and thought that it would reflect on her 
as a parent if I did, and so she was also very invested in making sure that 
she mitigated my symptoms and basically just dismissed them. 
   
 Participant E described denial of illness within community and cultural context that 
shaped her experience of EOBD: 
I want to say I’m African-American, first of all. A black woman. So I think 
mental illness especially in the black community is—how do I say this—
it’s something that black people, like, deny. Because black people for so 
long have always tried to be so strong and, you know, it’s just something 
that…for example, one of my friends was depressed and her father was 
like ‘only white people get depressed.’ You know, get over it, toughen up 
and keep going. 
 
Use of coping skills. In addition to treatment interventions, five participants described 
their own coping efforts and use of coping skills to alleviate symptoms and stressors. 
 Participant G described writing poetry, listening to music, and talking to others as helpful 
with agitation, anxiety, and depression. Participant B described art as both helpful and 
therapeutic.  
 Participant E described reading success stories of others with mental illness as inspiration 
and a source of strength. 
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I would read stuff about people who were bipolar. Or I would look at 
celebrities or other people that were famous and living their life 
wonderfully, that were bipolar. Like, I forgot…what’s his name? Robert 
Downey, Jr or something? That guy, Iron Man. He has mental disorders. 
And I know there’s some other woman that’s, like, gorgeous that has 
bipolar disorder. So that’s basically what I did, is I didn’t let it get me 
down. Obviously I propelled my life into something else.  
 
Effect on relationships 
A second theme of participants’ experience of EOBD was the changes that 
occurred in interpersonal relationships. Participants described their efforts navigating 
normative adolescent changes in peer and family relationships as well as the added 
element of changes prompted by the presence and course of EOBD illness, stigma, and 
engagement with the healthcare system.  
 Difficulty maintaining social functioning. Participants described difficulty 
maintaining peer and family relationships due to decline in social functioning, isolation, 
and conflict. While participants noted change as a normative part of adolescence, the 
difficulties noted below were attributed specifically to the impact of EOBD. 
Family relationships. All participants described change and conflict in family 
relationships, ranging from lack of understanding to fighting and aggression. Participant 
G described experiencing frequent family conflict she associated with EOBD, including 
yelling, arguing, and fighting with family members’ and identified rebuilding family 
relationships as her greater challenge during adolescence 
 Participant E described an intense argument with her sister that occurred when living 
with her sister following diagnosis: 
I lived with her [sister] when I transferred back and went to a different 
school. And one time she and I had an argument. She got really pissed off. 
I don’t remember what we’d argued about. And she told me—she’s like, 
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‘you know what…you are so annoying. I’m just going to take all your 
medicine and I’m just going to flush it down the toilet so you don’t have 
any medicine.’ And she was like ‘and then you’ll just have an episode 
again.’ And when she said that to me, I was like, wow. And it took me 
years to forgive her for saying that, because I was like, you’re my f***ing 
sister…how dare you, in the heat of an argument, use my mental disorder 
and threaten the argument on throwing away my medicine so that you’ll 
affect me. 
 
Peer relationships. Six participants also described experiencing difficulty and 
conflict in peer relationships. Participants described difficulty making and maintaining 
friendships due to the presence of EOBD symptoms and resulting changes in behavior.  
 Participant C associated difficulty maintaining friendships in high school with peers’ lack 
of knowledge and understanding of EOBD: 
I lost every single one of my friends in high school. People just saw me as 
a freak. They didn’t like--they didn’t like that I was just unstable. And I 
can see from their point of view. Who wants a friend, you know, who’s 
going through a hard time? and they try to help and nothing they do helps. 
So basically a lot of friends would give up on me or people would just 
walk out immediately. They just don’t want to deal with it, or they don’t 
like it.  
   
 Following hospitalization and beginning treatment, Participant H stated his parents 
transferred him to a different high school. Participant H then described the difficulties associated 
with social functioning while receiving treatment for EOBD:  
I knew I had to make friends all over again after losing all my friends, and 
I don’t know [pause] it was really rough with relationships with friends 
because I was zonked out on really heavy sedating meds that hadn’t gotten 
phased out yet since being in the hospital. So just kind of now, instead of 
dealing with having a manic episode while adjusting to going to a brand 
new high school, I was dealing with bipolar disorder diagnosis and 
medication while going to a brand new high school and that was just as 
rough in my opinion. 
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 Isolation. Four participants described an increase in isolation associated with 
onset and experience of EOBD symptomatology, including withdrawal from social 
situations, pushing others away, and selectively leaving their ‘safe space’ (e.g., bedroom). 
Participants described isolation occurring in conjunction with symptoms of depression 
and anxiety, as well as part of efforts to cope with EOBD symptomatology. 
 Participant B described isolation and a disruption in relationships associated with EOBD 
symptomatology: 
So [I] just became a lot more isolated. I guess because I was just crying 
all the time and I just would go by my feelings with friends. I think a lot of 
it was on my part, with my change in relationships just because I became 
more isolated. I would get attached to certain people but then detach and 
[pause] I would just go by my feelings and moods with people. 
 
 Participant A described an association between isolation and increase in 
symptomatology: 
I think that feeling socially isolated just makes everyone’s symptoms 
worse. That was a pretty big piece. And I don’t think I’ve felt as socially 
isolated as I did during my senior year at any other point in my life. 
 
 Seeking and receiving support. Participants described seeking and receiving 
support from others as a key component of their experience of EOBD throughout 
adolescence. Seven participants described having a support system, while two 
participants described a lack of support during adolescence. Participants also described 
seeking help and support upon noticing EOBD symptoms and receiving support from 
family, peers, and healthcare providers. 
Support. Seven participants described their family and peers as supportive during 
adolescence. Participants described support as separate from knowledge and understanding and 
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involvement in treatment. Support was described as listening, attempting to understand, and 
trying to help unconditionally. 
Participants B and H described their parents’ support in the process of coping with 
emerging symptoms, seeking help, and receiving the EOBD diagnosis.  
Participant B described approaching her mother upon noticing prodromal symptoms: 
I struggled a lot before that [EOBD diagnosis]. I came out to my mom and 
told her I had been having a lot of the mood swings, which she noticed. 
And I told her about all my suicidal thoughts, the trouble I’d been having. 
I opened up a lot. And she helped me get a therapist and stuff. 
 
Participants also described receiving support from friends and peers. Participant A 
described her friends as having an active role in advocating for her to seek treatment due 
to emerging symptoms:   
There were a couple people who I was friends with who I didn’t see in 
person, so some long-distance friendships. People who just saw my 
emotional patterns and were trying to persuade me to get a diagnosis 
because I wasn’t seeing anyone… I think that getting the bipolar diagnosis 
definitely confirmed what they had suspected, that there was something 
more significant going on than depression and they were much more 
vigilant in trying to help me. 
 
 Involvement of others in treatment. Six participants reported that family 
members provided referrals or facilitated treatment, coordinated with healthcare 
providers, participated in treatment sessions, and administered participants’ medication. 
Involvement of others in treatment was described as separate from support and lack of 
support, and was perceived as both beneficial and not beneficial. 
Participant G stated her mother would attend therapy sessions with her and would at 
times receive progress reports from providers. Participant B described her mother’s involvement 
as helpful in conveying emerging symptoms to the psychiatrist. Participant A stated her mother 
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recommended and paid for her to see a psychiatrist at age 17 when symptoms had not improved 
through therapy. 
For some participants, family involvement was not a positive experience. Participant C 
described her mother’s involvement in treatment as having a negative effect on therapeutic 
rapport: 
I was trying different medications and my mom only had to take me to 
therapy sessions. The therapist would eventually try to tell her what my 
mood disorders are and what are the actual symptoms and my mom would 
fight it. And eventually the therapist would get so tired of fighting with my 
mom they would—the therapist would say ‘your mom’s being right. You’re 
being lazy, so you need to step up or you need to help out your mom.’ It 
just felt—I changed therapists shortly after, but with that it didn’t feel like 
I actually had a therapist.  
 
 Loss of autonomy due to healthcare. Participants C, D, E, G, and H described 
incidents in which they felt excluded from their treatment team and experienced a loss of 
autonomy. Each of these participants described incidents when healthcare providers 
spoke only to their parents and they were not involved in treatment sessions or decisions. 
Additionally, participants D and H stated they were not able to administer their own 
medications for significant periods of time. Participants described feeling invalidated and 
frustrated, and associated the lack of inclusion and autonomy with their age.  
 Participant H described loss of autonomy: 
And so…from ages 14 to 16 I didn’t administer my own meds. My dad was 
the one who gave them to me every night, and he kept them locked up. And 
I don’t know if it was a lack of trust or what [pause] and my dad would 
frequently come to my psychiatrist appointments and there were times, 
especially if I was really depressed, he would just talk to the psychiatrist 
instead of me. And that made me feel really not included in my own 
treatment plan. So it definitely was less trust and more careful treatment. 
And it’s kind of weird because I didn’t cause myself to have bipolar 
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disorder, so why they thought that they needed to do that was [pause] I 
don’t know, maybe it was their own m.o . 
 
Lack of support. Participants A and C described having limited support during 
adolescence. Participant A described peer support as indicated above, but described an absence 
of family support characterized by her mother’s denial of illness.  
…and so I really didn’t feel support sometimes. I really didn’t feel support 
from family, and still don’t really feel support from family. 
 
Participant C described a lack of family and peer support, as well as limited support 
during her pregnancy at age 15. Participants A and C both described feeling alone and having 
‘no one there’ for support. 
Seeking help and support. Four participants described seeking treatment and support 
from others voluntarily upon noticing emerging symptoms. Each participant described reaching 
out to their parents for assistance accessing healthcare and for support in managing symptoms.  
Participant B described reaching out to her mother first for help seeking a psychiatrist, 
but also described seeking support from friends and church leaders in her support system. 
Participant B described receiving limited support and stigmatizing responses from friends 
and church leaders; this is discussed more fully as part of the theme of stigma.  
Change and Uncertainty 
Participants’ overall experiences of EOBD were characterized by change and 
uncertainty. All eight participants described their adolescence as a period of continuous 
changes in symptomatic states and course of illness, identity and sense of self, and 
relationships. Participants also described life changes that affected their experience 
during adolescence.  
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Change in illness. While each of the participants described experiencing 
depressive, manic, and comorbid symptoms, each of the 8 participants characterized their 
overall experience of EOBD as dominated by change, uncertainty, and instability of 
symptoms. Duration of episodes varied from days to weeks or months; the severity and 
frequency of symptoms similarly varied. The severity of manic and depressive episodes 
was described as ranging from disruptive to debilitating. While some participants 
described an experience dominated by depressive episodes, others described that manic 
episodes were more disruptive to their lives in adolescence.  
Participant G described her experience of changes in duration and type of episodic states 
I experienced depression for weeks at a time. It would come and go. And 
then I have moments of anxiety, aggravation, and irritability. And I was 
really becoming passive-aggressive towards everybody around me. 
 
 Participant B described experiencing instability in the type of symptoms as well as course 
of illness:  
I’ve heard of this thing called rapid cycling. I’m not sure what that is, but 
they [symptoms] would shift a lot. But there would be times where I’d 
have a long depression, like where I had it for a couple months. And there 
would be weeks of hypomania. But a lot of it was throughout the day, 
even. 
 
 All participants also described a change in the type of episodes they experienced 
throughout adolescence. . Participants E and H experienced manic polarity at onset of illness, 
and described a pattern in which manic symptoms largely subsided, while depressive episodes 
had become more dominant. Participants A and F described the inverse: a course of illness 
initially dominated by depressive episodes, and more recently characterized by manic episodes. 
Participant F also described experiencing more depression when younger. Participants C and G 
additionally described experiencing persistent symptoms of anxiety, irritability, and emotion 
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dysregulation. Participants described ideation for self-injury and suicide as overall decreasing 
throughout adolescence as well.  
Change in identity and sense of self. Each of the eight participants described 
experiencing changes in sense of self. Six participants described experiencing a change in 
identity that consisted of viewing themselves as different or defective as a result of 
EOBD. Three participants described a change in their thoughts, beliefs about themselves, 
and behavior occurring as a result of EOBD.  
View of self as different or defective. Six participants described experiencing a 
change in identity in which they came to view themselves as defective, damaged, or 
different from others due to EOBD—a sense of liminality and ‘otherness.’ Participants 
described themselves as flawed, abnormal, worthless, and weak. Participants described 
feeling that there was something ‘wrong’ with them, that they were an outcast, and that 
others would not care for them if they became symptomatic. 
  Participant A described her experiencing a change in identity due to the implications of 
an EOBD diagnosis, as opposed to her previous diagnosis of depression. 
I went from thinking that I was basically experiencing something that a lot 
of people go through to thinking that I was just having depression and 
when I was older like my siblings I would be able to get out of it from 
having that diagnosis and having the psychiatrist tell me this [bipolar 
disorder] is a lifelong thing that I’m going to have to manage that really 
shifted my sense of self. 
 
 Participant B described feeling worthless and not ‘good enough:’ 
I was very judgmental. I had this self-esteem thing going on as well as the 
bipolar, so I did go through a lot…just thinking I’m worthless and trying 
to be better looking. Like I had an eating disorder as well at 18. Um. I just 
didn’t think I was a good person. I just thought I wasn’t worth it, I guess. 
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 Changes in decision-making. Three participants described experiencing significant 
changes in their identity in the form of changes in thought patterns, perceptions, beliefs about 
themselves, and behavior. Participants described engaging in unhealthy behaviors, choosing not 
to pursue goals, and changes in coping patterns following EOBD diagnosis. 
Participant E described change in social behavior and viewing herself as flawed due to 
emerging EOBD symptoms: 
I knew there was something wrong, and because of that I thought I was 
flawed and I didn’t want to hang out with anybody. 
 
Participant G described changes in her thoughts, perspective, and behavior following 
EOBD diagnosis. Participant G described feeling that she had lost sight of her future and that her 
life was falling apart 
I got into really bad habits. I started drinking at parties, and smoking, and 
getting into a lot of bad habits and getting in trouble a lot. And I felt like 
before the [EOBD] diagnosis I had good grades and everything, and then 
it all started to decline rapidly. 
 
Changes in relationships. All eight participants described experiencing significant 
changes in family and peer relationships during adolescence. Participants described changes as 
occurring independently of EOBD as well as in response to EOBD. 
Participant D described the loss of her older brother as a significant change unrelated to 
EOBD that impacted other interpersonal relationships throughout adolescence: 
So yeah, around 11 or so, or 12 or so, my oldest brother was with my 
father. He took care of us at 28. He came out of the closet, and he decided 
to leave the house a week before telling me and my brother. So that was 
very depressing to me, because to me it felt like [pause] it felt like I lost 
him. It almost felt like a grieving session for death or something. That’s 
what it felt like. And relationship-wise, my family did start, kind of, turning 
different. And so I also behaved differently. A lot of my early relationships 
did fall apart at that time. That’s one thing that kind of triggered the 
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depression symptoms, but afterwards I did carry that and it kind of did 
ruin a lot of other relationships I had [pause] teacher-student 
relationships, whether friends, friend to me relationships, or mother-
daughter relationship… 
 
Participant H described experiencing a change in his relationship with his parents 
following hospitalization and diagnosis of EOBD: 
But as far as family goes, yeah, my parents definitely treated me 
differently from after I got diagnosed. They were less likely to allow me to 
do risky things or to stay out late with friends, which kind of sucked, 
because—I mean, I’m just talking as an angsty teen here—but it kind of 
sucked because I was already trying really hard to make new friends and 
then they’re not letting me do things with these people who could become 
my friends. 
 
All participants also described experiencing changes in peer relationships 
associated with EOBD. Participants attributed changes in peer relationships to 
symptomatic states, changes in illness, and peers’ limited ability to understand and 
provide support. Participants additionally acknowledged changes in their own behavior 
that placed strain on peer relationships; Participant E described deliberately creating 
conflict with others, and Participant F described her symptomatic behavior as “high 
maintenance” and off-putting to her friends. 
 Participant G described experiencing changes in peer relationships she associated with 
feeling ostracized, self-isolation, and lack of understanding: 
… nothing was working. Nobody understood what I was going through, 
even before the diagnosis. And I didn’t really know what was going on, 
and everybody was pushing me away, it felt like, and I was pushing them 
away. Nobody wanted to be near me. That’s what it felt like. 
Life changes. Participants described experiencing significant life changes associated with 
onset and experience of EOBD, such as moving and beginning a new school. Participant H 
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described onset of symptoms coinciding with beginning high school, while Participant A 
described onset of symptoms beginning with moving to attend a new school in a different state. 
Participant E described onset of symptoms beginning shortly before she graduated high 
school, and described exacerbation and experiencing her first full manic episode at age 17 while 
at college in a different state. 
…just from the stress of graduating and leaving the state that I was used 
to just triggered it [EOBD]. And all that stress and smoking was just too 
much for my body and it was just like [pause] it just triggered it. 
 
 Participant C stated she became a mother at age 15. Participant C described her 
pregnancy and motherhood as a significant life change and additional challenge in managing 
EOBD: 
I mean, it’s a lot of [pause] you’ve got a lot of responsibilities once a child 
is born and you’ve got to really step up your game. When the baby is 
awake and hungry you need to go feed the baby, otherwise you’re just 
neglecting a child. And it was a real big struggle for me. It’s not my 
intention to neglect my son but it was really hard for me to just fight 
[depression] and not get frustrated and get mad at my son and especially 
with his age and so I was really trying to struggle with being a mom and 
going through post-partum depression is the depression I’ve always had 
anyway… 
 
Impact on Identity 
A fourth theme identified by participants was the impact that EOBD had on their 
identity. Participants described an experience in which the process of normative 
adolescent cognitive, moral, and psychosocial identity development was altered due to 
the impact and implications of EOBD on their identity and sense of self. Participants 
described sub-themes of secrecy and selective disclosure of illness, difficulty trusting 
self, maintaining sense of self, and integration of illness into identity. 
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 Secrecy and selective disclosure of illness. Participants described a sense of 
secrecy associated with ‘hiding’ not only the illness but a portion of their identity from 
others. Secrecy was described in conjunction with isolation and disclosure of illness, but 
also with self-protection and vulnerability—that with EOBD the participants now had a 
defective portion of their identity that needed to be hidden. 
While Participant F described disclosing EOBD diagnosis to those she trusted, she 
described hiding the onset of symptoms from those she did not trust: 
I don’t think [they knew], of my high school friends. I don’t think they 
ever had any idea because I pretty much hid it from people that I wasn’t 
comfortable talking about it with. 
 
 Participants additionally described secrecy as related to judgment and fear of others 
finding out. Participant C described hiding symptoms out of fear of judgment and rejection: 
A lot of people—I never tried to show the symptoms to people that I feel 
like they might judge me [pause] But basically I’ve always been afraid to 
be judged. 
 
 Participant E further described bipolar disorder as “very, very private” and described her 
efforts to prevent others from finding out:  
I’ve always kept my mental health apart from everything else. I will seek a 
psychiatrist or a therapist somewhere super far away, like one I went to in 
[city], they were an hour and a half away where I knew nobody would see 
me. And I would pick up my medicine at a drugstore or a pharmacy super 
far away where the chances or odds of me running into somebody I know 
is very slim. I think that has a lot to do with the fact that I don’t want 
anybody to know…Even now I will go somewhere that’s a little bit further 
just for the sake of not running into anybody I know, or not having 
anybody know me. Seriously. It’s very, very private. 
 
 Related to participants’ description of secrecy was their discussion of disclosure 
of illness. While some participants described open disclosure of illness, those who 
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strongly endorsed secrecy described selectively disclosing EOBD to others. Selective 
disclosure was described as a means to maintain secrecy. 
Participant A stated that at the time of interview, she had never disclosed EOBD 
diagnosis to her siblings: 
I actually have never told my siblings that I have been diagnosed with 
bipolar disorder just because I don’t really trust them to understand so 
they just think that I have depression. 
 
Participant E described a very selective pattern of disclosure, stating that she told few of 
EOBD diagnosis: 
So no, I didn’t tell my friends, and ‘til today I only think maybe two of my 
ex-boyfriends know [and] one of my other friends. Not a lot of people 
know. Like I haven’t told that many people, actually. So no, they don’t 
know. 
 
 Participants also described selective disclosure of illness by family members. Participant 
F stated she and her family have not disclosed or discussed bipolar disorder diagnosis with 
extended family: 
Not anyone in my family besides my parents knows, just because we have 
a very bizarre family dynamic and it would just—it just doesn’t feel like 
the time or the space to let them know about it.  
 
In contrast, participants described a more open disclosure of illness with those 
they associated with lower risk of judgment and rejection. 
Participant F described disclosing her symptoms to her parents in adolescence, and 
described an open disclosure with friends to her: 
Probably over 20 [people know]—most of the people I’m friends with 
know about it. Especially because—I’m an only child, so I’m pretty good 
at being independent, and I don’t mind being alone—but I’m really open 
when I’m a depressive or manic state, that I need to be around other 
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people. So I feel like I just let people know. Like all my roommates have 
always known. Pretty much everyone close to me has always known. 
 
Participant C described open disclosure with her fiancé: 
But when I comes to my fiancé now, I’ll let everything shine through. He’s 
seen everything. 
 
 Participant H described an open pattern of disclosure of illness beginning in adolescence: 
I’d say ages 13 to 17, I would disclose—it was my choice to disclose it to 
people, if I felt I could trust you I would disclose it to you. From ages 18 
to now, 23, I feel like I would tell pretty much anyone as long as they 
weren’t malicious about it. And I don’t bring it up, but if someone asks or 
if it’s relevant I might tell them. 
 
 Adaptation and integration. Participants described the sub-theme of adaptation 
to EOBD as part of their identity, including preserving portions of their sense of self 
while integrating the illness. 
Participants described maintaining or exceeding levels of functioning throughout 
adolescence while experiencing EOBD symptomatology. Participants primarily referred to 
maintaining academic functioning.  
Participant F described depressive symptoms as a “really big problem” her senior year of 
high school, yet she performed well academically and was accepted to college. Similarly, 
Participant B described maintaining her academic performance through use of coping skills: 
 Participant C described experiencing significant sedation from psychotropic medication 
during high school, but described continuing to pass her classes: 
I would sleep all the time in class, but mostly due to the medications I was 
on. I think the biggest one that took effect was Seroquel, and basically I 
wasn’t awake at all at any time of day. And that really kind of ticked my 
parents off that I was sleeping all the time, and they get calls that I’m 
sleeping in the class. But I was still passing my classes, but to this day I 
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don’t even know how. I would do all the tests, I would do everything. It’s 
almost as if I learned in my sleep. 
 
Participants described efforts to maintain sense of self and integrate EOBD as disruptive 
and a struggle. Participant F described struggling with identity throughout adolescence due to 
EOBD: 
I struggled with self-identity and self-image for a pretty long time in 
middle school. So when I was 12 to about 16, I feel like I kind of got the 
hang of who I was. And I’ve pretty much had the same self-identity since 
being 16, but it was—yeah, it definitely just disrupted my self-worth and 
who I thought I was for a long time. 
 
 Participant E described adaptation and integration of EOBD as her greatest challenge 
during adolescence: 
I think my biggest challenge [during adolescence] was really just 
accepting this [EOBD] and honestly figuring out how to make this fit with 
my life, and how to still enjoy life and explore it, as well as live with it 
responsibly and not have another breakdown. So that was my biggest 
challenge, just trying to enjoy life. And that was my biggest challenge 
then. 
 
 While some participants described achieving a sense of self, others described a 
loss of self due to the presence and impact of EOBD.  
Participant G described feeling as if she lost identity with the onset of symptoms: 
Before I was able to be friends with everybody. I was doing good [sic] in 
school. I went to school every day. I was getting along with all my friends 
and teachers and all my siblings. But after a while depression started to 
set in and I didn’t feel like doing anything anymore. I felt like I lost who I 
was before, and things started to change around me. And I started to push 
everybody away and was more aggravated when people tried to talk to 
me. 
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Participant C described the process of searching how to find a sense of self: 
Basically I had a hard time trying to figure out who I was. I was changing 
myself a lot, whether it was like a physical appearance or I was changing 
my attitude toward a lot of things. Every single time. I didn’t know 
basically who I was. I didn’t know how to define myself because I couldn’t 
be true [pause] I mean, I was around a bunch of people all the time—I 
was around my parents, I was around people at school [pause] I mean, I 
was afraid that when I found my true self nobody was going to like me. 
 
 Emotional adjustment. All eight participants described experiencing an internal 
struggle and emotional adjustment to receiving the diagnosis of EOBD and throughout 
course of illness. Emotional adjustment included participants’ emotional reactions to the 
illness itself as well as fear related to what the illness meant for their lives and what it 
represented in terms of their identities. Participants described feeling out of control, 
having difficulty trusting their own thoughts and emotions, and fear of EOBD. 
 Emotional response to illness. All participants described experiencing strong 
emotional responses to the EOBD diagnosis and symptoms as well as to the implications 
EOBD had for their identity. 
Participants A and D described EOBD as fear provoking. Participant D also described 
experiencing confusion and sadness: 
It was confusing and kind of heartbreaking. Especially the prognosis. 
Being told by a psychiatrist you’re going to have to take meds your whole 
life. And you might die. They’re both kind of scary. 
 
 Participant E described feeling frustrated and blaming herself for what she perceived as a 
“flaw”: 
It [receiving the EOBD diagnosis] kind of made me frustrated, because it 
was just like, damn I have a flaw now. That’s what it was like. I was upset. 
That made me feel kind of weak, because I was upset that I could let 
something like that happen even though obviously you know it’s genetic, 
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and sometimes different environments and stuff like that [pause] but I was 
kind of upset that it happened to me. But I was kind of like, ‘well it is what 
it is.’ 
 
 Feeling out of control. Five participants further described a sense of feeling out 
of control and a fear of losing control over their thoughts, emotions, behaviors, and their 
lives due to EOBD.  Participants described feeling that EOBD was in control or worrying 
that the course of illness would take control over their lives, and expressed a fear of 
losing their identities and autonomy in the future.  
Participant A described feeling out of control over her emotions: 
I think that it [EOBD] meant that I was basically just emotionally unstable 
and that I like wasn’t able to have control over any of my emotions and 
that I was just constantly fluctuating between extreme emotional states. 
 
 Difficulty trusting self. Participants ultimately described the result of fear and 
feeling out of control in terms of distinguishing normative and authentic thoughts, 
emotions, and perceptions from symptomatic experiences. Participants described 
difficulty trusting themselves and differentiating their identity from EOBDEOBD 
symptoms.  
Participant A similarly described the inclination to merge her identity with symptoms: 
Feeling like if I just started getting into a mindset that was depressed I 
would immediately—and this might be part of the symptoms of 
depression—would immediately think that I was worthless or that I was 
letting the disorder control me. I think that’s definitely a huge piece. And 
there’s been other times where I join a bunch of activities or connect to a 
lot of things and people tell me that I’m overcommitting myself and that 
I’m crazy and that I do too much, to which I usually respond ‘yeah you’re 
right. I’m clinically insane.’ Which is not true. But I do sometimes identify 
myself as being those things when other people point out my abnormal 
behaviors. 
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 Participant E described the process of differentiating between bipolar symptoms and 
normative emotional and situational responses: 
And even if, let’s say I go through something today, and I’m crying. And 
I’m just like ‘why am I crying so much? Like, obviously maybe I need to 
take more medicine,’ or something. And sometimes I don’t give myself the 
credit I need. Like maybe I’m crying because I really am going through 
something and I need to let out these tears. Because crying is an emotion 
that every human has the right to feel. So something I think that I’ve just 
desensitized my emotions [pause] and sometimes I think I’ve given too 
much power to being bipolar and saying like ‘the reason I feel this way is 
because I’m bipolar so I need to try to get this under control. I don’t need 
to cry because maybe I’m overreacting.’ So I think that I do it to myself 
sometimes subconsciously and I don’t realize it. And then I have to go 
back and think about it and say ‘okay, maybe I was feeling that way on 
purpose.’ So it’s a constant battle and I think I’ll probably face that for 
the rest of my life [pause] knowing when it is my disorder and knowing 
when it is “normal.” Whatever normal is.  
 
Experience of Stigma and Labeling 
 All eight participants described stigma, self-stigma, and labeling as part of their 
experience of EOBD. Participants described stigma concurrent to diagnostic labeling within the 
healthcare system, as well as through family and peer relationships. Participants described stigma 
occurring in the absence of knowledge and understanding of illness, while having significant 
implications for identity development. Participants described internalizing stigma and diagnostic 
labeling, as well as efforts to challenge and reject stigmatizing messages.  
Notably, each participant used the word ‘crazy’ multiple times throughout their interview 
across all themes in reference to themselves as well as symptomatic states. Six participants used 
the word ‘crazy’ as a component of stigma and three participants referred to themselves as 
‘crazy’ when describing self-labeling and internalizing stigma 
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Labeling. All eight participants described experiencing stigma beginning at diagnosis 
and continuing throughout adolescence. Participants described family, peers, community, and the 
healthcare system as sources of stigma. Participants described stigma as unrelated to knowledge 
of illness, stating that stigmatizing beliefs occurred even in individuals who possessed 
knowledge of EOBD. Participants described an awareness that stigma associated with EOBD 
could be used against them to discredit them and devalue them. 
Participant E described stigma as isolating and addressed the importance of addressing 
stigma through psychoeducation:  
I think mental illness is something that is very stigmatized and very much 
needs to be talked about…The way I look at it is that I don’t think that 
mental illness is fairly treated compared to other diseases…when it comes 
to something like mental illness, it’s like “Ewwww, that crazy person! I 
hope it’s not schizophrenia and I hope they’re not trying to kill me!’…So 
just because it’s not physical, I think that people should understand mental 
illness and stuff that you can feel, that’s emotional, should receive just as 
much attention and just as much, you know, praise and recognition to help 
people to get through it as other illnesses and diseases do. So I think 
stigma is definitely something that isolates people. 
 
 As previously introduced, Participant B sought help and support from friends and church 
leaders due to emerging EOBD symptoms. Participant B described experiencing stigma rather 
than support: 
I did try telling several friends and leaders in my life, and a lot of them 
just had their own opinions so I got different reactions. Like some people 
saying ‘you’re going to be healed; you just need to pray it away’ to people 
giving me advice that wasn’t needed, I guess. And I had people try to 
diagnose me—like I had a person say ‘oh you’re schizophrenic, you’re 
probably not just bipolar.’ Just people thinking you’re crazy, you’re crazy. 
Not even understanding the disorder. 
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 Participants described an association between stigma, secrecy, and selective disclosure. 
Participants specifically mentioned incorporating secrecy and selective disclosure of illness, as 
described earlier, to avoid experiencing discrimination and devaluation associated with stigma.  
 Participant A described being “undercover” to minimize her experience of stigma: 
I feel the effects of stigma when I overhear people talking about people 
with mental illness and how difficult it is to interact with people who have 
mental illness so I feel like when I’m undercover and people don’t know, 
then I feel kind of stigmatized. But not like people directly telling me how 
they think bipolar disorder is after revealing that I have it. 
 
Self-labeling. In addition to experiencing devaluation and discrimination from others, 
seven participants described internalizing stigmatizing messages that resulted in self-judgment 
and self-criticism.  
Participant C described the process of internalizing stigma: 
…they would say stuff like ‘bipolar people just are very, just like, they 
need medication and their emotions are completely out of whack.’ And I 
started to believe that kind of stigma of ‘oh, you’re emotions are just out 
of whack,’ and I started to believe that’s actually okay for emotions to be 
out of whack, because I had bipolar disorder. I was like ‘well I have this 
excuse to be moody anytime I want just because I’m diagnosed with 
bipolar disorder.’ And it allowed me to get frustrated over anything. 
 
 Participants additionally described an association between self-stigma, sense of self, and 
symptomatic improvement. Participant A described self-stigma as having a negative impact on 
symptomatic functioning: 
…it’s got to be true that experiencing stigma worsens symptoms. Certainly 
identifying myself as crazy was not helpful in trying to recover. And also 
trying to think that—well, buying into stigma puts you in a deeper hole in 
trying to recover and trying to see that you can be something other than 
an image, to something other than an unstable kind of person. Um, yeah I 
think that stigma just makes it harder to change, so that would make the 
symptoms harder. 
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Challenging labeling. Five participants described efforts to challenge or reject 
stigma and self-stigma. Participants described their resistance toward stigmatizing beliefs 
as an ongoing struggle. Participants described challenging labeling and stigma from 
external sources such as community, social media, and peers; however, diagnostic 
labeling and stigma from the healthcare system were not mentioned. 
Participant H described accepting EOBD while not defining himself by the illness: 
I tried really hard not to identify myself as bipolar, but just to have it be a 
part of me but not who I am, if that makes sense. 
 
 Participant E described used the Olympics as an analogy when describing her efforts to 
challenge stigma: 
I feel like obviously life is a race. Everybody’s competing for something. 
Whether it’s a good job, or finding love and getting married and having 
kids--everybody’s competing for something. And it’s funny that the 
Olympics are on right now, because I compare it to the Olympics or a 
race. And I say that I don’t feel like I’m in like the Special Olympics for 
people who have a mental disorder. I don’t put myself in that category of 
saying that I’m different from other people. I’ve always looked at myself 
like I’m still the exact same, like I’m still the same person. And I’m gonna 
finish this race and win and beat everybody else, and be in the normal 
race, and not put myself in a special race. So I kind of gave myself 
strength in not making myself seem different from other people, but finding 
people that were doing normal things and living their life, and I just— you 
know, you just change and adapt to it. 
 
Presentation of Themes According to Research Questions 
 The phenomenology of EOBD is additionally presented as thematic responses to study 
research questions. While the research questions were developed to elicit participants’ 
experiences of distinct components of EOBD as identified by theoretical framework and the 
literature review, analysis of findings revealed that the phenomenology of EOBD consisted 
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instead of an interconnected web of themes as illustrated in Figure 1. Participants did not 
experience EOBD, relationships, identity development, or labeling independently, but rather in a 
combined pattern that was consistent across all participants.  
For each research question, themes and subthemes endorsed by five or more participants 
are presented as representative of the sample and overall experience of EOBD. Table 7 displays 
the themes and sub-themes characterizing participants’ experience of EOBD as organized by 
research question. 
Research Question 1: How do emerging adults describe the experience of EOBD 
during adolescence in terms of experience of symptoms; changes in individual, social, and 
family functioning caused by course of illness; and the experience and perception of stigma 
and self-stigma? Participants described their experience of EOBD across five themes: managing 
and coping with EOBD; effect on relationships, change and uncertainty; impact on identity; and 
experience of labeling. 
Managing and coping with EOBD. Participants described their experiences of the 
illness itself. All eight participants described experiencing both manic and depressive symptoms. 
While seven participants described experiencing comorbid symptoms such as anxiety self-injury, 
eating disorders, and ADHD, only four endorsed comorbid symptoms in response to the first 
research question. Six participants described their experience with utilizing treatment and 
accessing the healthcare system, including psychiatric and therapeutic services, psychotropic 
medication, and provision of psychoeducation. Five participants described their own denial of 
illness as well as their family members’ denial of EOBD diagnosis. Participants unanimously 
endorsed a pervasive lack of knowledge and understanding of EOBD—acknowledging their own 
confusion and lack of psychoeducation at onset of illness as well as deficits in knowledge and  
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Table 7. Presentation of Themes According to Research Question 
Research Question Themes Sub-themes 
1) How do emerging adults (ages 
18-25) describe the experience of 
EOBD during adolescence (ages 
13-17) in terms of experience of 
symptoms; changes in 
individual, social, and family 
functioning caused by course of 
illness; and the experience and 
perception of stigma and self-
stigma? 
Managing & Coping with EOBD 
Experience of illness 
Treatment and engagement with 
healthcare system 
Knowledge and understanding of 
illness 
Effect on Relationships Seeking and receiving support 
Change and Uncertainty Change in illness 
Impact on Identity Emotional adjustment 
Experience of Stigma and Labeling Labeling 
2)  How do emerging adults (ages 18-
25) characterize the cumulative 
influence of interactions with 
healthcare systems and treatment 
interventions on their experience 
of EOBD? 
Managing & Coping with EOBD 
Experience of Illness 
Treatment and engagement with 
healthcare system  
Perceptions of healthcare and 
treatment 
3) What are the characteristics of the 
relationship between EOBD, 
social and family relationships 
and the developmental transition 
to adulthood according to 
emerging adults? 
Managing & Coping with EOBD 
Knowledge & understanding of 
illness 
Use of coping skills 
Effect on relationships 
Difficulty maintaining social 
functioning 
Seeking & receiving support 
Change and Uncertainty Changes in relationships 
Impact on Identity 
Adaptation & integration 
Secrecy & Selective Disclosure of 
Illness 
4) How have stigma and self-stigma 
associated with EOBD affected 
the social, emotional, and 
cognitive development of 
emerging adults ages 18-25? 
 
Managing & Coping with EOBD 
Knowledge & understanding of 
illness 
Effect on relationships 
Difficulty maintaining social 
functioning 
Change and Uncertainty Change in identity 
Experience of Stigma and Labeling 
Labeling 
Self-labeling 
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understanding from family, peers, and healthcare providers. Five participants described attaining 
an understanding of EOBD throughout adolescence as well as treatment by healthcare providers 
with knowledge of EOBD; however, participants described denial of illness persisting despite 
psychoeducation and knowledge of EOBD. 
 Effect on relationships. Five participants described seeking help and support in response 
to EOBD symptoms from family and peers. Five participants described experiencing support 
during adolescence, while four participants endorsed experiencing isolation and difficulty 
maintaining social relationships. 
Change and uncertainty. Six participants characterized their experience of EOBD as a 
prolonged series of changes between symptomatic states. Participants described a lack of 
predictability and certainty in the duration and frequency of symptomatic episodes, time between 
episodes, and the nature of symptomatic episodes.  
 Impact on identity. Seven participants described experiencing an emotional response to 
receiving the EOBD diagnosis and to EOBD symptoms throughout adolescence. Participants 
described experiencing a wide range of emotions such as sadness, blame, anger, and fear, as well 
as feeling out of control over the illness and subsequently having difficulty differentiating 
between their sense of self and EOBD.  
 Experience of stigma and labeling. Participants unanimously described experiencing 
labeling and stigma associated with EOBD; this occurred in the form of diagnostic labeling as 
well as devaluation and discrimination from others associated with stigma. 
 Research Question 2: How do emerging adults characterize the cumulative influence 
of interactions with healthcare systems and treatment interventions on their experience of 
EOBD? All eight participants characterized the influence of healthcare and treatment with one 
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theme: managing and coping with EOBD. Participants described three sub-themes: experience of 
illness; treatment and engagement with the healthcare system, and perceptions of healthcare and 
treatment.  
  Five participants described their experiences of manic, depressive, and comorbid 
symptoms as a part of their experience with the healthcare system. All eight participants 
described accessing various levels and types of healthcare and treatment interventions for 
EOBD. Seven participants were prescribed psychotropic medication for EOBD during 
adolescence. Participants described beneficial aspects of medication, such as alleviating 
symptoms; as well as non-beneficial aspects such as exacerbating symptoms and disruptive or 
unpleasant side effects.  Six participants described their perception of healthcare and treatment as 
beneficial, referring specifically to psychotropic medications that were considered effective and 
healthcare providers who were knowledgeable of EOBD. Six participants described their 
experience of healthcare and treatment as non-beneficial referring to medications that were 
ineffective, psychiatric hospitalization, and healthcare providers who did not understand EOBD. 
Four participants described healthcare and treatment of EOBD as both beneficial and non-
beneficial; these participants described choosing to continue aspects of treatment that were 
effective (i.e., medication) while modifying or discontinuing aspects of treatment that were 
ineffective (i.e., changing providers). Participants’ perceptions of healthcare influenced their 
decisions to maintain or avoid treatment for EOBD.s’ experiences.  
Research Question 3: What are the characteristics of the relationship between 
EOBD, social and family relationships and the developmental transition to adulthood 
according to emerging adults? Participants described the relationship between EOBD and 
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interpersonal relationships across four themes: managing and coping with EOBD; effect on 
relationships; change and uncertainty; and impact on identity. 
Managing and coping with EOBD.  Participants identified knowledge and understanding 
of EOBD as an important factor in interpersonal relationships throughout adolescence. All eight 
participants described feeling that their interpersonal relationships were affected by their own 
limited knowledge of EOBD and the lack of knowledge and understanding of EOBD by family 
members and peers. Three participants described denial of illness within their support system. 
Two participants described feeling that their family or peers understood their experience with 
EOBD during adolescence. Participants differentiated between knowledge of illness and support; 
and as discussed below, participants described feeling support from family and peers who did not 
understand EOBD. Five participants described employing the use of coping skills in the absence 
of direction and understanding of their support system. 
Effect on relationships. While all participants described their interpersonal relationships 
as lacking knowledge and understanding of EOBD, each participant also endorsed receiving 
support from family and peers during adolescence. While this may appear paradoxical, 
participants indicated collectively that their family and friends often did not understand EOBD 
symptoms or course of illness yet remained largely supportive and helped to the best of their 
abilities. Two participants described a lack of support from family with greater support from 
peers and friends.  
All participants additionally described experiencing difficulty in interpersonal 
relationships. Six participants described difficulty making and maintaining friendships and 
experienced relationships as a stressor, while four participants described experiencing isolation 
and avoidance of those who they felt did not support them. 
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Impact on identity. Six participants described EOBD as significantly impacting their 
identity and developmental transition into adulthood. Five participants described EOBD as a 
barrier and obstacle in interpersonal relationships and goal attainment throughout adolescence.  
Change and uncertainty. Participants characterized their experience of EOBD and 
interpersonal relationships in terms of change. Participants described a bidirectional pattern in 
which changes and conflict in relationships were described as catalysts for changes in illness, as 
well as byproducts of changes in illness. All eight participants described changes occurring in 
interpersonal relationships as a mixture of normative adolescent life changes and changes 
occurring due to the onset of EOBD and course of illness. Five participants stated that their 
relationships did not change following EOBD diagnosis, as the changes had previously occurred 
intrinsically along with the onset of EOBD. Three participants described experiencing changes in 
symptoms associated with changes in relationships, such as increases in isolation and conflict as 
symptoms increase in severity.  
Research Question 4: How have stigma and self-stigma associated with EOBD 
affected the social, emotional, and cognitive development of emerging adults ages 18-25? 
Participants described their experience with stigma and EOBD across four themes: managing and 
coping with EOBD, effect on relationships, change and uncertainty; and experience of stigma 
and labeling. 
Managing and coping with EOBD. Four participants associated lack of knowledge of 
EOBD and understanding of the adolescence experience with stigma and self-stigma, and stated 
a need for psychoeducation. However, two participants described experiencing stigma and 
labeling from healthcare providers and others who did possess knowledge of EOBD. 
Additionally, two participants described experiencing stigma in conjunction with denial of 
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illness; this included the experience of devaluation discrimination due to EOBD associated with 
cultural beliefs.  
Effect on relationships. Six participants described difficulty maintaining social 
functioning due to stigma and self-stigma. Of the six participants, three described difficulty 
making and maintaining relationships, while three described isolating themselves from others in 
efforts to avoid judgment, rejection, and stigma.  
Change and uncertainty. Six participants described experiencing change in identity 
associated with stigma and self-stigma. Four participants described experiencing a change in 
sense of self and viewing themselves as different or defective due to stigma associated with 
EOBD. Two participants described experiencing changes in thought, perspective, and behavior 
associated with internalizing stigma, such as choosing not to pursue goals and having a 
foreshortened sense of future. 
Additionally, participants moderately endorsed experiencing a change in illness 
associated with labeling. Four participants described increases in depressive symptoms, isolation, 
and anxiety in response to experiencing and internalizing stigma.   
Impact on identity. Four participants moderately endorsed stigma and self-stigma as 
affecting their identity and sense of self. Three participants described having difficulty trusting 
their own thoughts, emotions, reactions, and reality-testing in response to exposure to stigma, 
and described difficulty differentiating between EOBD and their own identities. One participant 
described internalizing stigma and feeling out of control over the illness and herself. 
Labeling. All eight participants described experiencing diagnostic labeling and stigma; 
and six participants described internalizing stigma and endorsing labeling (i.e., “I am bipolar”). 
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All participants described experiencing devaluation and discrimination from family, peers, 
society, and healthcare associated with stigma and EOBD.  
Summary of findings. Study findings are presented here in two parts. First, the 
composite textural-structural description of participants’ experience is presented as the 
phenomenology of EOBD. Second, findings are presented in accordance with study research 
questions. Participants described EOBD as an interconnected experience in which 
symptomatology, interpersonal relationships, identity, and stigma were changing singularly and 
in multi-directional relationships; and ultimately, the interaction between EOBD and normative 
adolescent developmental processes.   
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Chapter 5: Discussion 
  In this chapter, study findings are reviewed concurrent to the study’s theoretical 
framework, research questions, and the existing knowledge base as presented in Chapter 2. 
 The purpose of this study was to increase understanding of the experience of early-onset 
bipolar disorder (EOBD). To explore the lived experience of EOBD, the study employed a 
transcendental phenomenological design constructed around two questions: a) what is the 
essence of the experience of the phenomenon; and b) in what context(s) did the experience occur 
(Moustakas, 1994)? Semi-structured interviews were conducted with eight participants ages 18 – 
25 who received a diagnosis of EOBD during adolescence (between ages 13 – 17). Interviews 
collected retrospective data regarding their experience of EOBD. While not built into the study 
design or research questions, participants discussed elements of their current experience of 
bipolar disorder in emerging adulthood during the course of their interviews. As previously 
indicated, this data was also transcribed and analyzed as a separate theme, emerging adulthood; 
and is included in a companion volume to this manuscript. 
As previously discussed, analysis of participant data identified five themes of 
participants’ experience of EOBD during adolescence: managing and coping with EOBD; effect 
on relationships; impact on identity development; experience of stigma and labeling; and change 
and uncertainty. These five themes and fifteen sub-themes were constructed and synthesized 
from raw codes and code families using ATLAS.ti output. Together, these five themes create the 
participants’ collective lived experience of EOBD during adolescence: a period in which 
participants struggled to balance normative development with onset of illness, inception of 
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stigma, and changes in sense of self and interpersonal relationships. Each of the five themes was 
endorsed by all eight participants, indicating saturation of data.  
While thematic findings of participants’ experiences of bipolar disorder during emerging 
adulthood fall outside the scope of this study, the researcher has maintained the data due to its 
value and potential for inclusion in additional research.   
Integration of Theoretical Framework and the Phenomenology of EOBD 
 The phenomenology of EOBD is supported by a multi-theoretical framework consisting 
of neurobiological theories, modified labeling theory, and theory of emerging adulthood. 
Integration of these theories provided a comprehensive perspective that was endorsed by 
participant data and study findings.  
Neurobiological theories. Neurobiological theories provide etiological and biological 
explanations for the onset of EOBD symptoms and course of illness. Participants described their 
experiences of the illness, including age of onset of symptoms; age of diagnosis; manic and 
depressive symptoms; suicidality; length, duration, and frequency of episodes, and longitudinal 
course of illness. Five participants described a progression of illness that included onset of 
depressive symptoms and diagnosis of depression in early adolescence (ages 12-14), with onset 
of manic or hypomanic symptoms and diagnosis of EOBD between ages 14-17.   
Seven participants described experiencing comorbid symptoms such as anxiety, self-
injury, ADHD, and eating disorders. All participants viewed EOBD as a byproduct of 
neurotransmitter dysregulation (“a chemical imbalance”) consisting of fluctuations in mood, 
energy, and emotion. Participants’ understanding of basic components of neurobiological 
theories of EOBD appeared to serve as a foundation for understanding and treating the illness. 
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While causal explanations, genetic considerations, and etiology of EOBD were not 
addressed in interview questions, three participants reported presence of mental illness such as 
bipolar disorder and depression in first-degree relatives.  
Modified labeling theory. Modified labeling theory explains the inception of stigma as 
an interactive process in which behaviors and beliefs associated with diagnostic labels are 
internalized. Individuals with the illness adopt behaviors associated with illness and impairment, 
while individuals without the illness adopt behaviors associated with discrimination and 
devaluation. 
Participants’ experience of EOBD reflected a pattern of labeling, stigma, and self-stigma 
consistent with modified labeling theory. All participants described experiencing discrimination 
and devaluation associated with EOBD labeling through interaction with interpersonal 
relationships (i.e., family and peers), society, and exchanges with the healthcare system and 
healthcare providers. 
Seven out of eight participants described internalizing beliefs and behaviors associated 
with illness in the form of self-labeling and endorsing stigma. Participants described self-labeling 
as a process originating with reception of stigma; and additionally described self-labeling in 
conjunction with changes in identity (viewing self as different or defective) and interpersonal 
relationships (isolation and secrecy), as well as fear of judgment.  
Theory of emerging adulthood. All eight participants described changes in their 
experience of bipolar disorder occurring as they transitioned into emerging adulthood. Within the 
theme of emerging adulthood, focusing on self and self-sufficiency was endorsed by all 
participants.  Consistent with Arnett (2006a), all participants described experiencing changes in 
work, relationships, and behavior patterns that focused on increasing independence and self-
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sufficiency. Participants described attaining an increase in knowledge of bipolar disorder and 
how to manage the symptoms to improve course of illness. Consistent with Arnett (2006b), each 
participant described experiencing varying degrees of recurrent symptomatology while 
experiencing increased self-esteem and sense of well-being. Participants described feeling 
empowered with greater ability to initiate life changes such as seeking out support and pursuing 
life goals. Participants’ focus on self and self-sufficiency appeared as a contrast to descriptions 
of feeling out of control and confused during adolescence.  
 Four participants additionally described increased interest in enacting systemic change to 
improve the experience of bipolar disorder for others. These participants explained their interest 
in this study as prompted by their hope of participating in a movement for change. Participants 
described the need for increased understanding of EOBD and the adolescence experience to 
improve healthcare and treatment interventions. 
 Participants described additional changes occurring in emerging adulthood. All 
participants described experiencing normative changes associated with adulthood, including 
moving away from home, attending college, and pursuing a career. One participant strongly 
endorsed additional changes in in identity and identity development occurring in emerging 
adulthood that included increased confidence and ability to reject stigmatizing messages. While 
all participants described a change in perspective associated with emerging adulthood, one 
participant described a sense of optimism “and hope for my adulthood” that they described was 
not present during their adolescence  
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Integration of Findings and Knowledge Base 
 This section compares study findings with the existing literature on EOBD. Study 
findings relevant to scope of EOBD, adolescent development, interactions with the healthcare 
system, interpersonal relationships, and stigma are presented. 
Scope of EOBD. Participant descriptions of EOBD course of illness were consistent with 
current knowledge within the literature. Participants described experiencing onset of symptoms 
between 7 and 17 years of age (M = 12.88; SD = 2.66) and receiving EOBD diagnosis between 
ages 13 and 17 (M = 15.56; SD = 1.50). Five participants described polarity of first episode as 
depressive, while three participants described polarity of first episode as manic. Participants with 
manic onset were diagnosed and treated during psychiatric hospitalization and reported no prior 
symptoms of any kind. Participants with depressive onset describing receiving diagnosis from an 
outpatient provider and onset of symptoms prior to diagnosis. 
Study participants described varying courses of illness, including differing duration and 
frequency of episodes. Study participants described seeking and receiving treatment within an 
average of three years of onset of symptoms (M = 2.69, SD = 2.27), as compared with ten years 
for adult-onset bipolar disorder (Torrey & Knable, 2002). Several participants reported receiving 
an initial diagnosis of depressive or anxiety disorder prior to EOBD diagnosis; this is consistent 
with a progressive onset of bipolar disorder illness in adolescents (Axelson et al., 2011); however 
due to small sample size no conclusions can be made. 
Participants described an overall course of illness in contrast to that of McGorry (2010).  
Instead of a course of illness consistent with polarity of first episode, participants in this study 
with manic symptom onset described depressive symptoms as more disruptive to functioning 
over time; and conversely, several participants who described depressive symptoms at onset 
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identified manic episodes as more severe. Furthermore, participants did not describe an 
association between earlier age of diagnosis and improved course of illness. 
Consistent with the findings of McMurrich et al. (2012), participants in this study 
described varying degrees of syndromic, symptomatic, and functional recovery in emerging 
adulthood (McMurrich et al., 2012). While some participants described an improved course of 
illness, others described continuing to experience persistent symptoms and challenges in 
treatment of bipolar disorder.  
EOBD and adolescent development. Study participant descriptions of identity and 
social development between ages 13 – 17 were consistent with cognitive and psychosocial 
development as established within the literature (Kohlberg, 1963; Piaget, 1964; Steinberg, 2005). 
Participants in this study described their sense of identity and social functioning as significantly 
altered, and in some cases impaired, by the presence of EOBD symptomatology as proposed by 
multiple authors (e.g., Alreja et al., 2009; Birmaher et al., 2006; Miklowitz & Johnson, 2006). 
Consistent with findings of Farley and Kim-Spoon (2011) and Pederson et al. (2007), study 
participants described experiencing depressive symptoms in conjunction with peer rejection, 
isolation, and decreased self-regulation. 
EOBD and interaction with the healthcare system. 
Psychotropic medication. Consistent with multiple authors (e.g., Cerit et al., 2012; 
Garnham et al., 2007; Judd et al., 2013), participants in this study described taking psychotropic 
mediation with varying results. While some participants described improvement in course of 
illness and reduction in symptoms they attributed to medication, other participants described 
continuing to experience symptomatic and functional impairment despite compliance with 
prescribed medications. 
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Therapeutic interactions. As previously stated, participants described responses to 
therapeutic interventions as both beneficial and non-beneficial. Participants who felt validated 
and supported by a provider that understood EOBD described a beneficial relationship; while 
other participants described the therapist as judgmental or lacking knowledge of EOBD and 
therefore described therapy as non-beneficial. While some participants described an improved 
sense of well-being, this study did not investigate improvement in treatment outcomes or 
symptomatology as identified by Miklowitz (2008). 
EOBD and interpersonal relationships. 
Informal and peer support. Study participants described peer relationships as a core 
component of their experience of EOBD. Participants described social functioning as influential 
to symptomatic functioning; and additionally described social relationship as impacted by EOBD 
symptomatology. The impact of peer and community support on empowerment, and role in 
stigma reduction, self-esteem, and risk of relapse (Brown et al., 2008; Corrigan et al., 2012; 
Davis, Kurzban & Brekke, 2012; Perlick et al., 2004) were not explored by participants; these 
are discussed as implications for future research, below. 
Family support. Participants from the current study described family relationships as part 
of the construct of interpersonal relationships. As with informal and peer support, dimensions of 
family support such as family stress and conflict, family cohesion, and family functioning were 
not explored in relation to influence on EOBD symptomatology. Participant accounts are 
descriptive and include the meaning associated with family relationships and dynamic. 
EOBD and stigma. Participants from the current study described their experiences with 
diagnostic labeling, stigma, and self-stigma. Consistent with Cerit et al. (2012), study 
participants described their experience of EOBD as both influencing and influenced by stigma 
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and self-stigma. As asserted by Crowe et al. (2012), study participants described feeling a loss of 
control over their lives, self-blame, and viewing ability to manage symptoms as part of their 
sense of self; . 
 Results are additionally consistent with findings by Moses (2009) and Camp, Finlay, and 
Lyons (2002).  Participants in this study described experiencing rejection and difficulties in 
social functioning associated with stigma.  In describing their efforts to reduce the impact of 
stigma, participants described adopting patterns of avoidance coping, including secrecy, 
isolation, and selective disclosure of illness. 
Implications for Social Work Practice  
 The healthcare system is a gatekeeper for adolescents with EOBD. Providers assess and 
generate EOBD diagnoses and provide treatment. As the course of illness is indefinite and 
requires lifelong care, the role of healthcare remains pivotal throughout the lifespan in mediating 
the course of bipolar disorder. However, the healthcare system is often the site of origin of 
labeling and stigma, and therefore carries important implications for identity development and 
social functioning across the lifespan as well. Social workers are present throughout medical and 
mental healthcare settings, and therefore have a unique influence over the range of treatment for 
EOBD. 
 Lack of knowledge and understanding of EOBD emerged as the most frequently 
occurring invariant constituent (code) across all participants’ experience of EOBD. Participants 
described lack of knowledge and understanding as a determinant in whether healthcare was 
beneficial, as influential within interpersonal relationships, and as a buffer against stigma and 
self-stigma. This carries powerful implications for providers; increasing individual and family 
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psychoeducation as well as provider education would greatly benefit adolescents as well as their 
support system.  
 Participants identified labeling and stigma as carrying significant implications for their 
developing sense of self and social functioning. Providers can minimize diagnostic labeling and 
inception of stigma through use of a collaborative method with the adolescent and parents that 
incorporates a strengths-based approach, as compared to traditional deficit-based medical 
models. Providers can additionally focus on integrating illness management with normative 
adolescent cognitive, emotional, and identity development. Participants described cognitive 
reframing—learning to reframe EOBD as an external experience that was not part of their 
identity and something they could learn to manage—as an important component of recovery, and 
one which they often accomplished with little support. Some participants additionally described 
providers as the primary or sole source of support. 
 The interconnectivity of themes present in participants’ experience of EOBD necessitates 
clinical approaches that address and incorporate each of these themes in treatment approaches. 
Providing psychiatric treatment and medication without therapeutic treatment is insufficient and 
does not address the scope and needs of EOBD. Additionally, providing therapeutic services that 
do not include family or do not address interpersonal functioning or identity development are 
similarly insufficient. The incorporation of multiple treatment and theoretical frameworks, along 
with a treatment model that addresses the neurobiological and developmental components of 
EOBD are needed to accurately and effectively treat EOBD. 
 As a further consideration, due to the early age of onset many participants did not have a 
‘before’ and ‘after’ diagnosis that are often incorporated into treatment of adult-onset bipolar 
disorder when reframing the illness, combating stigma, and preserving a sense of identity. 
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Instead, participants described one uniform, linear experience in which having bipolar disorder 
consumes much of their identity—leaving them with little else to identify with. 
 Finally, participants were eager to be informed of their illness, understand treatment 
options, and be an active part of treatment decisions; however, participants described being 
excluded from treatment team and decisions due to their age. Including adolescents in treatment 
decisions and explaining interventions can increase empowerment. Participants described 
seeking help upon noticing symptoms and described consistent coping efforts to improve well-
being; allowing adolescents a more active role could facilitate greater improvement.  
Social Work Education and Policy 
 According to the National Association of Social Workers and the Council on Social 
Work Education, social work best practices address the concerns presented above. The NASW 
Code of Ethics (2008) directs social workers to work with interdisciplinary teams when available 
(e.g., with healthcare providers such as psychiatrists and therapists), to maintain continuing 
education, maintain currency with research and emerging knowledge, engage in evidence-based 
practice, and refer out clients who they lack the specialization to treat. The CSWE Educational 
Policy and Accreditation Standards (EPAS; 2015) that informs and regulates social work 
education similarly instructs social workers to employ interdisciplinary knowledge and practice 
rooted in research and evidence-based practice. Educational content includes psychopathology 
and practice with individuals and families. Many social workers engage in clinical practice and 
hold state licenses. Licensure for clinical social work varies by state, but generally requires 
periodic continuing education and demonstration of advanced clinical skill.  
 The requirements for social work education, practice, and licensure address 
psychopathology and clinical practice at a broad level (NASW, 2006). At a micro level, agency 
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policies may enforce practice standards and require training specific to EOBD. However, the 
research and knowledge base for EOBD remain limited, and as such social workers’ knowledge 
base and practice abilities are similarly limited. Within the health disciplines, other therapists and 
psychiatrists similarly may be lacking the specialized knowledge needed to treat EOBD.  
 The opportunity and responsibility, then, may rest with the production and dissemination 
of research of EOBD. Increased research and dissemination of findings would increase the 
availability and exposure of healthcare providers to current and emerging knowledge; which 
would then be incorporated into practice and improve treatment and care for EOBD. Ultimately, 
EOBD remains underresearched. This study presents an increased understanding of EOBD with 
the intent to inform future research, and ultimately direct practice. 
Future Research 
 While previous studies have explored the etiology and treatment options for EOBD, 
much remains to be known about the impact of illness on developing identity and social 
functioning. The constructs of stigma and self-stigma in particular emerged from participant data 
with significant implications for the effects on identity development, social functioning, and 
inception within the healthcare system.  
 Stigma, self-stigma, and identity emerged as separate constructs with participants’ 
experiences however, participants frequently identified changes in identity associated with 
diagnostic labeling, stigma, and self-stigma. Viewing oneself as different or defective has 
significant implications for social functioning in the form of avoidance coping such as isolation 
and secrecy. Furthermore, participants described experiencing changes in illness that 
accompanied stigma, self-stigma, and changes in identity. Cerit et al. (2012) asserted a 
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bidirectional relationship between stigma and increase in symptomatology in adults with bipolar 
disorder; however, this remains unexplored in the adolescent population. 
Exploration of the influence of stigma in EOBD should include the identification of risk 
and protective factors for the development of self-stigma. Self-labeling in adolescence is 
associated with greater social, symptomatic, and functional impairment (Moses, 2009); yet also 
remains underresearched. Furthermore, participants’ additional discussion of emerging adulthood 
indicated adolescent experiences of stigma and changes in identity and social functioning 
significantly affected the transition to adulthood. Additional research is needed to identify risk 
and protective factors as well as the nature of the relationship between diagnostic labeling, 
stigma, and identity development in EOBD. 
 Participants described experiencing stigma from within the healthcare system. While 
discrimination and devaluation associated with stigma are separate constructs than mere 
diagnostic labeling, participants often discussed them interchangeably. Furthermore, the 
inception of discrimination and devaluation within the healthcare system is troubling in and of 
itself, and carries the potential of powerful negative consequences for identity and social 
development adolescents with EOBD. Research studies of healthcare professionals’ perspectives 
and practices with EOBD population could elicit a better understanding of the process of 
diagnostic labeling and inception of stigma; and in turn offer implications to improve healthcare 
services. 
 Additional prospects for further research that were not explored within this study include 
outcomes of EOBD on the family system; how social impairment associated with EOBD in turn 
affects normative adolescent cognitive development; and the concept of resilience in adolescence 
using ecological systems theory with implications for emerging adulthood . In summary, due to 
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the exploratory nature of this study and the volume of data collected, there are many avenues for 
continued research to improve conceptualization and treatment of EOBD. 
Strengths and Limitations 
 Phenomenological study design facilitated exploration of participants’ lived experiences. 
Semi-structured interview format provided participants with the ability to expand upon issues 
they wanted to emphasize. Data analysis allowed for participants’ experiences to be captured 
authentically in their own wording to obtain the essence of their experiences. Each participant 
that reviewed his/her their narrative noted the accuracy in how their stories were told, and felt 
satisfied that they had been heard. 
 While eight participants yielded saturation of data, a larger sample size of 10 – 15 
participants was desired. Challenges in recruitment resulted in a sample generated entirely 
through online advertising on a support group (DBSA) website and interviews completed via 
telephone. While it is uncertain if participants would have been as candid and open if the 
interviews were conducted in person, a face-to-face format would have been preferred. 
 Additionally, the study’s original design included partnering with a clinical agency to 
serve as a referral source, sample site, and would provide follow-up clinical services to 
participants if needed. Through the informed consent process, the researcher provided 
participants with contact information for follow-up care (211), with an emergency plan to call 
911 for a welfare check at the address the participant provided at the time of the interview if the 
participant indicated they were in a clinical crisis. While the interview questions explored 
participants’ lived experience of EOBD, the interviews were equally clinical in nature; and 
clinical support and follow-up would have been preferred. While calling 911 was not needed, 
several participants reported being currently or recently depressed at the time of the interviews 
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and/or became tearful during the interview. The researcher debriefed with each participant 
briefly following phone interviews; however, an improved research design would coordinate 
with a clinical site to provide supportive services such as debriefing following interviews. 
 Furthermore, the study’s sampling method and composition resulted in a reliance on 
retrospective data. While participants’ provided experience of EOBD augmented with the 
perspective and maturity from adulthood, their descriptions of EOBD were less recent. A sample 
of current adolescents may provide additional or different perspective or information on EOBD. 
 While not a weakness in phenomenological design, the absence of triangulation to 
confirm participant EOBD diagnosis is perhaps an approach that could enhance the measurement 
of EOBD. Use of diagnostic quantitative measures or referral from clinical diagnostician in 
additional research of EOBD would assist in confirming EOBD diagnosis and maximizing study 
validity. 
 The goal of this phenomenological study was to generate an improved understanding of 
EOBD; and as such, generalizability of findings was not incorporated into the study’s design. 
However, healthcare providers could aim to incorporate study findings into practice that are 
consistent with the literature and theoretical framework. Such examples include maximizing 
knowledge of EOBD, familiarity with adolescent developmental considerations, incorporation of 
support system, and therapeutic interventions to promote healthy sense of self and protect against 
internalizing stigma. 
Conclusion 
 Current research and clinical knowledge base of EOBD consists primarily of quantitative 
inquiries of etiology, neurobiology, and pharmacology. First-person qualitative inquiries are 
absent within the literature; as a result, our knowledge and treatment of EOBD is severely 
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limited. Current conceptualization and treatment of EOBD consists of extrapolating and 
translating adult theoretical models to an adolescent population. This study explicates the lived 
experience of EOBD, bringing to light considerations for treatment and research such as the 
impact of labeling and stigma, the importance of knowledge and understanding of EOBD in 
facilitating effective healthcare, and factors affecting adolescent identity development. 
Furthermore, participants’ retrospective lens provides insights into treatment and experience of 
bipolar disorder transitioning into emerging adulthood.  
Summary 
 Bipolar disorder occurs in approximately 1% of the population; and while the average 
age of diagnosis falls between ages 18 and 25, up to 66%of adults report onset of symptoms 
between ages 13 and 17 (Perlis et al., 2004). Within the last 20 years, the prevalence of bipolar 
diagnoses and pharmacological treatment for EOBD has increased; yet there is an absence of 
research into the phenomenology of EOBD.  
Collectively, healthcare providers and researchers have largely viewed and treated EOBD 
by extending and applying conceptualization of adult-onset bipolar disorder—‘from the outside 
in.’ By exploring and utilizing auto-biographical, retrospective data to construct the 
phenomenology of EOBD, this research study begins the process of viewing and treating EOBD 
‘from the inside out.’ Interviews with young adults who were diagnosed and treated for EOBD 
during adolescence provide a first-person perspective on not only the experience of the illness 
itself, but also the experience of labeling and stigma, identity development, interpersonal 
relationships, mediating factors and life changes, reactions and coping efforts; as well as insights 
into the transition from adolescence into adulthood. 
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Appendix C 
IRB Verbal Informed Consent Form 
 
Obtaining Verbal Informed Consent 
 
Researchers at the University of South Florida (USF) study many topics. To do this, we need the 
help of people who agree to take part in a research study. We are asking you to take part in a 
research study that is called: The Phenomenology of Early-Onset Bipolar Disorder. 
 
The person who is in charge of this research study is Kristin Smyth. This person is called the 
Principal Investigator. 
 
You are being asked to participate because you received a diagnosis of bipolar disorder during 
adolescence (between ages 13 – 17). The purpose of this study is to improve our understanding 
of the experience of early-onset bipolar disorder. 
 
If you take part in this study, you will be asked to participate in one telephone interview lasting 
approximately 45 – 60 minutes to discuss aspects of your experience of bipolar disorder as an 
adolescent. You may be contacted for a follow-up interview to provide clarification or additional 
information if needed. 
 
You have the alternative to choose not to participate in this research study.  
 
You should only take part in this study if you want to volunteer and should not feel that there is 
any pressure to take part in the study. You are free to participate in this research or withdraw at 
any time. There will be no penalty or loss of benefits you are entitled to receive if you stop 
taking part in this study.  
 
For any student participants: Your decision to participate or not to participate will not affect your 
student status or course grades.  
 
We are unsure if you will receive any benefits by taking part in this research study.  
 
This research is considered to be minimal risk.  
 
Upon completion of your participation in this study via telephone interview, you will receive a 
$20 gift card.  
 
140 
We must keep your study records as confidential as possible. We may publish what we learn 
from this study. If we do, we will not let anyone know your name. We will not publish anything  
 
else that would let people know who you are. However, certain people may need to see your 
study records. By law, anyone who looks at your records must keep them completely 
confidential. The only people who will be allowed to see these records are: 
 
• The research team, including the Principal Investigator, the Advising Professor, and all other 
research staff. 
• Certain government and university people who need to know more about the study. For 
example, individuals who provide oversight on this study may need to look at your records. This 
is done to make sure that we are doing the study in the right way. They also need to make sure 
that we are protecting your rights and your safety.) These include: 
 
• The University of South Florida Institutional Review Board (IRB) and the staff that work 
for the IRB. Other individuals who work for USF that provide other kinds of oversight 
may also need to look at your records. 
• The Department of Health and Human Services (DHHS).   
 
 
If you have any questions about this study, you can contact the investigator Kristin Smyth [407-
865-2404 or kristinsmyth@usf.edu]. If you have question about your rights as a research 
participant please contact the USF IRB at 813-974-5638. 
 
Would you like to participate in this study? [PI will record if verbal consent is given] 
. 
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Appendix D 
Semi-Structured Interview 
Today I’d like to ask you some questions to get a better understanding of your experience as a 
teenager with bipolar disorder.  
• First, how old were you when you were diagnosed with bipolar disorder? How old are 
you now? 
o What was it like to receive the diagnosis of bipolar disorder? What did the illness 
mean to you at that time? 
o How would you describe your experience of bipolar symptoms during your 
teenage years? What were your manic episodes like? Your depressive episodes?  
o Did you feel that other people (friends, family, healthcare providers) understood 
your experience of bipolar disorder? 
 
• Now I’m going to ask about some of the changes that may have taken place during your 
teenage years as a result of bipolar disorder. 
o After the onset of bipolar symptoms but prior to diagnosis, do you remember 
whether any changes occurred in relationships with your family or with friends 
during this time? 
o After receiving the diagnosis of bipolar disorder, do you remember any changes 
occurring in relationships with your family or friends during this time? 
o Do you feel that your sense of self (sense of identity) changed due to your 
experience of bipolar disorder during this time? If so, in what way? 
o Did you feel that you understood the changes in your life that were occurring due 
to bipolar disorder? 
o How did these changes affect you as you moved from adolescence into young 
adulthood? 
 
• Now I’m going to ask about how bipolar disorder may have affected you during your 
teenage years. 
o What were your greatest supports during this time? What were your greatest 
challenges? 
o Do you feel that you encountered stigma or labeling associated with bipolar 
disorder during this time? If so, what was that like? 
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o Did you experience self-stigma, in which you label or judge yourself, during this 
time? If so, what was that like? 
o Do you feel that any of the changes you experienced in your support system or 
related to stigma or sense of self had an effect on your bipolar disorder and mental 
health during this time? 
 
• Now I’m going to ask about your experience with the healthcare system during your 
teenage years. 
o Who diagnosed you with bipolar disorder? In what treatment setting (inpatient, 
outpatient)? 
o What events led up to the diagnosis? 
o Did you have a psychiatrist? A therapist? What was your experience with them? 
o Have you ever been hospitalized due to bipolar disorder? If so, what was that 
like? 
o Were you prescribed medication for bipolar disorder during this time? How 
would you describe your experience with medication? 
o Did you feel that the treatment you received was helpful? [Whether yes or no:] In 
what way? 
o Did your experience of bipolar disorder change during or after receiving 
treatment? If so, in what way? 
  
 
 
Appendix E 
Codebook 
code family definition specifiers 
when to use the 
code 
when not to use 
the code 
example quotation 
absence of labeling 
or stigma 
labeling absence of stigma none 
participant reports 
lack of stigma 
do not use if 
stigma is endorsed 
No, not from people close to me. 
accessibility or use 
of healthcare/ 
treatment 
healthcare 
accessing/utilizing 
services; tx services are 
accessible to participant; 
includes referrals or 
facilitation of healthcare 
use by others 
none 
use of tx services 
or ability (tx is 
available to 
access) 
see inverse: 
healthcare 
difficult to 
navigate 
And I was lucky enough to get connected to the 
campus health system and start receiving 
treatment again 
ambivalence or 
hesitation toward 
healthcare/ 
treatment 
healthcare 
participant states mixed 
feelings, indifference, or 
expressed hesitation 
toward healthcare 
services (including 
medication) 
specify if 
psychotropic 
medication is 
source of 
ambivalence 
reflects 
ambivalence, 
mixed feelings 
toward healthcare 
system or tx of 
any kind 
if referring to 
withdrawal from 
tx or avoidance of 
healthcare, use 
avoidance of 
healthcare system 
or tx 
… there’s been good things about the 
medication and there’s been bad things about 
the medication that I did really not sign up for. 
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avoidance of 
healthcare system or 
treatment 
healthcare 
avoidance of health 
services & tx 
(medication, psychiatry, 
therapist, hospitalization) 
specify if 
psychotropic 
medication is 
what participant 
is avoiding 
participant 
actively avoids or 
withdraws from tx 
or services 
(including 
psychotropic 
medication) 
if referring to 
ambivalence or 
mixed feelings 
toward healthcare, 
provider, or tx, 
use ambivalence 
or hesitation 
toward healthcare 
or tx 
And I was diagnosed with depression in 8th 
grade, but didn’t take any antidepressants 
because I didn’t believe in medication, and it 
was only until I got diagnosed with bipolar 
disorder when I was 17 that I considered taking 
medications 
challenging or 
rejecting labeling 
labeling 
rejecting stigma; refusing 
to endorse labeling or 
apply to self as part of 
identity 
none 
participant, 
family, or peers is 
described as 
disagreeing with, 
challenging, or 
rejecting labeling 
or stigma 
associated with 
illness 
do not use if 
participant 
endorses stigma 
or reports stigma 
And it’s funny that the Olympics are on right 
now, because I compare it to the Olympics or a 
race. And I say that I don’t feel like I’m in like 
the Special Olympics for people who that have 
a mental disorder. I don’t put myself in that 
category of saying that I’m different from other 
people. 
change in illness 
experience 
of illness 
refers to change in 
symptomatic state; 
includes succession of 
symptoms or change in 
episodic mood states; 
increase or decrease in 
state of illness 
(symptoms); includes 
recovery/remission and 
recurrence of symptoms; 
note: if participant 
describes change in 
illness and identifies 
cause/trigger (i.e., 
relationships, stigma), 
none 
description is of 
the progression or 
succession of 
symptomatic/epis
odic states 
(stages) of illness 
(i.e., symptoms 
improving or 
worsening); 
includes 
participant 
description of 
cycling or 
changing between 
mood states 
if referring to 
concurrent 
presence of non-
bipolar symptoms, 
use comorbid 
symptoms/ 
diagnoses 
I experienced depression for weeks at a time. It 
would come and go. And then I have moments 
of anxiety, aggravation, and irritability. And I 
was really becoming passive-aggressive 
towards everybody around me. 
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code both 'change in 
illness' and the 
identified trigger 
changes in decision-
making 
impact on 
identity 
changes in focus, thought 
and behavior patterns 
before age 18 
none 
description of 
changes in 
perspective; can 
refer to maturity 
or growth 
if code applies to 
experience over 
age 17, use EA 
version of code 
I got into really bad habits. I started drinking at 
parties, and smoking, and getting into a lot of 
bad habits and getting in trouble a lot. And I 
felt like before the diagnosis I had good grades 
and everything, and then it all started to decline 
rapidly. 
 
changes occurring in 
relationships 
Interpersonal 
relationships 
changes in structure or 
content of interpersonal 
relationships; can be 
positive, neutral, or 
negative; includes family 
and peers; can be 
attributed to symptoms or 
illness 
specify peer or 
family 
relationships 
(or other) 
participant is 
describing 
changes that have 
occurred 
with/among 
family members 
or peers; i.e., 
family members 
moving away 
inverse: no 
change in 
relationships; if 
referring to 
participant's 
difficulty 
functioning 
socially, use 
'social 
impairment' 
But as far as family goes…yeah, my parents 
definitely treated me differently from after I got 
diagnosed.  
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comorbid symptoms 
/ diagnoses 
experience 
of illness 
symptoms that are not 
bipolar (i.e., substance 
abuse, anxiety, self-
injury); participant report 
of experiencing multiple 
symptomatologies 
(bipolar + other); 
emphasis is on 
concurrent symptom 
states or presence of 
non-bipolar symptoms 
none 
participant refers 
to experiencing 
other mental 
health symptoms 
outside the scope 
of bipolar disorder 
(past or present); 
do not use with 
bipolar 
symptoms; 
change in illness 
reflects successive 
change in 
symptomatic 
states (not 
concurrent 
symptoms) 
So before I hallucinated, I remember we were 
watching a video on YouTube or something 
and I had a panic attack, and I couldn’t breathe 
or anything, and I was like ‘yo what is going 
on, like I just can’t breathe.’ And so anxiety is 
also something that goes along with a lot of 
disorders. Like literally, a panic attack. 
denial of illness 
reactions & 
coping 
denial of illness; 
resistance to diagnosis 
(by participant, family, 
peers) 
specify 
participant, 
family, peers, 
or other 
description of 
denying, 
sublimating 
presence of illness 
(presence, 
symptoms, course 
of illness) 
for avoidance or 
resistance to tx, 
use avoidance of 
healthcare or tx; 
inverse: 
acceptance of 
illness 
And my mom was also very adamant about the 
fact that she didn’t want to have a child with 
mental illness, and thought that it would reflect 
on her as a parent if I did, and so she was also 
very invested in making sure that she mitigated 
my symptoms and basically just dismissed 
them 
 
depressive 
symptoms 
experience 
of illness 
DSM-5 depressive 
symptoms 
none 
participant is 
recounting or 
describing 
depressive 
symptoms 
all other 
symptoms 
When I was depressed I remember laying in 
bed for months just watching tv, um, just 
showering was hard, anything like that. I 
played thoughts in my head over and over, like 
I wasn’t good enough, like no one cared about 
me, and just stuff like that. I would cry a lot, so 
sometimes I would fall asleep crying and wake 
up crying. 
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difficulty in 
relationships 
Interpersonal 
relationships 
social impairment or 
difficulty functioning in 
interpersonal 
relationships; losing 
friends, inability to make 
friends, losing family 
relationships; 
interpersonal 
relationships present as 
significant stressor or 
challenge 
specify 
participant, 
family, peers, 
or other 
participant 
description of 
difficulty with 
interpersonal 
functioning due to 
symptomatic 
impairment; 
description of 
stress or conflict 
in interpersonal 
relationships 
if participant is 
describing 
changes rather 
than conflict, use 
‘changes 
occurring in 
relationships’ 
I lost every single one of my friends in high 
school. People just saw me as a freak. They 
didn’t like…they didn’t like that I was just 
unstable. And I can see from their point of 
view. Who wants a friend, you know, who’s 
going through a hard time? and they try to help 
and nothing they do helps. So basically a lot of 
friends would give up on me or people would 
just walk out immediately. They just don’t 
want to deal with it, or they don’t like it. 
difficulty trusting 
self 
impact on 
identity 
experience of difficulty 
trusting their own 
thoughts, emotions, 
impulses, & reality-
testing due to experience 
of symptoms or illness; 
related to distinction 
between self and illness; 
struggle to distinguish 
between normative 
emotions and 
symptomatic episodes 
none 
participant 
describing 
difficulty 
distinguishing 
self/sense of self 
from symptoms/ 
illness 
different from loss 
of self or loss of 
identity 
let’s say me and my boyfriend get into an 
argument. And I get kind of sad, right? I do 
sometimes question myself, and I’m like ‘am I 
sad because I have a disorder? Or am I sad 
because this is how everybody else would be 
feeling given the circumstance that they had an 
argument with their boyfriend? 
disclosure of illness 
Interpersonal 
relationships 
disclosure of illness or 
openness re: 
illness/symptoms to 
others (can be open 
disclosure in general or 
referring to a singular 
disclosure) 
none 
refers to 
participant's 
openness and 
disclosure of 
illness 
for selective 
disclosure use 
'selective 
disclosure of 
illness' 
And my parents…I’m pretty open with them so 
I had talked about it with them pretty early on, 
so they knew that I was having these really 
severe bouts of sadness. 
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effecting greater 
change (EA) 
emerging 
adulthood 
focus or awareness of 
need for greater 
change/improvement in 
society or community; 
related to activism and 
advocacy; contributing to 
others -- after age 18 
none 
experience 
occurred age 18+ 
experience 
occurred ages 13-
17 
So it’s been a challenge, but that’s why I 
became a social worker, because I want to help 
other people. And that’s what one of my 
friends says. She’s like ‘you know social 
workers…we become something that we didn’t 
have growing up, that we didn’t have 
ourselves. And so that that’s what shows us to 
actually be that person that you wish you 
would’ve had. So that is why I’m a social 
worker. Because there are people out there that 
go through even worse things, and I’m like ‘I’ll 
help them get through it the way I helped 
myself get through it when I wished I had 
somebody to help me get through it.’ 
emotional response 
to illness 
reactions & 
coping 
description of emotional 
adjustment in response to 
diagnosis, symptoms, or 
illness itself; includes 
confusion, anger, shame, 
blame, disbelief, shock, 
sadness 
none 
description of 
emotional 'fallout' 
following 
symptomatic 
episode or 
diagnosis; 
emotional impact 
of illness 
if participant 
refers to 
confusion (not 
understanding 
course of illness 
or situation) 'lack 
of knowledge/ 
understanding 
(confusion) 
It kind of made me frustrated, because it was 
just like, damn I have a flaw now. That’s what 
it was like. I was upset. That made me feel kind 
of weak, because I was upset that I could let 
something like that happen even though 
obviously you know it’s genetic, and 
sometimes different environments and stuff 
like that…but I was kind of upset that it 
happened to me. 
fear of illness 
reactions & 
coping 
expressing fear of illness 
or symptoms; related to 
fear of recurrence and 
fear of losing control 
over life due to illness 
none 
expression of fear 
of the illness 
itself, including 
feeling powerless 
and/or loss of 
control over self, 
future, or illness 
if code applies to 
experience over 
age 17, use an EA 
code 
I do always have this underlying feeling that 
something will go wrong, like the medication 
will stop working or something and I’ll have to 
be dealing with it more heavily again. And I’m 
afraid of that. 
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feeling out of 
control 
reactions & 
coping 
feeling helpless or 
powerless; loss of control 
over life, symptoms, self 
due to illness; separate 
from confusion 
none 
sense of feeling 
powerless or 
helpless over life 
circumstances, 
self, or future 
different from fear 
of illness--this 
code specifically 
addresses 
currently feeling a 
loss of control/ 
autonomy 
And because I didn’t know what was going on 
and because I didn’t have control over myself I 
didn’t want to hang out with anybody else 
focusing on self & 
self-sufficiency 
(EA) 
emerging 
adulthood 
focus has changed to self 
and increasing self-
sufficiency; changes in 
perspective on life, 
work, relationships, 
behavior patterns after 
age 18; refers to 
internal/intrinsic process 
moving into adulthood 
specify if 
emphasis is on 
increased 
knowledge & 
understanding 
of illness 
refers to change in 
mentality 
(maturity), not life 
changes 
do not use code if 
participant is 
referring to 
changes in life 
circumstances or 
optimism/ 
possibility 
(future) 
I felt that maybe it was time for me to focus, to 
really focus on what I wanted to achieve in life. 
Focus on my goals. 
functioning or 
excelling despite 
illness 
impact on 
identity 
succeeding and/or 
maintaining level of 
functioning (e.g., in 
school) following onset 
of symptoms 
none 
discussing success 
/ continuing 
functioning 
despite illness 
between ages 13-
17 
Do not use if 
participant is 
describing decline 
in functioning 
I managed to keep really good grades 
healthcare or 
treatment is 
beneficial 
healthcare 
discussion of experience 
of healthcare system or 
treatment interventions & 
outcomes as positive or 
beneficial (medication, 
therapy, psychiatry, 
hospitals) and/or 
healthcare providers 
specify if 
participant 
identifies 
psychotropic 
medication or 
provider 
description of 
healthcare 
treatment, 
providers, or 
services as 
resulting in 
positive outcomes 
Inverse of 
healthcare of 
treatment is not 
beneficial 
I just know that since I started taking the 
medication my life has improved immensely. 
And there has not been a point where I have 
gone off my medication and had issues. So I 
think that is—that has to be what is helping 
150 
healthcare or 
treatment is not 
beneficial 
healthcare 
discussion of experience 
of healthcare system or 
treatment interventions & 
outcomes as ineffective, 
detrimental, or negative; 
includes lack of 
supportive healthcare 
providers, negative 
experience with 
providers/facilities; 
medication side effects, 
etc. 
specify if 
participant 
identifies 
psychotropic 
medication or 
provider 
description of tx 
outcomes, 
providers, or 
services as 
ineffective or 
negative 
Inverse of 
healthcare or 
treatment is 
beneficial 
I had been seeing a psychologist earlier in the 
year who had not been very helpful and I had 
stopped seeing her. 
healthcare system 
difficult to navigate 
healthcare 
experience of difficulty 
trying to find, access, or 
continue healthcare 
services 
none 
cannot find or 
access tx services 
(e.g., finances, 
insurance, 
healthcare 
restrictions, etc.) 
partial inverse of 
accessibility or 
use of healthcare; 
And a huge issue at my school is that the whole 
counseling and psychological services section 
is not well-funded and does not have many 
employees, so the wait to get in there is very 
long. So I saw them for about three months 
before they told me that I would need to get 
providers elsewhere. So I got a referral 
identity 
development & 
exploration (EA) 
emerging 
adulthood 
description of identity 
development/growth and 
enhanced sense of self 
after age 18 
none 
focus is on 
identity/sense of 
self & growth 
if referring to 
increased maturity 
or focus on 
independence, use 
focusing on self 
&self-sufficiency 
(EA); if referring 
to life changes, 
use life changes 
(EA) 
Looking back I think I can see how significant 
those changes were, and how it really pushed 
me sort of to really develop a new sense of self 
and how that self has changed since college is 
also very interesting 
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identity 
development 
(merging old & new 
identities) 
impact on 
identity 
adjustment and 
adaptation or integration 
of illness with 
preexisting sense of self; 
creating a new normal 
none 
preserving sense 
of self while 
integrating 'new' 
identity w/ 
addition of illness 
if over 18, use EA 
code 
So previously I think my biggest challenge was 
really just accepting this and honestly figuring 
out how to make this fit with my life, and how 
to still enjoy life and explore it, as well as live 
with it responsibly and not have another 
breakdown. 
illness as a barrier or 
obstacle 
reactions & 
coping 
illness/symptoms 
presenting as challenge, 
barrier, or obstacle 
toward goals or 
relationships 
none 
(life) goals are 
described as 
unattainable or 
difficult to attain 
due to illness 
do not use if 
barrier is a factor 
other than illness 
I think it was just hard because it added an 
extra layer of already stressful—because I was 
diagnosed my senior year, which is such a 
horrifically stressful year because you are 
applying to college and figuring out pretty 
much where the next step of your life was—the 
fact that I had this mental illness on top of it 
was just incredibly hard. 
 
illness as a trauma 
reactions & 
coping 
experience of illness as 
traumatizing; lasting 
impact on identity; 
related to fear of 
recurrence 
none 
description of the 
experience of the 
illness (including 
symptoms and tx) 
as an actual 
trauma/ 
traumatizing 
does not include 
other traumatic 
experiences (use 
trauma code) 
like I was so traumatized the first time that I 
found out I was bipolar that I never wanted 
anything like that to ever happen again 
isolation or secrecy 
Interpersonal 
relationships 
deliberately limiting 
social contact with 
family and/or friends; 
also includes the sense of 
'hiding' part of their self 
or identity from others in 
terms of vulnerability 
and self-protection 
none 
report of literal 
isolation, 
seclusion, and/or 
avoidance of 
social interaction; 
includes 'hiding' 
identity and self 
due to 
vulnerability 
if referring to 
hiding illness 
(selective 
disclosure), use 
selective 
disclosure 
So I literally just isolated myself and didn’t 
want to talk to anybody 
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knowledge & 
understanding of 
illness 
reactions & 
coping 
knowledge & 
understanding of EOBD; 
description of 
attaining/increasing 
knowledge of symptoms, 
course of illness; 
understanding what's 
going on (specific to 
experience of the illness 
itself) 
can specify if 
participant, 
family, peer, 
provider 
expressing or 
describing 
understanding of 
symptoms, course 
of illness, or 
symptoms; can 
refer to 
participant, 
family, peers, 
healthcare 
providers etc. 
inverse: lack of 
knowledge or  
understanding 
(confusion) 
No, I definitely felt like I understood it the 
whole time. The doctors explained to me what 
it meant, and I definitely could relate to exactly 
what they were saying about the symptoms of 
it, and about what was going on with me. So I 
could say like, ‘yeah that’s exactly what’s 
going on with me, so these symptoms and this 
thing going on in my head, that must be bipolar 
disorder. That must be what I have,’ you know? 
labeling or stigma labeling 
description of labeling or 
stigma associated with 
bipolar disorder or 
mental illness; 
participant may specify 
source (culture, 
social/peers, family, 
healthcare system) 
specify source 
of stigma - 
family, peer, 
community, 
culture, 
healthcare 
participant 
identifies or 
describes 
experience of 
being labeled or 
stigmatized 
if referring to 
internalized 
stigma, use ‘self-
labeling’ 
Mental illness is something that’s so under-
talked about that when you do see it or when 
you do hear it, nobody knows. Of course what 
people think they know….do you know what 
I’m saying? Homeless people are everywhere. 
So you see mental illness or some type of 
disorder everywhere. You see [them] there on 
the street and nobody’s helping them. And 
nobody essentially cares. And even in other 
countries, if somebody is disabled or 
disordered or mental, ‘oh they’re demonic!’ or 
‘oh they’re possessed!’ Stigma is just 
everywhere 
lack of knowledge 
or understanding 
(confusion) 
reactions & 
coping 
absence / limited 
knowledge of illness; 
description of not 
understanding or having 
limited knowledge of 
symptoms, course of 
illness and related life 
changes; includes 
confusion related 
can specify if 
participant, 
family, peer, 
provider 
expressing 
confusion or 
describing lack of 
knowledge 
regarding illness 
and related 
symptoms or 
changes 
inverse: 
knowledge/ 
understanding of 
illness 
I think that at the time I knew very little about 
the disorder so most of what I was basing my 
experience off of was what I had heard of in the 
media and, um, I definitely didn’t have a very 
good understanding of, like, the realities of 
bipolar disorder at the time. 
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to/caused by the illness 
lack of support 
Interpersonal 
relationships 
absence of involvement 
of participant's support 
system 
none 
description of 
limited or no 
support 
(emotional, 
financial, 
guidance etc.); 
can refer to family 
or peers 
if referring to 
healthcare, use 
'lack of supportive 
healthcare 
providers' code 
…and so I really didn’t feel support sometimes. 
I really didn’t feel support from family, and 
still don’t really feel support from family. 
 
life changes 
mediating 
factors 
changes in life 
circumstances between 
age 13 - 17 
none 
description of 
major life 
changes, such as 
moving, school 
change, changes 
in family 
structure, 
birth/death, etc. 
does not include 
normative 
developmental 
changes 
I moved from New York to North Carolina and 
that was a huge shock. 
 
life changes (EA) 
emerging 
adulthood 
major life changes 
occurring after age 18; 
change in direction 
regarding interpersonal 
relationships, work and 
education goals 
none 
refers to literal 
(external)  
changes in 
circumstance, 
relationships, 
situation etc. after 
age 18 
for intrinsic 
changes related to 
maturity and 
focus/goals, use 
focusing on self 
(EA) code; if 
referring to 
identity 
development, 
growth, or sense 
But the path that I was on—all this partying 
and drinking—probably I would not be in the 
position that I am today had something not 
happened, had something not forced me to get 
my life together and forced me to focus on 
myself and my well-being, my mental health, 
physical health. Had something not happened I 
don’t know where I would be today 
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of self use 
identity 
development 
(EA) 
loss of autonomy 
due to healthcare 
system 
healthcare 
loss of independence or 
sense of identity during 
interactions with 
healthcare system (as a 
result of interaction with 
healthcare providers or 
tx) 
none 
participant 
expressing 
perceived loss of 
self or 
independence 
attributed to 
interactions with 
healthcare 
providers or tx 
system 
loss of self or 
independence due 
to other factors 
And so…from ages 14 to 16 I didn’t administer 
my own meds. My dad was the one who gave 
them to me every night, and he kept them 
locked up. And I don’t know if it was a lack of 
trust or what…and my dad would frequently 
come to my psychiatrist appointments and there 
were times, especially if I was really depressed, 
he would just talk to the psychiatrist instead of 
me. And that made me feel really not included 
in my own treatment plan. 
loss of self 
impact on 
identity 
perceived loss of self or 
loss of identity due to 
illness and/or stigma 
none 
description of loss 
of self as a result 
of illness; 'self' is 
replaced or 
changed due to 
symptoms and/or 
stigma 
differs from fear 
of illness (loss of 
self is current and 
code pertains to 
identity rather 
than illness); and 
loss of control 
(loss is the self vs 
autonomy or 
independence) 
But after a while depression started to set in 
and I didn’t feel like doing anything anymore. I 
felt like I lost who I was before, and things 
started to change around me. 
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manic and/or 
hypomanic 
symptoms 
experience 
of illness 
DSM manic and/or 
hypomanic symptoms 
none 
participant is 
describing manic 
or hypomanic 
symptoms 
all other 
symptoms 
I would say my manic episode probably started 
sometime right around when high school 
started, like the beginning of the year. And it 
only took me 6 to 8 weeks into high school to 
have full-blown manic feelings and to have my 
mom realize ‘okay, you need to go to the 
hospital.’ [laughs] But it was definitely a lot of 
classic symptoms of bipolar mania…it was like 
delusional thoughts, hard to relate to people in 
social situations, grandeur thoughts, 
grandiosity…towards the end was I was being 
hospitalized there were some hallucinations 
going on…just kind of out of touch, having that 
out of touch feeling…feeling like you’re on top 
of the world, you can get anything done…just 
having really elated thoughts, elated emotions 
that were blown out of proportion. And just 
like overly emotional in situations, like no 
control over. 
mistrust 
Interpersonal 
relationships 
inverse; lack of trust in 
family or peer 
relationships 
none 
description of 
mistrust in family 
or peers 
distinct from 'lack 
of support' and 
'conflict in 
relationships' 
refers to 
participant's 
explicit lack of 
trust 
I mean, I jumped from therapist to therapist 
after that one therapist, because I didn’t—I 
always thought they had different agendas so I 
didn’t really trust a lot of them.  
 
optimism/ sense of 
opportunity & 
possibility 
reactions & 
coping 
change in outlook that 
includes increased focus 
on opportunity and 
none 
expressing 
possibility of 
good and 
if code applies to 
experience over 
age 17, use EA 
So I feel like there is hope for my adulthood. 
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possibility; optimistic positivity version of code 
optimism/ sense of 
opportunity & 
possibility (EA) 
emerging 
adulthood 
participant explicitly 
states hope/positive 
outlook for the future; 
discussion of increased 
sense of possibility, 
improvement of self & 
circumstance, and 
opportunity, 
independence, and 
increased autonomy -- 
after age 18 
none 
specific to 
increased sense of 
possibility in life 
and increased 
ability to enact 
change (after 18) 
if referring to 
increased maturity 
or focus on 
independence, use 
focusing on self 
&self-sufficiency 
(EA); if referring 
to life changes, 
use life changes 
(EA); if referring 
to identity 
development, use 
identity 
development 
(EA) 
I think it changed me for the better. Even 
though that’s like…it’s like a blessing in 
disguise. 
others involved in 
treatment 
Interpersonal 
relationships 
participation or 
involvement of family or 
peers in tx of any kind 
none 
family member 
attends or 
participants in tx; 
facilitates 
appointments or 
medication 
Does not refer to 
healthcare 
providers 
” and then I had talked to a psychiatrist in 
there, and then they brought my family in. and 
so we had this group therapy counseling 
session ‘your daughter has bipolar 
disorder…can you recall”—and that I didn’t 
like—“can you recall when you think the 
symptoms started?” and that I didn’t like. I 
didn’t think I should’ve been in the room, but I 
was in the room. So it would be like my parents 
and siblings talking about when they thought I 
had episodes 
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psychoeducation healthcare 
provision of 
psychoeducation by 
healthcare provider to 
individual or family; 
discussion of illness & 
course of illness 
none 
referring to 
education on 
illness, symptoms, 
course of illness; 
can refer to 
psychoeducation 
of individual, 
family, peers etc. 
do not use with 
other tx 
modalities (e.g., 
supportive 
psychotherapy) 
Yes, they said it was a mood disorder mostly. 
Nothing to do with physical or real bad mental 
issues, but they said I would need to take 
medicine for it, come back for treatment, and 
basically get it in check to see if everything 
was okay. 
 
psychotropic 
medication 
healthcare 
discussion of experience 
of medication (includes 
discussion of treatment 
and side effects) 
none 
participant 
discusses 
experience/ 
reaction to taking 
medication, 
impact of 
medication, side 
effects of 
medication (can 
be positive, 
neutral, or 
negative) 
for other tx 
interventions, use 
healthcare or 
treatment is/is not 
beneficial 
And so the one I switched to, I’ve been on it 
this whole time. I’ve had the same prescription, 
everything since I got diagnosed. And they said 
they can reduce it, and I was like ‘no, let’s not 
reduce it because I don’t want to have another 
episode.’ The medicine I’m on now is just 
like…it works, obviously. 
relationships 
affecting identity 
Interpersonal 
relationships 
family/peer relationships 
impacting sense of 
identity 
specify family 
or peer (or 
other) 
relationships 
description of 
change in 
identity/sense of 
self due to family 
or peer 
relationships 
report of no 
change in identity 
due to 
relationships 
And that was something that was so painful and 
hurtful that it made me feel different from my 
family, from my siblings. And it made me feel 
like I had something that was wrong with me. 
So that was rough. So that was one of the 
relationships that had changed that impacted 
how I identified my disorder and how I coped 
with it. Which is probably why I’m so private 
now, because even my own sibling had said 
that and I was like, wow okay, that was harsh.  
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relationships not 
changing 
Interpersonal 
relationships 
no changes occurring in 
interpersonal 
relationships 
none 
participant reports 
no changes 
(positive, neutral, 
or negative) 
occurring in 
relationships 
inverse: 'change in 
peer relationships' 
and/or 'change in 
family 
relationships' 
I think it has been a problem that was ongoing 
for such a long time before I got the diagnosis 
that there wasn’t really a significant change. 
 
religion/ spirituality 
mediating 
factors 
discussion of the role of 
faith, religion, or 
spirituality in 
participant's experience -
- can be positive, neutral, 
or negative; can also 
refer to religion as a 
support or a challenge 
none 
participant 
discussing the 
impact or role of 
religion in 
experience of 
EOBD 
If not referring to 
impact on illness 
(i.e., general 
discussion) 
My dad practices mindfulness and considers 
himself Buddhist, so we were very not wanting 
to medication for a long time. 
seeking help/support 
reactions & 
coping 
voluntarily seeking 
support or treatment 
(from others or 
healthcare system); 
includes seeking 
healthcare providers, tx 
services, medication 
none 
Emphasis is on 
act of voluntarily 
seeking out 
support 
(clinical/tx or 
emotional) from 
healthcare or 
support system 
if describing use 
of healthcare 
services, use 
accessibility or 
use of 
healthcare/tx 
I voluntarily asked my parents to go to therapy 
when I was 17 because I knew something was 
wrong. 
selective disclosure 
of illness 
Interpersonal 
relationships 
selective disclosure of 
illness by participant, 
family or peers OR to 
family or peers 
none 
participant, family 
members, peers 
are selectively 
disclosing or not 
disclosing illness 
(can have 
positive, neutral, 
or negative tone) 
for open 
disclosure use 
'disclosure of 
illness' 
And even the person I’m dating now, they 
don’t know that I’m bipolar. 
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self-labeling / 
endorsing stigma 
labeling 
participant has applied 
stigmatizing beliefs or 
labels to themselves; 
internalized/endorsed/ 
self-directed labeling & 
judgment 
none 
participant 
identifies self-
labeling or 
describes self-
labeling or self-
stigma (is 
endorsing stigma 
or labeling) 
do not use if 
participant is 
referring to stigma 
stemming from 
outside source 
Certainly identifying myself as crazy was not 
helpful [laughs] in trying to recover. And also 
trying to think that—well, buying into stigma 
puts you in a deeper hole in trying to recover 
and trying to see that you can be something 
other than an image, to something other than an 
unstable kind of person 
suicidality 
experience 
of illness 
referring to the concept 
of suicide; can be 
abstract thought, 
ideation, or plan; can 
refer to participant, 
family, peer, healthcare 
provider etc. 
none 
discussion of 
suicide or 
possibility/though
t of suicide 
distinct from self-
injury and 
depressive 
symptoms 
And I always kind of knew I was kind of 
defeated and I wanted to defeat myself, I 
wanted to hurt myself, I wanted to end my life. 
I did several suicide attempts to try to do that. 
And all the suicide attempts that I have done 
have failed.  
 
support 
Interpersonal 
relationships 
support from others 
(emotional, financial, 
guidance); family and/or 
peer relationships as 
source of strength and 
help 
specify source 
of support - 
family, peer, 
community, 
school, etc. 
description of 
emotional, 
financial support 
or guidance from 
family, peers, 
community 
does not include 
family 
participation in tx 
but can include 
assistance 
obtaining tx 
And people I became friends with when I was 
17—so the same year I was diagnosed—are 
still some of my closest friends. They’ve kind 
of watched the whole process go through, and 
are really really supportive and were supportive 
then too 
 
trauma 
mediating 
factors 
trauma or abuse 
experienced by the 
participant 
none 
participant 
description of 
trauma or abuse 
(i.e., domestic or 
family abuse, 
rape, physical 
abuse) 
if participant 
describes 
additional 
symptoms caused 
by trauma (i.e., 
anxiety or ptsd), 
use comorbid 
symptoms to code 
the trauma-
induced non-
Once again, with my specific situation it’s very 
hard to explain because there were days where 
I was literally not allowed to do anything by 
someone I used to live with. To the point that 
they would knock my door down if I wanted to 
escape and go to my room… 
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bipolar symptoms 
use of coping skills 
reactions & 
coping 
Participants’ use of 
coping skills or symptom 
management-based skills 
none 
discussing efforts 
to alleviate 
symptoms, 
interpersonal 
stressors, or cope 
with difficulty 
(situation-based 
or emotion-based) 
Does not include 
medication 
management 
(as far as supports) I was a writer too. 
view of self as 
different or 
defective 
impact on 
identity 
description of feeling 
'other' (liminality); 
different from peers 
and/or family; can also 
include feeling abnormal, 
damaged, defective, 
weak, or flawed 
none 
description of self 
as not being 
normal; weak, 
flawed or 
damaged; can 
include feeling ' 
undeserving, or 
defective in some 
way due to 
illness; refers to 
identity and sense 
of self 
Do not use if 
participant is 
describing stigma 
I knew there was something wrong, and 
because of that I thought I was like flawed and 
I didn’t want to hang out with anybody. / I 
didn't think I was a good person. 
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Appendix F 
Member Checking: Summary of Themes 
Managing and Coping with EOBD 
Experience of illness: Participants described their experience of EOBD itself, including 
symptoms and course of illness. Three participants described the polarity of their first episode as 
manic, while five participants described their first episode as depressive in nature. Participants 
described manic and hypomanic symptoms in terms of increased energy and productivity, 
impulsivity, decrease in rational decision-making, increase in risky behavior, increased social 
activity, increased energy and hyperactivity, racing thoughts, decreased sleep, euphoria and 
elation, agitation and aggression, delusional thoughts, grandiosity, and hallucinations. 
Participants characterized depression as low mood, sadness, social isolation, decreased focus and 
clarity of thought, decreased motivation, decreased ability to do things, crying, and spending a 
great deal of time in bed.  
Seven of the eight participants described experiencing symptoms of diagnoses of other mental 
health conditions, including anxiety, self-injury, eating disorders, and substance abuse. Only one 
participant described experiencing exclusively manic and depressive symptoms throughout 
adolescence. Two participants reported experiencing suicidal ideation with suicide attempt. 
Treatment and engagement with the healthcare system:  Participants described their interactions 
with the healthcare system, providers, and treatment as a core components of their experience of 
EOBD. Participants reported receiving inpatient and outpatient care, including psychiatric 
hospitalization, psychiatrists, and therapists. Some participants reported avoidance of aspects of 
healthcare, including delay seeking treatment, medication noncompliance, and stopping 
treatment.  
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Psychotropic medication emerged as one of the largest components of participants’ experience of 
EOBD. All participants reported taking medication. Most participants reported improvement in 
symptoms, while some reported medications appeared to make symptoms worse. Participants 
identified medication side effects as a significant challenge and the most commonly described 
reason for discontinuing medication. Most participants reported continuing medication 
throughout adolescence. 
 
Perceptions of healthcare and treatment: Participants identified several components of healthcare 
and treatment as beneficial, including therapists with whom they felt rapport, psychiatry, and 
effective medication. Participants identified components of healthcare that were not beneficial, 
including psychiatric hospitalization, staff who were undereducated or did not understand, 
medication that was ineffective and/or had significant side effects, and judgment or labeling from 
healthcare providers. Some participants reported difficulty accessing healthcare due to 
considerations such as insurance, finding available providers (i.e., were wait-listed); getting 
medication on time; and coordinating between providers (i.e., between pharmacy and 
psychiatrist). 
Use of Coping Skills: In addition to healthcare and treatment interventions, participants 
described their own efforts to alleviate and manage symptoms through use of coping skills such 
as writing/journaling, listening to music, playing sports, talking to others and utilizing support 
playing video games, and reading inspirational success stories of other people. 
Knowledge and understanding of illness: Participants described knowledge (and lack of 
knowledge) of illness as an important component of illness management. Participants described 
not understanding the experience of prodromal symptoms, or onset of symptoms; participants’ 
described attaining an increase in knowledge of EOBD throughout adolescence. Several 
participants described a sense of knowing that ‘something was wrong’ prior to receiving 
diagnosis. Participants described a general lack of understanding by family and peers. 
Participants reported receiving psychoeducation from providers as well as self-educating through 
their own research. 
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Lack of knowledge and understanding was the most common sub-theme across all participants 
and all domains of the study. Knowledge and understanding was described as the determining 
factor in whether healthcare was beneficial; participants described providers with 
knowledge/understanding of EOBD as helpful and beneficial, while providers perceived as 
lacking of knowledge of EOBD were considered non-beneficial.  
Effect on Relationships 
Difficulty maintaining social functioning: Participants described difficulties in maintaining 
relationships, social functioning, and experiencing conflict in family and peer relationships due 
to EOBD symptomatology and isolative behavior. Participants described isolation as a 
component of decline in social functioning through avoidance of social situations, pushing others 
away, and selectively leaving their ‘safe space’ (i.e., house or bedroom). 
Seeking and receiving support: All participants described experiencing support in some form 
from family and/or peer relationships during adolescence. Support was described as others’ 
wanting the best interest of the participant, and was described as not contingent on possessing 
knowledge/understanding of EOBD. Some participants described feeling lack of support from 
family and peers, both prior to and following diagnosis; as well as from healthcare providers. 
Participants described voluntarily seeking treatment or reaching out to support system for help 
upon noticing prodromal symptoms. Involvement of others included referrals for treatment, 
participation in treatment sessions, coordination with providers, and administration of 
psychotropic medication. 
Impact on Identity 
Secrecy and selective disclosure of illness: Participants described experiencing a change in sense 
of self that included viewing EOBD as something to be kept secret and selectively disclosed to 
others. Participants described being ‘undercover’ to maintain their privacy; as well as hiding 
their illness and their identity in effort to minimize vulnerability to judgment, rejection, and harm 
from others.  
Adaptation and integration: Participants described normative adolescent identity development as 
a challenge due to EOBD. Participants described experiencing confusion and struggling to 
maintain sense of self and self-image, and integration of ‘new’ self-image following diagnosis. 
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Participants described efforts to maintain portions of their sense of identity following diagnosis 
and experience of symptoms, most notably maintaining prior levels of academic performance 
and motivation for prior goals. 
Emotional adjustment: Participants described a range of emotional responses to receiving EOBD 
diagnosis, including self-blame, frustration, shame, and feeling nervous and a sense of not 
knowing what to expect. One participant described the diagnosis as “heartbreaking” while 
another said it felt like their life would never be the same again. Participants described a fear of 
EOBD itself; specifically the fear that symptoms would return and would not remit. Participants 
described experiencing a perceived loss of self concurrent to symptomatic states and recovery 
from symptomatic episodes. Participants similarly described feeling out of control over EOBD; 
specifically inability to control symptoms and worrying the illness was controlling them.  
Experience of Stigma and Labeling 
Labeling or stigma: All participants described experiencing diagnostic labeling and stigma from 
healthcare providers, as well as stigma from family, peers, community, and culture/society. 
Self-labeling: Participants described applying stigmatizing beliefs to self-label, and described 
increased distress, isolation, selective self-disclosure, and in some cases worsening of symptoms. 
Self-labeling and labeling were described in conjunction with secrecy and selective disclosure of 
illness, as well as perceived judgment and criticism from others. 
Challenging or rejecting labeling: Participants described challenging and refusing to accept or 
endorse stigmatizing beliefs and self-labeling; participants associated labeling (and rejecting 
labeling) with resilience and significantly impacting their identity. 
Change and Uncertainty 
Change in illness: Participants’ overall experience of EOBD was characterized by change, 
uncertainty, and instability. Duration of episodes varied from days to weeks or months, as did the 
severity and frequency of symptoms experienced. The severity of manic and depressive episodes 
was described as ranging from disruptive to debilitating. While some participants described an 
experience dominated by depressive episodes, others described that manic episodes were more 
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disruptive to their lives in adolescence. The presence of comorbid symptoms and suicidal 
ideation were described as additional challenges to managing bipolar symptomatology. 
Changes occurring in relationships: Participants described EOBD as disruptive of relationships. 
Changes in family and peer relationships included family members moving away or becoming 
estranged, changing friend groups and social patterns. Participants also described varying 
changes in dynamic with their parents following diagnosis, including increased support, 
increased stigma, and increased conflict.  
Change in identity and sense of self: Participants described experiencing changes in thought, 
perspective, and behavior associated with EOBD diagnosis and illness. Changes included 
engaging in unhealthy behaviors (partying, substance use), choosing not to pursue goals, and 
change in coping patterns. Participants described a change in identity and view of self as 
defective, damaged, or different from others; sense of liminality and ‘otherness.’ Participants 
described feeling flawed, abnormal, worthless, and weak. Participants stated they felt there was 
something ‘wrong’ with them, that they were an outcast and different from their peers, and that 
they felt others may not know how to handle them if symptomatic. 
Life changes: Participants reported experiencing significant life changes, often prior to onset of 
symptoms. Changes included moving, changes in school/beginning new school, and changes in 
family relationships. One participant described becoming a mother at age 15 as a significant life 
change. 
 
 
